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Abstract 
The opportunistic fungus, Aspergillus fumigatus, is a leading cause of morbidity 
and mortality among the immunocompromised population. Experimental and clinical 
findings have established that phagocytic defenses are critical in the recognition and 
clearance of A. fumigatus.  Previous studies found that Toll-like receptors (TLRs), 
specifically TLR2 and TLR4, were essential in the detection of the mold.  Furthermore, 
one study found that mice deficient in TLR9 lived longer than their wild-type 
counterparts following challenge with A. fumigatus.  We sought to determine the role of 
TLR9 during A. fumigatus infection.  Our results show that A. fumigatus contains 
unmethylated CpG DNA, the natural ligand of TLR9.  Furthermore, A. fumigatus DNA 
stimulates a potent pro-inflammatory response in mouse bone marrow derived dendritic 
cells (BMDCs) and human plasmacytoid dendritic cells (pDCs).  A genome wide analysis 
showed that A. fumigatus DNA contains 87 human and 23 mouse putative 
immunostimulatory motifs.  The response to A. fumigatus DNA is TLR9-dependent, as 
BMDCs from TLR9-/- mice were unresponsive to the fungal DNA.  In addition, HEK293 
cells cotransfected with human TLR9 and NFκB driven Luciferase conferred 
responsiveness to A. fumigatus CpG-rich sequences found in the fungal DNA.  Our 
results show that TLR9 detects A. fumigatus DNA, resulting in the secretion of 
proinflammatory cytokines.  
While pDCs secrete IFNα in response to A. fumigatus DNA, these cells have been 
mainly described to play critical roles in the antiviral responses.  The role of pDCs during 
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fungal infections remains to be elucidated.   Our data show that CD304+ peripheral blood 
pDCs challenged with A. fumigatus hyphae secrete large concentrations of IFNα and 
TNFα in response to infection. Furthermore, the response appears to be TLR9-
independent.  However, pDCs spread over the hyphae and inhibit fungal growth.  
Furthermore, pDCs undergo cell lysis upon incubation with A. fumigatus.  The antifungal 
activity of the pDCs was retained in the cell lysates, suggesting that this response was 
mediated by an intracellular factor.  Addition of exogenous Zn2+, but not Fe3+, partially 
restores hyphal growth.  In addition, western blot of pDC lysates show that these cells 
have the Zn2+-binding protein calprotectin.   
Over 60% cell death is observed in the pDC population following a 2 hour 
incubation with A. fumigatus.  The observed pDC cell death can be partially attributed to 
gliotoxin, as pDCs challenged with A. fumigatus stains deficient in production of the 
mycotoxin result in decreased pDC cytotoxicity.  Furthermore, pDC cell death occurs 
independent of contact with the mold, confirming that pDC cell death is mediated by a 
secreted fungal factor.  In addition, our results show that pDCs are required for the host 
response against A. fumigatus.  Mice depleted of their pDCs are more susceptible to A. 
fumigatus infection than the control counterparts, suggesting that pDCs play a role in the 
antifungal response. Also, we observe a 5-fold increase in the pDC population in the 
lungs of infected mice.  Therefore, the possibility of these cells playing a role in 
recruiting and communicating with other immune cells cannot be eliminated. 
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Upon maturation, pDCs acquire characteristics of conventional DCs (cDCs) such 
as upregulation of major histocompatability complex (MHC) and becoming more 
phagocytic.  Whether mature pDCs are involved in the detection of and responses against 
fungal pathogens remains to be determined.  Here we show that mature pDC secrete 
IFNα and TNFα in response to A. fumigatus conidia as early as 6 hours post-challenge.  
While cytokine secretion of mature pDCs against A. fumigatus does not require 
opsonization, it requires for A. fumigatus being alive and growing.  Furthermore, 
supernatants from conidial growth induced cytokine secretion by the mature pDCs.    
The work presented in this thesis establishes that the nucleic acids in A. fumigatus 
serve as a pathogen associated molecular pattern (PAMP) that can induce a TLR9-
dependent response.  Furthermore, I show that pDCs secrete cytokines and induce an 
antifungal response against A. fumigatus conidia and hyphae.  While the pDC population 
in the blood appears to be small, our work shows that these cells could be intimately 
involved in the antifungal responses against A. fumigatus. 
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Aspergillus 
 
 Overview of fungal pathogens 
  
The kingdom Mycota includes between 100,000 to 1,000,000 species that 
habituate in a variety of environments (Levitz 2004) .  These eukaryotic disease causing 
organisms in humans are saprophytic organisms that can adapt to changes between 
environmental temperature and body temperatures (Garcia-Solache and Casadevall 2010; 
Murphy 1991).  Due to increased numbers of immunocompromised hosts, the clinical 
relevance of fungal infections has increased significantly over the last three decades 
(Romani 2004).   Mycotic disease rarely occurs in “normal” hosts; however, these 
opportunistic pathogens infect hosts that have a variety of immunodeficiencies.  
Furthermore, pathogenic fungi can cause a range of infections; from allergy to systemic 
infections.   Among the most studied fungal pathogens are Cryptococcus neoformans, 
Candida albicans, Histoplasma capsulatum and Aspergillus fumigatus (Guarro et al. 
1999). 
Fungi are usually non-invasive organisms.  Fungal pathogens cause infection by 
taking advantage of weaknesses in the host immune system, evading the immune 
response or overwhelming the host response mechanisms (Murphy 1991; Romani 2004).  
For example, C. albicans is part of the natural flora of the genital tract.  Under normal 
conditions this poses no threats; however, the pathogenicity of C. albicans is greatly 
dependent on host immune status and disease presentation (Achkar and Fries 2010).   C. 
albicans infections of the mucosal surfaces are more prevalent among 
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immunocompromised hosts, but vulvovaginal candidiasis is a common disease among 
immunocompetent woman (Achkar and Fries 2010).  Other fungal pathogens, like C. 
neoformans, H. capsulatum and A. fumigatus, are found in the environment and infection 
normally occurs via inhalation of the organism (Karkowska-Kuleta et al. 2009).   
The frequency of invasive fungal infections has greatly increased as a result of 
progress in transplantology, increased HIV infections and increased cancer treatment 
(Person et al. 2010).  Although anti-fungal medicine is available; some fungal pathogens 
have evolved to become resistant to drug treatment.  Furthermore, scientists are just 
starting to understand the mechanisms of pathogenesis of these infectious agents (Levitz 
2004; Mansour et al. 2004; Romani 2004).  The work presented in this thesis concentrates 
on the immune responses against A. fumigatus.        
The Genus Aspergillus 
 The genus Aspergillus belongs to the ascomycete group and contains 
approximately 200 species, but only a few are considered human pathogens (Dagenais 
and Keller 2009; Hohl and Feldmesser 2007a).  These saprophytic molds are ubiquitous 
to the environment and play essential roles in nitrogen and carbon recycling (Latge 
1999).  Organisms in this genus were first characterized in 1729 by Pier Antonio Micheli, 
a priest biologist, who noticed the resemblance between the spore bearing structure of the 
fungi and the aspergillum (holy water sprinkler) (Bennett 2010).   Three centuries later, 
we now use the word aspergillum to describe the asexual spores used by members of the 
Aspergillus genus.  However, it is important to note that at least one third of the 
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Aspergillus species can also reproduce sexually (Dyer and Paoletti 2005; Kwon-Chung 
and Sugui 2009a).  
 Members of the Aspergillus genus are widely distributed in nature, growing in 
almost all environments.  Aspergillus spores are common components of aerosols, and 
because of their small size, they can easily disperse (Bennett 2010; Latge 1999).    
Similar to other genuses in the fungal kingdom, Aspergilli are characterized by their 
particular eating mechanism known as digestion then ingestion.  These organisms 
degrade matter by enzyme secretion into the environment, where they obtain the 
necessary nutrients, and then they ingest the polymers (Bennett 2010; Latge 1999).   
 Aspergilli are of great importance for humans.  Some species play roles in 
industrial processes including enzymes, commodity chemicals and food preparation 
(Dagenais and Keller 2009).  Aspergillus spp are used in research to understand the 
parasexual cell cycle, metabolic pathways and hyphal polarity.  Other fungi from this 
genus are plant pathogens; affecting crops with toxic metabolites that can cause disease 
in animals, including humans.  Finally, a few species are known to cause invasive disease 
in humans (Bennett 2010; Dagenais and Keller 2009).  The most studied of these species 
is A. fumigatus. 
 Aspergillus fumigatus 
Aspergillus fumigatus belongs to the genus Aspergillus, subgenus Fumigati 
division fumigati.  A. fumigatus was first described in 1863 by Johann Baptist Gerog 
Wolfgang Fresenius (Latge 1999).  Like other members of the Aspergillus spp, A. 
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fumigatus plays a role in the aerobic decomposition of organic materials and recycling 
environmental carbon and nitrogen (Dagenais and Keller 2009; Latge 1999).  Although 
the natural environment of A. fumigatus is the soil, this mold can be found in almost 
every environment in the world.   
A. fumigatus and other Aspergillus species, produces small hydrophobic spores 
known as conidia during the asexual reproduction cycle.  The small size of the conidia 
and the properties of the cell wall allow it to be easily distributed in the water or air.  
Once in the air, the small conidia (2-3 µm) can travel great distances and colonize new 
niches.  The primary ecological niche for this fungus is decaying vegetation (Latge 
1999).  Upon colonization, A. fumigatus releases enzymes that breakdown and degrade 
the organic material that is subsequently taken up by the fungus (Tekaia and Latge 2005).   
A. fumigatus conidia not only colonize organic matter, the aerosolized conidia are 
readily inhaled by humans and upon the right conditions disease is established.  A. 
fumigatus is the most common species of Aspergillus spp. to cause human disease in 
immunocompromised hosts (Levitz 2004; Montagnoli et al. 2006; Netea et al. 2006).   
The most common route of infection is inhalation of the conidia, where it can reach deep 
pockets in the alveoli.   If the host conditions are appropriate, life-threatening invasive 
and disseminated disease may develop (Askew 2008).    
A. fumigatus Growth and Culture 
 
 6 
 
The small and dormant conidia (2-3 µm) are round, uniform size with nuclei that 
are arrested in interphase.  In the presence of nutrient sources, morphological changes can 
be observed as early as 1 hour post addition of nutrient rich media or nutrients found in 
the environment.  In the earliest stages of germination, nuclear decondensation and 
adhesion to the substrate are observed (Bennett 2009).   The next step in conidial 
germination is rehydration and cell wall growth, a process known as conidial swelling.   
Conidial swelling takes places within 4 hours at 37°C from the time dormancy is broken.  
The swollen conidia polarize and the first germ tube is observed within 6 hours at 37°C.  
Nuclear decondensation prepares A. fumigatus conidia for DNA replication, a process 
that is usually observed within a couple of hours, followed by mitosis.  Germ tubes 
continue polar growth to become hyphae.   Hyphae continue polar growth (Latge 1999; 
Latge 2007).  Within 2-4 hours from germ tube germination, septa form and the first 
branches emerge from the apical side of the septa.  Hyphae continue to grow, extend and 
branch; giving rise to visible colonies within 24 hours of awakening.  Conidiophores, the 
asexual reproductive structures, can be observed by 36 hours (Fontaine et al. 2010) 
allowing the cycle to begin again (Figure 1.1). 
The life cycle and growth of the filamentous fungus A. fumigatus can be 
considered an essential pathogenicity factor.  A. fumigatus exhibits multiple morphology 
changes during its life cycle (Pihet et al. 2009; Tronchin et al. 2008).  The asexual 
conidia are the primary means of environmental dispersal, due to the small size and the 
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Figure 1.1.  Biological cycle of A. fumigatus 
The natural niche of A. fumigatus is decaying matter and organic material.  Colonies of 
the mold produced from conidiophores generate thousands of green-grey spores, also 
known as resting conidia. These small conidia (2-3µm) become readily aerosolized.  
Upon encountering a nutrient-rich environment, the resting conidia shed the hydrophobic 
outer layer and begin to grow.  During conidial swelling, A. fumigatus rehydrates and 
changes in the cell wall expose carbohydrate moieties that were protected by the outer 
layer.  Swollen conidia polarizes, giving rise to germ tubes.  Additional changes in the 
cell wall are responsible for the plasticity of the germ tubes.  These germ tubes become 
septated and continue their polar growth to become hyphae, the invasive form of the 
mold.   
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 resistance to severe environmental conditions.  Upon encountering the appropriate 
environmental conditions, which may be after years of latency as a conidium, A. 
fumigatus activates a series of physiological and biochemical pathways that allows 
conidial germination.  A. fumigatus is unable to germinate in anaerobic condition or in the 
presence of respiratory chain inhibitors; proper growth conditions require the presence of 
water, carbon, sources of phosphate and nitrate, and oxygen (Krappmann and Braus 
2005; Rhodes 2006). 
The fungal cell wall 
During A. fumigatus germination, growth and polarization, the fungal cell wall 
undergoes dramatic changes (Latge 1999).  The A. fumigatus cell wall is primarily 
composed of a polysaccharide matrix with some proteins required for cell wall synthesis 
and nutrient uptake anchored to the “cytoskeleton”.  In the A. fumigatus resting conidia, 
there are two layers comprising the cell wall.  The most outer layer is hydrophobic and 
mainly comprised of melanin, small cystein-rich proteins that form a hydrophobic layer 
known as hydrophobins and rodlet proteins (Fontaine et al. 2010; Pihet et al. 2009).  The 
second electron translucent layer is comprised of polysaccharides (Fontaine et al. 2010). 
During conidial germination and swelling, the cell wall undergoes dramatic changes.  
The first change observed during conidial swelling is the loss of the most outer layer, 
resulting in the exposure of different sugars to the environment.  Although there are six 
main glycans that comprise the cell wall of A. fumigatus:  β-1,3 glucan, chitin, 
galactomannan, α-1,3 glucan, β-1,3/1,4 glucan and a polymer of galatosaminogalactan; 
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conidial swelling is characterized by the emergence of β-1,3 glucans to the cell surface 
(Latge 2007; Latge et al. 2005).      
In addition to the polysaccharide structure, the cell wall is coated with proteins.  The 
major group of cell wall proteins is the glycophosphatidylinositol(GPI)-linked proteins, 
which is connected to the polysaccharide membrane (Levdansky et al. 2010).  Other 
proteins required for cell wall biosynthesis and nutrient uptake have also been found in 
association with the A. fumigatus cell wall. 
The morphological changes of A. fumigatus and the plasticity of the cell wall can be 
considered important virulence factors of the filamentous mold.  During fungal growth 
and morphological changes, some of the cell wall components like galactomannan are 
released into the environment where they can elicit an immune response (Latge 1999; 
Latge 2001; Latge 2007; Latge 2010).  Furthermore, the fungal cell wall contains many 
transient proteins and enzymes which have been found to be antigenic (Gastebois et al. 
2009).   
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Aspergillosis 
A. fumigatus is the primary causative species of human aspergillosis (Dagenais and 
Keller 2009).  Infection occurs via the respiratory tract, upon encountering the proper 
host A. fumigatus germinates resulting in disease. The clinical manifestations of this 
multifaceted disease are determined by the host immune response.  Aspergillosis can 
present itself as allergic, saprophytic (germination of the mold on the mucous crust of 
sinonasal cavities) or invasive forms (Latge 1999; Levitz 2004).    
The allergic presentations of aspergillosis occur following repeated exposure to the 
conidia and antigens of Aspergillus; however, there is no colonization of the lungs.  Some 
forms of allergic disease include asthma, allergic sinusitis and alveolitis.  Most severe 
forms of the disease involve mycelial growth of A. fumigatus in the lungs, and therapeutic 
intervention is usually required.  Allergic bronchopulmonary aspergillosis (ABPA) is one 
of the most severe complications caused by Aspergillus spp and is mainly found in 
patients suffering from asthma and cystic fibrosis (Dagenais and Keller 2009; Latge 
1999; Levitz 2004; Pettigrew et al. 2010).   Aspergilloma or fungus ball is usually found 
in preexisting pulmonary cavities caused by other lung disorders and in chronically 
obstructed paranasal sinuses.  Aspergillomas consist of a spheroid mass of hyphae with 
sporulating structures at the periphery; the most common symptom of aspergillomas is 
hemoptosis. 
Invasive aspergillosis (IA) is the most severe form of disease, and has emerged as an 
infectious disease with high morbidity and mortality among immunocompromised 
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patients.  The higher risk groups involve acute leukemia patients, bone marrow and solid 
organ transplant patients, cancer patients and HIV-infected hosts.   IA is also found as a 
common infectious complication of chronic granulomatous disease; however, this disease 
is rarely found in immunocompetent hosts.  In neutropenic patients,  IA is characterized 
by thrombosis and hemorrhage from rapid and extensive hyphal growth (Dagenais and 
Keller 2009).   However, the observed outcome of infection with A. fumigatus as 
determined by the host immune status and response to the fungal infection.  
The pathogen A. fumigatus 
A. fumigatus infectious cycle 
 
The saprophyte A. fumigatus can be readily found in the environment, as its 
natural niche is dead or decaying matter.  During the asexual reproduction cycle, 
conidiophores produce and releases conidia, the infectious propagules of the mold.  The 
secretion and propagation of the small spores is the first step in the infectious cycle.  The 
small size of the conidia allows them to be easily dispersed into the air, where they can be 
found in both indoor and outdoor environments.  Human infection begins with inhalation 
of the airborne conidia.  The microscopic size of the conidia allows the deposition of 
these spores in the bronchioles or alveoli.  In healthy individuals, this is the end of the 
infectious cycle.  Epithelial cells and alveolar macrophages, the primary resident 
phagocytes of the lungs, recognize and clear the infection without sign of disease.   
In immunocompromissed host, conidia are able to bypass mucociliary clearance 
and establish infection in the alveoli.  A. fumigatus conidia that escape the host’s first line 
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of defense undergo conidial swelling.  The isotropic growth of the conidia marks the 
emergence of A. fumigatus from dormancy.  Establishment of infection requires a warm 
and nutrient rich environment, conditions shared between the usual environmental niche 
of A. fumigatus in compost and the pulmonary alveoli.  Upon germination in the alveoli 
polar growth results in generation of hyphae, the invasive form of A. fumigatus.  
Therefore, the morphological switch from unicellular conidia to multicellular hyphae 
allows A. fumigatus to invade host tissue.   
 Cells of the immune system are key regulators of A. fumigatus infection.  
Phagocytes are the first immune cell type to encounter the pathogenic mold and clear the 
infection, in most cases without adverse effects.  Conidia are phagocytosed by alveolar 
macrophages, while hyphae are killed extracellularly by neutrophils.  In addition to cell 
mediated clearance of A. fumigatus, several host factors have been described to be 
involved in the development of disease. 
A. fumigatus Virulence Factors 
 
 The virulence of A. fumigatus is mediated by several factors such as proteins 
involved in fungal growth and conidial germination, as well as secreted factors from the 
cell wall (Latge 2001).  In addition to secreted factors, the virulence A. fumigatus is 
dependent on escaping recognition of the conidia by the host immune system, allowing 
deposition in the lung alveoli and the establishment of infection. 
Environmental conidia are covered with a hydrophobin layer formed by the RodA 
protein that limits their recognition by the immune system; hiding the β-1,3-glucans from 
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recognition by alveolar macrophages (Aimanianda et al. 2009; Brakhage et al. 2010a).    
Furthermore, the green pigment that confers conidia its unique color, DHN-melanin, an 
important component of the cell wall, was also identified as virulence factor for A. 
fumigatus (Pihet et al. 2009).  The DHN-melanin layer is lost upon conidial swelling, 
allowing the exposure of highly immunogenic β-glucans.  One study suggested a role for 
A. fumigatus melanin in the modulation of host response, as conidia lacking the melanin 
layer stimulated human PBMC defective in dectin-1 less potently than cells isolated from 
healthy donors  (Chai et al. 2009).     
A. fumigatus produces and secretes various hydrolytic enzymes that facilitate lung 
tissue colonization.  Three major proteases have been shown to be secreted during 
infection:  an alkaline serine protease, Alp; a metalloprotease, Mep; and an aspartic 
protease, Pep.  These enzymes are known to play a role in the recycling of organic 
material in the environment; however, the penetration into the lung requires the fungi to 
use extracellular enzymes to penetrate the pulmonary epithelium (Rementeria et al. 
2005).   
A. fumigatus Secondary Metabolites 
Secondary metabolites also play a role in A. fumigatus virulence.  These secreted 
small molecules have been shown to be detrimental to the host cells by exerting 
immunosuppressive and proapoptotic effects on host cells.  The A. fumigatus Af293 
genome has revealed numerous genes that encode for non-ribosomal peptides and 
polyketide synthetases, which are responsible for secondary metabolite production.  
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Secondary metabolites play roles in conidial germination, hyphal growth, and cell wall 
structural components.  However, some of these secondary metabolites have also been 
shown to be implicated in A. fumigatus pathogenicity. 
Gliotoxin, fumagilin, fumagatin and helvoic acid are some of the A. fumigatus 
toxins (Bok and Keller 2004).  Regulation of these toxins is mediated by LaeA, a nuclear 
protein required for the expression of secondary metabolites.  Studies with LaeA deletion 
strain of A. fumigatus (ΔLaeA) show reduced virulence in a mouse infection model. 
Furthermore, the decreased virulence of ΔLaeA correlated with the lack of secondary 
metabolite production (Bok et al. 2005; Bok and Keller 2004; Kale et al. 2008).  In 
addition, ΔLaeA A, fumigatus did not show any changes in the morphology of the conidia, 
cell wall composition or fungal growth (Sugui et al. 2007a).  Recent data suggest that the 
difference in fungal recognition by macrophages between A. fumigatus ΔLaeA and the 
wild type counterpart is due to decreased hydrophobin (RodAp) layer in the deletion 
strain.  In addition to a deficiency in the production of secondary metabolites, wild type 
A. fumigatus was shown to have 60% more RodAp than the LaeA deletant (Dagenais et 
al. 2010).  
The best studied secondary metabolite is the epipolythiodioxopiperazine (ETP) 
gliotoxin (Kwon-Chung and Sugui 2009b; Sugui et al. 2007b). Gliotoxin was first 
identified in 2004 as the product of a 12-gene cluster in the A. fumigatus genome that 
resembles the ETP sirodesmin (Gardiner and Howlett 2005).  Mutations in different 
genes of the cluster resulted in loss of gliotoxin production, confirming the initial 
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findings (Bok et al. 2006; Kwon-Chung and Sugui 2009b; Spikes et al. 2008; Sugui et al. 
2007b).    Additional studies have showed that gliotoxin can be recovered from sera 
during IA (Lewis et al. 2005).  Deletion studies in GliZ, a Zn2Cys6 binuclear transcription 
factor, resulted in loss of detectable gliotoxin.  Expression of multiple copies of GliZ in 
the A. fumigatus genome resulted in increased gliotoxin production, suggesting that GliZ 
is essential for gliotoxin production.   In a mouse pulmonary infection model, Bok et al. 
showed decreased virulence in A. fumigatus strains lacking LaeA when compared to the 
wild-type and complemented strains (Bok et al. 2005; Bok et al. 2006; Bok and Keller 
2004; Kale et al. 2008).  Although decreased survival was observed in mice infected with 
ΔGliZ and ΔGliP, the difference was not significant between mice infected with wild-
type A. fumigatus and the deletion strains (Bok et al. 2006; Sugui et al. 2007b). Gliotoxin 
has also been shown to inhibit the nuclear translocation of the transcription factor NF-κB, 
to inhibit reactive oxygen species and inhibit phagocytosis.  Recent studies showed that 
A. fumigatus gliotoxin can induce apoptosis but not necrosis in human monocytes and 
neutrophils, serving as an evasion mechanism for the fungus (Orciuolo et al. 2007; 
Stanzani et al. 2005).  
Host factors involved in disease 
   
 Qualitative and quantitative disorders on phagocyte function are among the most 
important host factors predisposing patients to invasive infection with A. fumigatus 
(Shoham and Levitz 2005).   The major risk factor for development of IA is neutropenia, 
the duration and severity of the immunodeficiency has been found to be proportional to 
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the development of disease (Maschmeyer et al. 2007).   In hematopoietic stem cell 
transplant patients (HSCT), T cell suppression induced by total body irradiation increases 
the risks of developing IA.  Furthermore, high-dose corticosteroids and T cell suppressive 
drugs given pre-transplantation have also been identified as risk factors (Maschmeyer et 
al. 2007; Sherif and Segal 2010).   
Recently, patient specific risk factors were described.  Polymorphisms in toll-like 
receptors (TLRs) were found to correlate with increased susceptibility to A. fumigatus 
infection (Bochud et al. 2008; Carvalho et al. 2008a; Kesh et al. 2005; Pamer 2008).  In 
HSCT patients, polymorphisms in TLR1 and TLR6 were correlated to increased 
susceptibility to IA (Kesh et al. 2005); while polymorphisms in the IL-10 gene may either 
play a protective role or increase the risk of IA (Sainz et al. 2007; Seo et al. 2005). 
Overview of the Immune System 
 
  The observation that an individual infected with a certain pathogen could gain 
protection against this pathogen gave rise to the field of immunology.  Our bodies have 
evolved to fight infections, and protect us from subsequent infections with the same 
organisms.  This protection is based on the initial recognition of pathogens, 
differentiating the pathogenic cells from self and generating memory against invading 
pathogens.  Therefore, host defenses can be divided into two categories:  innate and 
adaptive (or acquired) immune responses.  
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The adaptive arm of the immune system is responsible for the elimination of the 
pathogens in the late phase of infection (Loiarro et al. 2010).   Unlike the innate arm of 
the immune system, the adaptive immune system recognizes infectious agents based on 
clonal selection.  A pre-existing repertoire of memory B cells and T cells, generated by 
genetic recombination of antigen receptor genes after exposure, are capable of 
recognizing and selectively eliminating foreign antigens.  This antigenic specificity 
allows the adaptive immune system to distinguish extremely subtle differences among 
antigens.  In addition, there is ample diversity among the recognition molecules that 
allows recognition of billions of unique structures on foreign antigens.  The specificity of 
acquired immune system can differentiate between two organisms with minor genetic 
variations.  One important aspect of acquired immunity is the ability to develop 
immunogenic memory and generate a specific reaction the second time the same antigen 
is encountered.  This allows for life-long immunity to an array of infectious agents after 
initial exposure. 
The innate immune system constitutes the first line of defense against infection.   
The evolutionarily conserved system provides protection by means of physical, chemical 
and cellular barriers mediated by germline-encoded receptors that can detect a limited 
repertoire of microbial structures associated with infection (Kawai and Akira 2010).     
The primitive innate immune system is capable of discriminating self antigens 
from exogenous antigens.  The detection of exogenous antigens is facilitated by the 
recognition of pathogen associated molecular patterns (PAMPs), a process which usually 
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leads to an inflammatory response. These PAMPs include nucleic acids, viral proteins, 
components of the bacterial and fungal cell wall such as LPS and β-1,3-glucans that are 
conserved among a wide range of pathogens making them the perfect target for host 
recognition.  The host response is mediated by pattern recognition receptors (PRRs), 
germ line encoded receptors responsible for recognizing PAMPs and initiating a 
signaling cascade that leads to the activation of cytokines and chemokines.  By the 
initiation of these signaling cascades, the innate immune system communicates with other 
components for the activation of the adaptive immune response. 
The mammalian immune system depends on the fine interplay between innate and 
adaptive immunity for the effective clearance of invading pathogens (Akira 2009; Kawai 
and Akira 2009).   Phagocytes, like macrophages and dendritic cells (DCs), mediate these 
“non-specific” responses by recognizing and triggering proinflammatory response against 
invading pathogens  (Mogensen 2009).   
 
Pattern Recognition Receptors 
 
The innate immune system relies on evolutionary conserved structures on PAMPs 
through a limited number PRRs.  The innate immune response is primarily mediated by 
phagocytes and antigen presenting cells (APCs) like macrophages and dendritic cells, 
which express different PRR.  To date, several groups of PRRs have been described and 
characterized into four main families:  the TLRs, the retinoid acid-inducible gene I (RIG-
I) like receptor (RLR), the C-type lectin receptors (CLRs) and the nucleotide-binding 
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oligomerization domain (NOD) like receptors (NLRs) (Akira 2009; Kawai and Akira 
2009) (Figure 1.2).    
PRRs are expressed on the cell surface or in intracellular compartments and their 
activation leads to the secretion of proinflammatory cytokines.   Phagocytic cells, such as 
dendritic cells (DCs), neutrophils and macrophages, are primarily responsible for 
mediating this evolutionarily ancient form of defense.  Each phagocyte bears a subset of 
PRRs that mediates recognition of the pathogen by either direct recognition (by 
expression in the cell surface or intracellular vesicles) or indirect via soluble PRRs in 
bodily fluids.  Recognition of PAMPs results in an array of cellular responses triggered 
by a variety of intracellular signaling cascades.  Activation of these cascades results in 
microbial uptake by phagocytosis, induction of microbial killing machinery such as the 
respiratory burst and production of cytokines and chemokines. 
The TLRs comprise the best studied family of PRR.  The TLR family is 
composed of thirteen (TLR1-TLR13) members, all responsible for the detection and 
signaling in response to different PAMPs.  TLRs recognize non-self antigens either on 
the cell wall or the lumen of intracellular vesicles, such as the phagolysosome.  TLRs can 
detect a wide range of PAMPs including lipids, lipoproteins, proteins, glycans and 
nucleic acids (Kumagai and Akira 2010; Takaoka and Shinohara 2008).   
The RLRs and NLRs were characterized by their ability to detect nucleic acids on 
the cytosol of host cells (Figure 1.2).  In addition to DNA, the NLRs can detect 
components of the bacterial cell wall, viruses and parasites (Kumagai and Akira 2010).  
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The RLRs RIG-I, melanoma differentiation associated gene 5 (MDA-5) and the negative 
regulator LGP2 were identified as RNA helicases involved in antiviral responses.  These 
RLRs recognize viral RNA in the cytosol, during viral replication, and are capable of 
inducing the activation of IFNα.  Recently a cytoplasmic DNA receptor was identified as 
a member of this family of PRR, DNA-dependent activator of (interferon regulatory 
factor) IRF (DAI).  DAI can recognize Z-form DNA in the cytosol and induce the 
production of type I IFNs (Takeuchi and Akira 2010; Vilaysane and Muruve 2009). 
On the other hand, the NLRs are cytoplasmic PRRs composed of a central 
nucleotide binding domain and C-terminal leucine-rich repeats.  NLRs contain either a 
pyrin domain or a baculovirus inhibitor of apoptosis protein repeat domain and a CARD 
domain; therefore, they are not are not involved in transcriptional regulation of 
inflammation.  Rather, NLRs are components of the inflammasome and are responsible 
for the regulation of caspase 1 activation.  In conjunction with TLRs, the NOD receptors 
are capable of inducing type 1 IFN (Takaoka and Shinohara 2008). 
The CLRs are membrane bound receptors characterized by the presence of 
carbohydrate binding domain.  These CLRs are responsible for detecting sugars on 
bacteria and fungi (Figure 1.2).  Upon their activation they can stimulate the production 
and subsequent secretion of proinflammatory cytokines.  
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Figure 1.2.  Overview of Pattern Recognition Receptors and their ligands 
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Overview of TLRs (TLRs and signaling) 
TLRs are a conserved family of Type I transmembrane proteins, originally 
identified by their homology with Drosophila melanogaster Toll.  Toll was first 
identified by its role in dorso-ventral development and essential anti-Aspergillus response 
in the fly (Lemaitre et al. 1996).  TLRs are a family of glycoproteins composed of an 
extracellular ligand binding domain, a series of leucine-rich repeats and a cytoplasmic 
Toll/IL-1R (TIR) domain.  Ten TLRs have been identified in humans and twelve have 
been identified in mice.  These TLRs are expressed on a number of cell types, like DCs, 
macrophages, T cells, B cells and epithelial cells.  In addition, TLRs can be found in cell 
surface or in intracellular compartments; where they act as PRRs.   
TLRs play an extremely important role in the control of most pathogens by means 
of recognizing specific PAMPs (See table 1.1).  In general, TLRs can be subdivided into 
groups, according to the PAMP they recognize:  TLR1, TLR2, TLR4 and TLR6 
recognize lipids, while TLR3, TLR7, TLR8 and TLR9 recognize nucleic acids (Figure 
1.4).  The natural ligands of TLRs are indispensable components of the pathogen, and 
because of this the pathogen will not mutate to lack the essential building blocks 
recognized by TLRs.  However, due to the high rate of mutations in nucleic acids, TLRs 
detect pathogenic DNA or RNA due to small differences between the host and the 
pathogenic nucleic acids (Haas et al. 2008; Hacker et al. 2000; Kawai and Akira 2008). 
Signaling for all TLRs, except TLR3 and partially TLR4, are dependent on the 
adaptor molecule MyD88.  Interactions between the TLRs and the adaptor molecule takes 
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place via TIR domain interactions, leading to activation of signaling cascade which 
results in the production of proinflammatory cytokines and chemokines.   However, 
MyD88 is not the only adaptor protein.  TLR4 is able to signal via a MyD88-dependent 
and MyD88-independent mechanisms.   TLR3 and MyD88-independent TLR4 signal via 
the TIR-domain-containing adapter-inducing interferon β (TRIF).  Signaling via TRIF 
results in the activation of interferon regulatory factor 3 (IRF3) and IFNβ production. 
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TLRs Ligands Target Microbes 
TLR1 Triacyl lipopeptides Mycobacterium 
TLR2 Peptidoglycans 
GPI-linked proteins 
Lipoproteins 
Zymosan 
Conidia and Hyphae 
Phospolipomannan 
Gram Positive Bacteria 
Trypanosomes 
Mycobacterium 
Yeast and other fungi 
Aspergillus spp 
Candida albicans 
TLR3 Double Stranded RNA (dsRNA) Viruses 
TLR4 LPS 
F-protein 
Conidia 
Mannan and Glucoronoxylomannan 
O-linked mannose 
Gram Negative Bacteria 
Respiratory Syncytial Virus 
Aspergillus fumigatus 
Cryptococcus neoformans 
Candida albicans 
TLR5 Flagellin Bacteria 
TLR6 Diacyl lipopeptides 
Zymosan 
Mycobacterium 
Fungi  
TLR7 Single Stranded RNA (ssRNA) 
 
Viruses 
 
TLR8 
(human) 
ssRNA Viruses 
TLR9 Unmethylated CpG Dinucleotides 
DNA-containing immune complexes 
Bacteria 
Autoimmunity 
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Viral infection 
Unmethylated DNA 
 
 
Viruses 
Aspergillus fumigatus 
Candida albicans 
Cryptococcus neoformans 
TLR10 Unknown Unknown 
TLR11 
(mouse) 
Uropathogenic Bacteria 
Profilin-like molecule 
Bacteria 
Toxoplasma gondii 
TLR12 Unknown Unknown 
TLR13 Unknown Unknown 
 
Table 1.1  Toll-like Receptors and their natural ligands 
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Toll-like Receptor 9 
Endosomal TLRs play an important role in the recognition of nucleic acids such 
as single-stranded RNA (ssRNA), double-stranded RNA (dsRNA) and unmethylated 
CpG DNA.  TLR9 is responsible for the detection of single-stranded DNA (ssDNA) rich 
in unmethylated CpG motifs (Figure 1.3A).  From a historical perspective, the 
observation that bacterial DNA from Mycobacterium bovis was capable of promoting 
immunostimulatory and antitumor effects was a landmark (Bauer et al. 2008; Tokunaga 
et al. 1984).  This was the first piece of evidence that DNA from pathogens could 
stimulate an inflammatory response in non-B and non-T cells, and that the response could 
be reproduced by stimulation with short single stranded oligonucleotides (ssODN) (Ishii 
and Akira 2006).   The immunostimulatory ability of microbial DNA was found to be 
mediated by the presence of palindromic unmethylated CpG dinucleotides (Krieg 1995; 
Krieg et al. 1995).   In contrast to microbial DNA, vertebrate DNA was shown to have 
reduced stimulatory activity due to methylation of the CpG DNA and the relatively low 
frequency of these motifs in the genome (Figure 1.3B).  However, during certain 
autoimmune diseases humans are capable of reacting to their own DNA (Bauer et al. 
2008).    
TLR9 signaling requires translocation of the receptor from the endoplasmic 
reticulum into the endosome.   Upon binding DNA, activation of TLR9 requires 
endosomal acidification and dimerization in order to initiate a response (Figure 1.3A).  
Upon recognition of CpG DNA, TLR9 undergoes conformational changes that results in 
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the interaction with MyD88.  Subsequent activation of a signaling cascade results in the 
translocation of interferon regulatory factors 7 (IRF7), IRF3 and NF-κB (Latz et al. 
2007a; Latz et al. 2004b).  These transcription factors translocate to the nucleus were they 
are responsible for initiating the transcription of cytokines.  To date, three classes of CpG 
have been identified: the A-class ODNs are potent inducers of IFNα in plasmacytoid DCs 
(pDCs) and poor inducers of B cell activation, the B- class ODNs are strong B-cell 
stimulation, and C-class ODNs are capable of inducing B cell activation and IFNα 
secretion.  Expression of TLR9 differs between human and mouse cells.  This difference 
in expression is most evident in DCs, which are responsible for linking innate and 
adaptive immune responses.  Whereas TLR9 is expressed exclusively on pDCs in 
humans, TLR9 is expressed in both conventional DCs and pDCs (Ishii and Akira 2006).  
The best studied role of TLR9 is during recognition of unmethylated viral ssDNA. 
During viral replication, ssDNA can be found in the cytoplasm and endosome of infected 
cells, where it can induce a TLR9-dependent response (Gilliet et al. 2008).   Furthermore, 
bacterial unmethylated ssDNA is also capable of engaging TLR9 and inducing a response 
(Figure 1.3A).  The immunostimulatory response of each bacterial species analyzed 
correlated with the number of CpG motifs found in the genome (Dalpke et al. 2006).  
Parroche et al showed that DNA from Plasmodium falciparum was capable of initiating a 
TLR9-dependent response; and that the response was enhanced when the DNA was 
associated with hemozoin (Parroche et al. 2007).   In addition to the microbial DNA 
recognition, TLR9 has been shown to play a role in autoimmunity.  TLR9 recognizes 
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unmethylated self DNA in Lupus patients. (Lamphier et al. 2006; Means et al. 2005; Tian 
et al. 2007). 
While umethylated CpG DNA was immunostimulatory, TLR9 signaling can be 
inhibited by methylation of the DNA, inverted CG sequence or cleavage at the CG 
sequences (Duramad et al. 2005) (Figure 1.3B).  The initial observation was made by 
Krieg et al; he observed that Adenovirus serotype 2 was non-stimulatory and was capable 
of inhibiting activation by bacterial DNA (Krieg 2006; Krieg et al. 1998).   Furthermore, 
methylated bacterial CpG DNA motifs were shown to be inhibitory for TLR9 stimulation 
(Pisetsky and Reich 2000).  Similar results were observed for human telomeric DNA 
repeats (Gursel et al. 2003).     
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Figure 1.3.  Overview of TLR9 signaling 
A.  Unmethylated CpG DNA is taken into endosomal TLR9+ compartment.  Once in the 
endo-lysosome, the DNA binds to TLR9 which induces conformational chanes and 
dimerization of the receptor.  Signaling cascade is subsequently activated, leading the 
nuclear translocation of NF-κB and transcription of IRF3/7.  As a result, proinflammatory 
cytokines are secreted; including type I IFN and TNFα. 
B.  Upon methylation of the DNA, inversion of CG sequences or cleavage of CG, the 
DNA enters the TLR9+ compartments.  While TLR9 still binds the DNA, there are no 
comformational changes and the receptor will not dimerize.  As a result, the signaling 
cascade is blocked or inhibited.  Alternatively, inhibition of endo-lysosomal acidification 
will block dimerization of the receptor and activation of downstream signaling. 
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Host Immune Responses against A. fumigatus 
 
Host responses to A. fumigatus begin with the physical barriers of the respiratory 
tract.  Upon inhalation, the conidia are deposited in airway surfaces where they can be 
removed by the ciliary action of the respiratory epithelium.  The respiratory epithelium 
works by trapping the conidia, recognizing the pathogen via soluble pattern recognition 
molecules and secreting microbicidal peptides responsible for killing the pathogen.  As 
the size of the conidia is ideal for alveolar deposition, the inhaled spores can bypass these 
physical barriers and reach the alveoli (Figure 1.4)   
Phagocytes are essential in the clearance of A. fumigatus.  Once the conidia reach 
the broncheo-alveolar spaces, alveolar macrophages recognize and phagocytose A. 
fumigatus, resulting in killing of the spores.   With a variety of soluble and surface bound 
PRR, alveolar macrophages secrete proinflammatory cytokines and restrict the initial 
spread of the conidia.  Killing of the conidia by alveolar macrophages has been shown to 
occur via non-oxidative mechanisms.     
In addition to alveolar macrophages, neutrophils and conventional DCs are also 
responsible for phagocytosing A. fumigatus conidia.  Neutrophils have been shown to 
eliminate swollen conidia in the lungs after internalization by respiratory burst and 
degranulation.  The host immune system has evolved to recognize the different 
morphologies of A. fumigatus (Park and Mehrad 2009).  The conidia that are not 
eliminated during the host’s first round of defense can germinate to become hyphae.  
Neutrophils are the primary cell type responsible for killing of the hyphae.  Hyphal  
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Figure 1.4. Infectious Cycle of A. fumigatus.    
Infectious cycle of A. fumigatus starts with the inhalation of aerosolized conidia by a 
susceptible host. Due to the perfect size of the conidia, these spores can reach 
bronchoalveolar spaces in the lungs.  In an immunocompentent host, the infection is 
usually eliminated by professional phagocytes such as blood alveolar macrophages.  In 
the immunocompromised host, conidia can reach the alveoli.  In these hosts, due to the 
lack of immune recognition, A. fumigatus germinates into hyphae- the invasive form of 
the mold.  Development of disease is highly dependent on the status on the immune 
system of the host.  During neutropenia, the lack of PMNs allows for excessive hyphal 
growth and dissemination of the mold.  Corticosteroid induced immunosuppression, on 
the other hand, allows for PMN recruitment and the exacerbated response causes tissue 
damage.  
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killing by neutrophils occurs via both oxidative and non-oxidative mechanisms (Figure 
1.5).  The importance of the oxidative killing mechanism by neutrophils has been well 
characterized in the context of chronic granulomous disease (CGD).  This inherited 
disease results from mutations in genes encoding for components of the NADP (NADPH) 
oxidase complex, resulting in an impaired oxidative response and higher susceptibility to 
IA (Grimm et al. 2010).  Although mechanisms of oxidative stress are important in the 
killing of A. fumigatus during infection, neutrophils are capable of eliminating hyphae by 
both oxidative and non-oxidative mechanisms (Park and Mehrad 2009).  
DCs are the link between innate and adaptive immunity (Figure 1.5).  Previous 
data showed that DCs could phagocytose conidia and transport them to the lymph nodes 
(Bozza et al. 2002).  The recognition and phagocytosis of A. fumigatus by DCs occurs via 
distinct mechanisms, dependent on whether the DCs encounter conidia or hyphae. In 
addition, priming of T-lymphocytes at the lymph nodes was dependent on the 
morphology encountered; as confirmed by cytokine secretion (Bozza et al. 2002).  
Signaling of DCs, via cytokines, stimulates disparate Th1/Th2 T-cell responses that could 
be either beneficial or detrimental to the host (Bozza et al. 2009).  Furthermore, 
activation of Th17 cells has also been suggested to play a role in the outcome of A. 
fumigatus infection.  
Recognition of A. fumigatus, in all its morphologies, occurs via both soluble and 
cell associated receptors that recognize microbial structures.  For example, binding and 
phagocytosis of resting conidia induce scant inflammatory responses.  In a pulmonary 
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Figure 1.5.  Host Responses against A. fumigatus.  
Inhaled resting conidia in the lungs are covered with a melanin outer layer which is 
secreted into the environment upon conidial swelling.  Exposure of β-glucans in swollen 
conidia allows alveolar macrophages to detect the conidia by TLR2 and by Dectin-1.  
Upon detection by alveolar macrophages, an inflammatory response is initiated resulting 
in the phagocytosis and killing of the conidia in phagolysosomal compartments.  
Neutrophils are also recruited into the site of infection where the conidia are killed via 
oxidative and non-oxidative mechanisms.  In most cases if the infection is controlled, the 
conidia will not germinate into hyphae.  During disease, some of the conidia escape 
killing by professional phagocytes and germinate into hyphae.  PMNs recognize and kill 
the hyphae via oxidative and non-oxidative mechanisms, as well as the generation of 
neutrophil extracellular traps (NETs) which inhibit fungal growth.  In addition, DCs 
recognizes components of the mold and initiate an adaptive immune response.  A 
dysregulation of the Th1/Th2 response will determine the outcome of disease.  While a 
Th1 response is favorable for the outcome of the disease, a Th2 response will benefit the 
pathogen and may contribute to an unfavorable outcome of the disease.  Activation of 
Th17 pathway, acting by negatively regulating the Th1 mediated immune resistance to A. 
fumigatus, resulting in an uncontrolled Th1 inflammatory response.  In addition, Tregs 
have been shown to play a role in the early phase of infection by mediating an anti-
inflammatory response. 
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 infection model, mice were challenged with live and heat killed resting conidia.  Results 
showed optimal CD4+ T cells to live conidia but not heat-killed resting conidia.  
Exposure of β-glucan, particularly in the tips of A. fumigatus hyphae, is associated with 
increased secretion of tumor necrosis factor (TNFα) and CXCL2 by macrophages (Balloy 
et al. 2005; Meier et al. 2003; Steele et al. 2005).  In addition, increased hyphal damage is 
mediated by neutrophils, resulting in an inflammatory response and host tissue damage.     
Antifungal responses mediated by TLRs 
 
TLRs play an important role in the control of most pathogens; therefore, it was 
expected that they played a role in the recognition and antifungal responses to A. 
fumigatus.  Over the last decade the evidence that TLRs play a role in the antifungal 
response has increased significantly, particularly the role of TLR2 and TLR4.  Studies 
with A. fumigatus and TLRs have yielded conflicting results, depending on the strain and 
infection model used.     
Initial studies with human blood stimulated with A. fumigatus hyphae suggested that 
secretion of TNFα, IL-1β and IL-6 occur via a TLR4 dependent mechanism (Wang et al. 
2001).   Subsequent studies showed a reduction in TNFα secretion when mouse 
macrophages deficient in TLR2 and MyD88 were stimulated with different morphologies 
of A. fumigatus (Mambula et al. 2002).  The same study showed that CD14 played a role 
in the antifungal response in human cells, but not in the mouse system (Mambula et al. 
2002).   Later studies (Meier et al. 2003; Netea et al. 2003) showed that both receptors, 
TLR2 and TLR4, were involved in the anti-A. fumigatus response.   In one study, 
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peritoneal macrophages from TLR4-/- ScCr mice showed decreased TNFα, IL1α and IL1β 
secretion when stimulated with conidia but not hyphae, as compared to the wild-type 
controls.  In addition, a reduction in cytokine secretion was observed upon stimulation of 
TLR2-/- macrophages, with either conidia or hyphae (Netea et al. 2003).  Meier et al 
showed TLR2 and TLR4 mediated NF-κB translocation upon stimulation with A. 
fumigatus (Meier et al. 2003).  Consistent with the previous findings, A. fumigatus 
antigens induce secretion of IL-12 via TLR2 and IL-6 via TLR4 in mouse BMDCs 
(Braedel et al. 2004).  Stimulation of human monocyte-derived dendritic cells with A. 
fumigatus results in CD86 expression and upregulation of MHC and co-stimulatory 
proteins (Braedel et al. 2004).   Furthermore, PMN mediated antifungal activity occurs 
via two distinct oxidative pathways that involve TLR2 or TLR4 (Bellocchio et al. 2004b).     
The role of TLRs has also been shown in vivo.  Studies with mice deficient in TLR2, 
TLR4, TLR9, MyD88 and IL1-R1 and wild type mice, showed decreased survival for 
MyD88-/- and TLR4-/- but increased survival was observed for the remaining groups 
(Bellocchio et al. 2004a).   Studies with immunocompromised TLR2-/- mice challenged 
with A. fumigatus showed decreased survival, as well as cytokine secretion, when 
compared to the TLR2+/+ counterparts (Balloy et al. 2005). 
In addition to TLR 2 and TLR4, other TLRs have been shown to also play a role in 
the detection of A. fumigatus PAMPs.  One study showed that TLR9-/- mice infected with 
A. fumigatus conidia were more susceptible to the infection than the wild type or MyD88 
deficient counterparts.  Furthermore, the fungal burden in TLR9 deficient mice was 
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higher than the fungal burden in the wild type mice (Bellocchio et al. 2004a; Bellocchio 
et al. 2004b).  In addition, studies in mouse infection models showed delayed mortality 
when TLR9-/- mice, depleted of neutrophils, were challenged with A. fumigatus when 
compared to TLR9+/+ immune deficient counterparts (Ramaprakash et al. 2009).    
The importance of TLRs has also been shown during A. fumigatus disease.  
Polymorphisms in different TLRs have been shown to increase susceptibility to infection 
in an array of immunodeficiencies (Pamer 2008).  Studies performed with a cohort of 336 
hematopoietic-cell transplant patients showed that polymorphisms in TLR4 can increase 
the risk of IA (Bochud et al. 2008).  Furthermore, Bochud et al showed that the haplotype 
was present in two single nucleotide polymorphisms (SNPs) that resulted in a strong 
linkage disequilibrium that affected TLR4 function.  These result were confirmed by 
comparing 103 IA patients to control patients (Bochud et al. 2008).  Another study 
examined the association between SNP in TLR1, TLR4 and TLR6 genes and 
development of IA from 22 patients with IA and 105 unaffected hematopoietic stem cell 
transplant patients (Kesh et al. 2005).  Kesh et al found that the mutations in TLR1 
239G>C (Arg80>Thr) and   TLR6 745C>T (Ser249>Pro) were associated with IA (Kesh 
et al. 2005).  The role of TLRs during infection was also assessed for susceptibility to 
non-invasive forms of pulmonary aspergillosis (Carvalho et al. 2008a).   Carvalho et al 
found an association between the TLR4 mutation Asp299Gly and chronic cavitary 
pulmonary aspergillosis.  This group also found that ABPA was associated with a 
mutation on TLR9 (T-1237C) (Carvalho et al. 2008a).   
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Other Aspects of Innate Immune System involved in anti-A. fumigatus responses 
 
In addition to the TLR responses to A. fumigatus, other PRRs have also been 
shown to be involved in the recognition and antifungal responses to this opportunistic 
pathogen.  Recognition of A. fumigatus cell wall components exposed at different growth 
stages has become an important topic of research, particularly in the search for vaccines.   
Other PRR (C-type Lectins, Cytosolic PRR) 
 
PRR are widely distributed, and can be found bound to cell membranes or soluble 
(Figure 1.6).  In addition to TLRs, other cytosolic PRRs have been identified.  Among 
these non-TLR s receptors are the RLR and the NLR.  The RLRs belong to the family of 
RNA helicases that can detect viral RNA in the cytoplasm of infected cells and induce a 
type I IFN response.  To date, the RLRs have only been shown to play a role in the 
antiviral response; however, it is possible that pathogenic DNA and RNA from other 
pathogens could induce an RLR-dependent response. 
The NLR constitute a large family of cytosolic PRR characterized by the presence 
of N-terminal protein interaction domain, a central nucleotide-biding domain and a C-
terminal LRR. The NLRs and the inflammasomes are responsible for the activation of 
inflammatory processes including pyroptosis (Fernandes-Alnemri et al. 2007; Suzuki and 
Nunez 2008).   A. fumigatus was recently shown to activate the NLRP3 inflammasome 
(Said-Sadier et al. 2010) (Figure 1.6).  Although no IL-1β could be detected upon conidia 
challenge, a human monocyte cell line secreted the cytokine in response to hyphal 
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fragments.  The ability of A. fumigatus hyphae to induce the NLRP3 inflammasome is 
dependent on production of reactive oxygen species (ROS) and pro-IL-1β cleavage was 
shown to be dependent on the activation of Syk tyrosine kinase, which has been 
identified to be downstream from dectin-1 (Said-Sadier et al. 2010).  
Another group of non-TLR PRRs are the CLRs.  This superfamily of proteins is 
characterized by the presence of one or more C-type Lectin-like domains (CTDLs).   
Most proteins in this family are type II transmembrane proteins, with two exceptions- 
Mannose Receptor and DEC-205.  C-type lectins play essential roles in cell-cell 
adhesion, detection and recognition of pathogens, and apoptosis. 
Several CLRs play roles in the clearance of fungal pathogens.  As with TLRs, the 
distribution of these receptors is varied among different cell types.   During the antifungal 
response, the CLRs bind exposed carbohydrates on the fungal cell wall (Figure 1.6).  
Among the CLRs, Mannose Receptor (MR), dectin-1, dectin-2, dendritic cell specific 
ICAM-3-grabbing non-integrin (DC-SIGN) and the collectins have been shown to be 
involved in the antifungal response.  
One of the best characterized CLRs in the anti-Aspergillus response is Dectin-1. 
This CLR is a glycosylated type II transmembrane receptor, that contains a carbohydrate 
binding domain and a ITAM-like motif (Reid et al. 2009).  Dectin-1 is the major receptor 
for recognition of β-1,3-glucans, a major component of the A. fumigatus cell wall.  
Dectin-1 is localized in the cell membrane of various cell types, such as: neutrophils, 
monocytes and dendritic cells.  Upon engagement of the receptor, Dectin-1 can induce 
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the secretion of proinflammatory cytokines such as TNFα, IL-2, IL-10, IL-12 and MIP2; 
induce ligand phagocytosis; and induce a respiratory burst.  Although signaling via 
Dectin-1 can induce the secretion of cytokines independently of the TLRs; however, they 
may cooperate to induce a specific response to the pathogen (Brown 2006; Goodridge et 
al. 2009).     
Exposure of β-1,3-glucans during A. fumigatus conidial germination leads to 
activation of dectin-1 (Hohl et al. 2005).  Hohl et al showed that dectin-1 is internalized 
into the phagolysosome of alveolar macrophages that have ingested conidia where it can 
stimulate the secretion of TNFα and MIP2 upon β-glucan exposure.  The response was 
shown to be specific to dectin-1, as blocking the receptor with antibody resulted in 
decreased TNFα/MIP2 (Hohl et al. 2005).  Subsequently, it was shown that dectin-1 is 
responsible for recognizing swollen conidia and small hyphae ; with a responses that 
correlated with the level of exposed β-glucan (Gersuk et al. 2006; Steele et al. 2005).  
Further studies have shown that dectin-1 and TLR2 can cooperate to augment the anti-
Aspergillus response (Gersuk et al. 2006; Luther et al. 2007).  
Other CLRs have also been shown to play a role in the responses to A. fumigatus. 
DC-SIGN is one of these CLRs and is primarily expressed on DCs (van Kooyk and 
Geijtenbeek 2003). DC-SIGN was shown to bind conidia using stably transfected 
monocytes.  In addition, the binding and internalization of A. fumigatus conidia by DC-
SIGN was confirmed by blocking the receptor with anti-DC-SIGN antibody (Serrano-
Gomez et al. 2004).  Another member of the CLR family, MR, is expressed primarily on 
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macrophages and DCs (Willment and Brown 2008).  Recent data suggests a role for MR 
in the recognition of A. fumigatus galactomannans, which is exposed after the melanin 
outer layer on conidia is shed (Chai et al. 2009).  Expression of other CLRs, such as 
dectin-2 is more limited to DCs (Willment and Brown 2008).  Dectin-2 signals by 
association with FcRγ, and subsequent phosphorylation that leads to activation of NFκB, 
production of TNFα and phagocytosis (Hollmig et al. 2009).  Dectin-2 recognizes high 
mannose structures, similar to those found in hyphal forms of fungi.  Recently it was 
shown that Dectin-2 plays a role in the recognition of A. fumigatus (Barrett et al. 2009). 
 
Role of complement and antibody in responses against A. fumigatus 
Inhaled conidia quickly encounter the host complement system in addition to 
phagocytic cells (Figure 1.6).  Complement activation can take place via three pathways:  
the alternate pathway, the lectin pathway (MBL) and the classical pathway (CP).  Even 
though target discrimination is different among these pathways, their activation leads to 
C3b binding to invading cell for opsonization and phagocyte killing.  Activation of the 
alternative pathway is mediated by reverse recognition; it recognizes markers on host 
cells and activates on cells lacking these markers.  For example, Factor H is the first host 
pattern recognition molecule, capable of recognizing host-associated molecular patterns 
such as  polyanions present on host cells but not on pathogens.  (Pangburn et al. 2008).   
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Activation of the alternative complement pathway begins with the cleavage of C3.  
Subsequently, progression of the cascade leads to generation of C5 convertase and the 
formation of complement complexes.  The formation of these complexes forms pores on 
the target surfaces, leading to pathogen killing.  These complexes have been shown to 
play a role in bacterial clearance; however, due to protection impaired by the melanin 
outer layer of the conidia these complexes play a minor role in the antifungal 
response(Sturtevant and Latge 1992a; Sturtevant and Latge 1992b).   
 
  A. fumigatus, like other pathogenic fungi, can induce cleavage of C3, deplete 
hemolytic complement activity and conidia can bind C3b (Figure 1.6).  Initiation of the 
alternative complement pathway by Aspergillus spp is dependent on the morphology 
encountered. Activation of the pathway is slow with resting conidia, which correlates 
with the low immunogenicity of the outer layer (Kozel 1996).  Deposition on C3b on 
conidial cell wall has been shown to induce phagocytosis in macrophages (Bouchara et 
al. 1994).  One study with 29 strains of A. fumigatus showed that conidia can only 
activate the alternative complement pathway and that activation of MBL by the conidia 
can lead to cleavage of C3 bypassing C2 (Dumestre-Perard et al. 2008).  Furthermore, it 
was shown that Factor H, a central component of the alternative pathway, binds to 
conidia but not hyphae (Behnsen et al. 2010).   
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Figure 1.6.  Innate Immune Recognition of A. fumigatus 
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Thesis overview 
Phagocytic defenses have been shown to be critical for effective host defenses 
against Aspergillus fumigatus.   One study (Bellocchio et al. 2004a) found that mice 
deficient in TLR9 challenged with A. fumigatus lived longer than wild type mice.   
Furthermore, polymorphisms in the TLR9 have been suggested to play a role in the 
development of aspergillosis (Carvalho et al. 2008b; Lanciotti et al. 2007).  However, 
whether A. fumigatus DNA could induce aTLR9-dependent immune response remains to 
be elucidated. 
Our work shows that human plasmacytoid dendritic cells secrete pro-
inflammatory cytokines in response to fungal DNA (Ramirez-Ortiz et al. 2008).  In 
addition, it has been suggested (Romani et al. 2004; Romani et al. 2006; Romani et al. 
2009) that A. fumigatus conidia can stimulate an IDO-dependent TLR9 response in both 
human and mouse pDCs. Most of the previous works on fungal infections have focused 
on the responses by conventional dendritic cells (Ibrahim-Granet et al. 2003; Latge 
1999).   Furthermore, pDCs are high producers of type I interferon and can be found 
circulating in the blood, where they constitute less than 1% of the total mononuclear 
cells.  Therefore, we wanted to determine whether pDCs play a role in the antifungal 
response to Aspergillus fumigatus.  
It has been shown that the type of immune response to fungal pathogens is 
dependent on the fungal morphotype encountered (Bozza et al. 2002).  Previous data 
(Bozza et al. 2002; Ibrahim-Granet et al. 2003; Paris et al. 1997) have shown that A. 
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fumigatus conidia are phagocytosed by macrophages and neutrophils.  Furthermore, one 
study suggested that murine pulmonary DCs internalize both conidia and hyphae through 
distinct phagocytic mechanisms and receptors.  Our published data show that immature 
pDCs secrete cytokines in response to fungal DNA suggesting that these cells may be 
involved in the immune response to A. fumigatus (Ramirez-Ortiz et al. 2008) in both the 
mouse and human system.  In the mouse, TLR9 is expressed in cDCs and pDCs, as well 
as macrophages.  In the human, macrophages and cDCs lack TLR9 and it is mainly 
expressed in pDCs and B cells.  These cells are a subset of DCs characterized by the lack 
of TLR4 and the presence of TLR7/9 (Kadowaki et al. 2001; Kool et al. 2009).  
Furthermore, data from clinical studies (Carvalho et al. 2008a) on immunocompromised 
patients suffering from invasive aspergillosis show that polymorphisms in the TRL9 gene 
increases susceptibility to infection with the mold (Carvalho et al. 2009; Carvalho et al. 
2008a).   Human and mouse pDCs have been shown to be important during the antiviral 
response (Takeuchi and Akira 2009); however, whether human pDCs  play a role in 
antifungal host defenses remains to be elucidated. 
During the germination process, morphological changes in the dimorphic fungi, 
A. fumigatus,  result in the exposure of different sugars and proteins in the cell wall 
(Bernard and Latge 2001; Gastebois et al. 2009).  During an infection, fungal conidia 
germinate into hyphae.  In a healthy individual, the infection is cleared before 
germination of the conidia by alveolar macrophages and neutrophils.  However, in an 
immunocompromised host, the conidia may germinate to hyphae and immune cells are 
exposed to the stimuli for a longer period of time.  Very little is known about the role of 
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human dendritic cells in the antifungal response to A. fumigatus.  Furthermore, whether 
mature pDCs are involved in the process remains to be elucidated.  Since mature pDCs 
acquire characteristics of conventional DCs, and they become phagocytic (Drenou et al. 
2005) it is possible that they may be involved in the clearance of Aspergillus resting or 
swollen conidia. 
Aim 1:  To determine whether fungal DNA contains unmethylated CpG motifs capable 
of stimulating TLR9; thereby potentially influencing the host response to fungal 
challenge 
Aim 2:  To determine whether Aspergillus fumigatus hyphae interact with human 
plasmacytoid dendritic cells; thereby, potentially contributing to the antifungal immune 
response 
Aim 3:  To determine whether mature pDCs recognize and induce a response against the 
different morphologies of A. fumigatus; thereby contributing to the anti-A. fumigatus 
response.  
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Chapter II 
Toll-Like Receptor 9-Dependent Immune Activation by Unmethylated CpG Motifs 
in Aspergillus fumigatus DNA 
 54 
 
Abstract 
Phagocytic defenses are critical for effective host defenses against the opportunistic 
fungal pathogen Aspergillus fumigatus.  Previous studies found that following challenge 
with A. fumigatus, Toll-Like Receptor 9 (TLR9) knockout mice survived longer than wild 
type (WT) mice.  However, the mechanism responsible was not defined. Here we 
demonstrate that A. fumigatus contains unmethylated CpG sequences, the natural ligand 
for TLR9.  A. fumigatus DNA and synthetic CpG-rich oligodeoxynucleotides (ODNs) 
containing sequences found in the A. fumigatus genome potently stimulated the 
production of pro-inflammatory cytokines in mouse bone marrow-derived dendritic cells 
(BMDCs) and human plasmacytoid dendritic cells.  The response was decreased when 
the fungal DNA was treated with a CpG methylase or CpG-specific endonucleases.  A 
role for TLR9 was demonstrated as cytokine production was abolished in BMDCs from 
TLR9-deficient mice.  Moreover, transfection of HEK293 cells with human TLR9 
conferred responsiveness to synthetic CpG-rich ODNs containing sequences found in A. 
fumigatus DNA.  Taken together, these data demonstrate that TLR9 detects A. fumigatus 
DNA resulting in the secretion of pro-inflammatory cytokines, which may contribute to 
the immune response to the pathogen.      
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Introduction 
Aspergillus fumigatus is a widely distributed opportunistic fungal pathogen.  
Exposure generally occurs when airborne spores (conidia) are inhaled into the lungs or 
sinuses (Shoham and Levitz 2005).  While inhalation of conidia rarely causes disease in 
the normal host, immunocompromised persons are prone to develop invasive 
aspergillosis (Hohl and Feldmesser 2007b).  Despite new additions to the antifungal 
armamentarium, mortality rates in those with established disease exceed 50 percent (Hohl 
and Feldmesser 2007b).  Clinical and experimental studies have demonstrated that the 
innate immune responses of phagocytes are essential for effective host defenses against 
A. fumigatus (Shoham and Levitz 2005; Walsh et al. 2005). 
A critical component of innate defenses is the ability of phagocytes to recognize 
structurally unrelated and evolutionarily conserved microbial constituents referred to as 
“pathogen- (or pattern-) associated molecular patterns” (PAMPs) (Akira et al. 2006). 
Among the receptors that recognize PAMPs are the mammalian toll-like receptors 
(TLRs), a family of at least 12 members that initiate signaling pathways through a series 
of adaptor proteins, including MyD88, TIRAP/MAL, TRIF, and TRAM. This results in 
activation of downstream signaling pathways and the subsequent production of 
inflammatory cytokines and the initiation of adaptive immune responses. Some TLRs, 
including TLR1, TLR2, TLR4, TLR5 and TLR6, are primarily expressed on the plasma 
membrane where they recognize specific molecules on the surface of microbes, including 
fungi (Akira et al. 2006; Levitz 2004). Others, including TLR3, TLR7, TLR8 and TLR9, 
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are found in intracellular compartments and signaling responses require ligand 
internalization  (Akira et al. 2006; Latz et al. 2004a).  
TLR9 is activated by DNA rich in unmethylated CpG motifs, whereas DNA 
lacking such sequences is either inert or inhibitory (Hemmi 2000; Latz et al. 2007b). 
Studies using CpG-containing oligodeoxynucleotides (ODN) have defined sequences that 
stimulate immune responses(Krieg 2006). The optimal CpG motif appears to be 
GACGTT for mice and GTCGTT for humans. The number of CpG motifs and the 
spacing of the motifs also influence immunostimulatory capacity. A-class CpG-
containing ODNs strongly stimulate plasmacytoid DC (pDC) IFNα responses but poorly 
induce B cell proliferation(Krieg 2006). In contrast, ODNs of the B-class are weak 
inducers of pDC IFNα but strong inducers of B cell proliferation. C-class ODNs have 
intermediate effects.  
In the human, TLR9 is found mainly on pDC and B cells. In contrast, the cellular 
distribution of TLR9 in the mouse is much broader and includes myeloid DC, pDC, 
monocytes, macrophages, and B cells. Clinical trials of CpG-DNA, used as adjuvants in 
vaccines and as part of treatment for infectious diseases and neoplasms, are ongoing 
(Krieg 2007). Originally, TLR9 was thought to be specific for bacterial and viral DNA 
(both of which are rich in unmethylated CpG motifs). However, recent studies have 
suggested a role for TLR9 in the recognition of eukaryotic DNA. Mammalian DNA, 
when complexed with anti-DNA antibodies, is a potent self-antigen for TLR9 and may 
play a role in promoting systemic lupus erythematosus and other autoimmune diseases 
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(Barrat et al. 2005). Moreover, TLR9-dependent stimulation of murine DC by malarial 
DNA has been demonstrated (Parroche et al. 2007).   
A possible role for TLR9 in host defenses against fungal infections was suggested 
by Bellocchio et al. (Bellocchio et al. 2004a; Bellocchio et al. 2004b). TLR9-/- mice 
paradoxically survived longer than wild-type mice following challenge with Candida 
albicans hyphae and A. fumigatus conidia. Compared with wild-type mice, the TLR9-/- 
mice had an organ fungal burden that was significantly lower and a shift in Th1/Th2 
reactivity in favor of Th2 cells. Moreover, the TLR9-/- mice infected with A. fumigatus 
had a markedly reduced inflammatory response in the lungs.  These data led us to 
hypothesize that fungal DNA contains unmethylated CpG motifs capable of stimulating 
TLR9 and thereby influencing the host response to fungal challenge. Here we 
demonstrate that DNA obtained from A. fumigatus stimulates TLR9-dependent responses 
in human and murine cells.  
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Results 
A. fumigatus contains unmethylated CpG DNA.   
We sought to determine if genomic DNA extracted from A. fumigatus contained 
unmethylated CpG motifs. DNA was treated with HpaII and MspI. These two 
endonucleases cleave DNA containing the sequence 5’…CCGG…3’.  However, they 
differ in that HpaII only cleaves unmethylated CpG sequences whereas MspI cleaves 
both methylated and unmethylated CpG sequences.  Both HpaII and MspI cleaved A. 
fumigatus DNA (Figure 2.1). To demonstrate the specificity of the cleavage reaction, the 
DNA was treated with the CpG methyltransferase, M.SssI, prior to restriction enzyme 
digest. Methylation abolished the capacity of HpaII but not MspI to cleave the DNA. 
These results demonstrate that A. fumigatus DNA contains unmethylated CpG sequences.  
A. fumigatus induces TNFα and IL-12p70 production in mouse BMDCs.   
In order to determine if A. fumigatus DNA was immunostimulatory, we measured TNFα 
and IL-12p70 release following incubation of the DNA with BMDCs. Cells treated with 
the fungal DNA potently stimulated production of both cytokines, with concentrations 
observed similar to that seen following stimulation with E. coli DNA and the synthetic 
ODN, CpG 1826 (Figure 2.2).  However, when the cells were treated with enzymatically 
methylated A. fumigatus DNA, the cytokine response was nearly completely abolished.  
Similarly, treatment of the DNA with the CpG-specific endonucleases, HpaII and MspI, 
potently reduced cytokine production.   
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Figure 2.1:  A. fumigatus DNA contains unmethylated CpG sequences. 
Genomic DNA was isolated from A. fumigatus and left untreated or treated with the 
indicated enzymes. “+” indicates treatment, “-”  indicates absence of treatment. The 
digest was then analyzed by 1% Agarose gel electrophoresis with ethidium bromide-
staining.  Left lane shows a DNA ladder with numbers indicating the size of the DNA, in 
kB.  Figure is representative of 12 individual experiments, each with similar results 
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Figure 2.2: Stimulation of murine BMDC by A. fumigatus DNA. 
BMDCs were stimulated by transfecting 2.5 μg/mL of A. fumigatus DNA or E. coli DNA 
that was left untreated (DNA), or treated with the CpG methyltrasferase, M.SssI (Meth 
DNA), MspI or HpaII.  CpG 1826 at 3 µg/mL served as a positive control while 
unstimulated cells and GpC 2137 were negative controls.  After 24 hours, supernatants 
were collected and TNFα (A) and IL-12p70 (B) concentrations were determined by 
ELISA. Data are means ± SE of 5 individual experiments. p<0.001 by one-way ANOVA 
with Bonferroni post test comparing TNFα and IL-12p70 stimulated by untreated A. 
fumigatus or E. coli DNA compared with any treatment. 
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A. fumigatus DNA stimulates TNFα secretion in a TLR9-dependent manner.   
Given the role of TLR9 as an intracellular sensor of unmethylated CpG-rich DNA, we 
next compared cytokine responses of BMDC derived from WT and TLR9-/- mice 
following stimulation with A. fumigatus DNA. In the BMDC from WT mice, native DNA 
stimulated TNFα release in a dose-dependent manner (Figure 2.3). Methylated DNA also 
induced TNFα production, although lower levels were detected compared with untreated 
DNA. However, neither untreated nor methylated A. fumigatus stimulated TNFα release 
from TLR9-/- BMDC.  
DNA from A. fumigatus stimulates the production of Type I IFN in human pDC. 
Immunostimulatory CpG-rich motifs differ between mice and humans (Hochrein and 
Wagner 2004). Therefore, we next determined whether A. fumigatus DNA would also 
stimulate human pDC, a cell type which highly expresses TLR9 (Uematsu and Akira 
2007).  A. fumigatus DNA stimulated IFNα production in human pDC obtained from 7 
different donors (Figure 2.4a) in a dose-dependent fashion (Figure 2.4b). As was 
observed with murine DC, cytokine production was significantly decreased if the DNA 
was methylated.   
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Figure 2.3: A. fumigatus DNA stimulates TNFα secretion in a TLR9-dependent 
manner. 
BMDCs from WT and TLR9-/- mice were transfected with the indicated concentrations of 
A. fumigatus DNA that was left untreated (Af DNA), or treated with the CpG 
methyltrasferase, M.SssI (met Af DNA) and incubated at 37° C.  After 24 hours, 
supernatants were collected and TNFα concentrations were determined by ELISA.  
Concentrations of TNFα released from unstimulated WT and TLR9-/- BMDC were 225 
pg/mL  ± 40  and 134 pg/mL ±18, respectively.   Data are means ± SE of a representative 
(out of four) experiment performed in triplicate. p<0.001 by one-way ANOVA with 
Bonferroni post-test comparing TNFα stimulated by Af DNA in WT BMDC with any 
other group at DNA concentrations of 3 and 10 µg/mL. 
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Figure 2.4: Stimulation of human pDC by A. fumigatus DNA. 
Human pDCs were isolated from PBMC by positive selection using CD304+ magnetic 
beads.  (A) pDCs were stimulated with 10 μg of A. fumigatus DNA which was either left 
untreated or methylated with the CpG methyltrasferase, M.SssI. Unstimulated and CpG 
2236 (10 µg/ml)-stimulated pDC served as negative and positive controls, respectively.  
After 18-24 hours, supernatants were collected and analyzed by ELISA for IFNα.   
Results are shown as means ± SE of seven individual donors. p<0.001 comparing 
untreated and methylated DNA by one-way ANOVA with Bonferroni post-test. (B) As in 
(A), except a dose response curve was performed comparing untreated and methylated A. 
fumigatus DNA.  Data are means ± SE of a representative (out of three) experiment 
performed in triplicate. p<0.001 comparing untreated and methylated DNA at 
concentrations 1, 3 and 10 µg/mL by two way ANOVA with Bonferroni post test. 
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ODNs containing CpG-rich motifs present in the A. fumigatus genome stimulate 
signaling and cytokine responses in a TLR9-dependent fashion.   
Next, we took advantage of the nearly complete (98.0%) deciphering of the A. fumigatus 
genome to determine the GC content of the genome and to search for putative 
immunostimulatory CpG-rich motifs in A. fumigatus DNA. The GC content of the 
sequenced portion of the A. fumigatus genome was determined to be 49.8%. Moreover, 
the percentage of CpG dinucleotides sequences was 5.35%.  Using the conservative 
search criteria described in the Methods section, 23 and 87 potential murine and human 
immunostimulatory motifs were identified, respectively (Table 2.1). A sample of these 
ODNs was then synthesized on a phosphothiorate background and tested for their 
capacity to stimulate murine BMDC and human TLR9-transfected HEK293 cells.   
The six synthesized ODNs containing murine-like motifs stimulated BMDC 
derived from wild-type mice to secrete TNFα, although there was considerable variation 
in their stimulatory capacities (figure 2.5a). The most potent of the ODNs, mAF2 and 
mAF5, stimulated TNFα concentrations that were nearly as high as that seen with CpG 
1826. In contrast, cytokine levels stimulated by mAF3 and mAF6 were barely above 
background. None of the ODNs stimulated cytokine release from TLR9-/- BMDC above 
background levels (Figure 2.5b).   
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Human-Like Motifs Mouse-Like Motifs 
ID CpG Motif 
Number 
of Hits ID CpG Motif 
Number 
of Hits 
hAF1 TCGTCGTTGTCGTCGTC 9 mAF1 TCGACGTCGACGTT 2 
hAF2 TCGTCGTTGTCGTC 8 mAF2 TTGACGTTTCCGACGTT 1 
hAF3 TCGTCGTCGTCGTT 8 mAF3 TTGACGTTGGGGACGTT 1 
hAF4 TCGTCGTCGTCGTCGTT 4 mAF4 CTGACGTTCATGGACGTT 1 
hAF5 TTGTCGTTGTTGTCGTT 2 mAF5 CCGACGTTCCTGACGTT 1 
hAF6 CTGTCGTTCGAGGTCGTT 1 mAF6 TTGACGTTGACTGACGTA 1 
hAF7 TCGTCGTTCTCGTCGTC 1   TTGACGTTCGACGTG 1 
hAF8 TCGTCGTCGTCCGTCGTT 1   TTGACGTCTGTGACGTT 1 
hAF9 CCGTCGTGACTGGTCGTT 1   TCGACGTTTGAGACGTA 1 
hAF10 CTGTCGTTCCGTCGTC 1   TCGACGTTTAGGACGTA 1 
  TTGTCGTCGTCGTT 6   TCGACGTTCCGACGTC 1 
  TCGTCGTTGTCGTT 4   TCGACGTTCCCCGACGTC 1 
  TTGTCGTTGTCGTT 3   CTGACGTTTGTGACGTG 1 
  TCGTCGTTATCGTCGTC 2   CTGACGTTTCGACGTG 1 
  TCGTCGTCGTTGTCGTT 2   CTGACGTTGGGAGACGTA 1 
  TCGTCGTTTCGTCGTT 1   CTGACGTCCAGGACGTT 1 
  TCGTCGTTGGCGTCGTT 1   CTGACGTATTGACGTT 1 
  TCGTCGTTGCGTCGTT 1   CCGACGTTTGACGTG 1 
  TCGTCGTTGAAGTCGTT 1   CCGACGTTGGTGACGTC 1 
  TCGTCGTTCTCGTCGTT 1   CCGACGTTGCCGACGTA 1 
  CTGTCGTTTCTGTCGTT 1   CCGACGTCGAGACGTT 1 
  CTGTCGTTGTGTCGTT 1   CCGACGTCGACGTT 1 
  CTGTCGTTATAGTCGTT 1 
  CTGTCGTCGTCGTT 1 
  CCGTCGTTCACAGTCGTT 1 
  TTGTCGTTGTTGTCGTA 1 
  TTGTCGTTGTGGTCGTA 1 
  TTGTCGTTGTCGTCGTC 1 
  TTGTCGTTGTCGTC 1 
  TTGTCGTTGTCGTA 1 
  TTGTCGTTGGTCGTG 1 
  TTGTCGTTAGTCGTC 1 
  TTGTCGTCACAGTCGTT 1 
  TCGTCGTTGTTGTCGTC 1 
  TCGTCGTTGTCGTCGTG 1 
  TCGTCGTTGCTGTCGTC 1 
  TCGTCGTTCTTGTCGTA 1 
  TCGTCGTTAGTCGTCGTC 1 
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  TCGTCGTGGTCGTT 1 
  TCGTCGTGACGTCGTT 1 
  TCGTCGTCTCCGTCGTT 1 
  TCGTCGTCCGTCGTT 1 
  TCGTCGTCAACGTCGTT 1 
  CTGTCGTGTCGTCGTT 1 
  CTGTCGTCGGTGTCGTT 1 
  CCGTCGTTTTGTCGTC 1 
  CCGTCGTTGTCGTC 1 
  CCGTCGTGTCGTCGTT 1 
  CCGTCGTGCGTCGTT 1 
 
Table 2.1.  Putative Immuno-stimulatory sequences found in A. fumigatus genome
 71 
 
 
Unstim mAF1 mAF2 mAF3 mAF4 mAF5 mAF6 CpG1826 GpC2137
0
500
1000
1500
2000
2500
3000 WT
10 g/mL
1 g/mL
3 g/mL
TN
F
 (p
g/
m
L)
Unstim mAF1 mAF2 mAF3 mAF4 mAF5 mAF6 CpG1826 GpC2137
0
500
1000
1500
2000
2500
3000 TLR9-/-
TN
F
 (p
g/
m
L)
A
B
 
 72 
 
Figure 2.5: Stimulation of murine BMDC by ODNs containing CpG-rich motifs 
present in the A. fumigatus genome. 
BMDCs from WT (top panel) and TLR9-/- (bottom panel) mice were stimulated with the 
indicated mouse-like CpG motifs (see supplemental table).  CpG 1826 served as a 
positive control while unstimulated (Unstim) cells and GpC 2137 were negative controls. 
After 24 hours, supernatants were collected and TNFα concentrations were determined 
by ELISA. Data are means ± SE of a representative (out of three) experiment performed 
in triplicate.  
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Next, ODNs representing human-like CpG motifs were assessed for their capacity 
to stimulate HEK293 cells stably co-transfected with human TLR9 and an NF-κB-driven 
luciferase reporter gene.  All ODNs tested induced luciferase activity, with the level of 
activity generally increasing in a dose-dependent manner (figure 2.6).  As was observed 
with the murine-like motifs, the stimulatory capacity of the individual ODNs was quite 
variable. hAF1, which occurs nine times in the A. fumigatus genome, was at least as 
potent as the positive control, CpG 2007. The control ODN, GpC 2137, did not induce 
the activation of the TLR9-transfected cells. The ODNs tested in figure 6 did not induce 
significant luciferase activity in HEK293 cells stably transfected with human TLR7 and 
an NF-κB-driven luciferase reporter gene (data not shown).  
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Figure 2.6: Stimulation of human TLR9-transfected HEK293 cells by ODNs 
containing CpG-rich motifs present in the A. fumigatus genome. 
HEK293 cells stably co-expressing human TLR9 and the NF-κB-driven luciferase 
reporter construct were stimulated with the indicated human-like CpG motifs (see 
supplemental table). CpG 2007 served as a positive control while GpC 2137 was a 
negative control. After 18 hours, luciferase activity was determined in the cell lysates.  
Results are expressed as fold induction over unstimulated cells. Data are means ± SE of a 
representative (out of four) experiment performed in triplicate.    
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Discussion 
Innate immunity plays a critical role in microbial defenses by allowing the host to 
rapidly respond to a challenge and by providing a bridge to adaptive immunity. The 
strong association of invasive aspergillosis with qualitative and quantitative disorders of 
phagocyte function suggests innate recognition of Aspergillus is of particular importance 
in defending against this ubiquitous fungus. Previous studies by our laboratory and others 
have demonstrated that following incubation of phagocytes with A. fumigatus conidia and 
hyphae, TLR2- and TLR4-dependent signaling cascades are stimulated, leading to 
proinflammatory cytokine production (Chignard et al. 2007; Luther et al. 2007; Mambula 
et al. 2002; Roeder et al. 2004a; Roeder et al. 2004b). Here, we demonstrate a putative 
contribution of another TLR, TLR9, to defenses against aspergillosis.  
Whereas the ligands for TLR2 and TLR4 on A. fumigatus remain undefined, 
several lines of evidence establish unmethylated CpG-rich fungal DNA as the ligand for 
TLR9. First, using restriction endonucleases and DNA methylases, the presence of 
unmethylated CpG sequences (the natural ligand for TLR9) in A. fumigatus DNA was 
demonstrated. Second, stimulation of murine DC from TLR9-/- mice with A. fumigatus 
DNA resulted in greatly impaired cytokine production compared with that seen with 
wild-type DC.  Nevertheless, the possibility that some stimulation induced by the A. 
fumigatus DNA was due to mechanisms independent of TLR9 cannot be excluded.  DC 
from TLR9-/- mice did secrete some residual TNFα after treatment with A. fumigatus 
DNA.  Similarly, some residual cytokine secretion was observed after stimulation of 
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wild-type DC with methylated DNA.  This residual response could be due to other 
intracellular DNA sensors, including DAI (DNA-dependent activator of IFN-regulatory 
factors) (Takaoka et al. 2007) and an as yet unidentified sensor dependent on TANK-
binding kinase 1 (Ishii et al. 2008). 
In a survey of 15 bacterial species, the immunostimulatory capacity of bacterial 
DNA samples directly correlated with the frequency of CpG dinucleotides (Dalpke et al. 
2006). In that study, the CpG frequency ranged from 1.44% to 12.21%. Our analysis of 
the A. fumigatus genome determined the frequency of CpG dinucleotides sequences to be 
5.35%, similar to that of bacterial DNA. Mammalian DNA is thought to be less 
immunostimulatory compared with bacterial DNA because the frequency of the CpG 
motif is suppressed. In addition, mammalian, but not bacterial, DNA is highly methylated 
(Akira et al. 2006). Although mammals and fungi share membership in the eukaryotic 
kingdom, we found that CpG motifs in A. fumigatus DNA had a low level of methylation. 
Thus, the pattern of degradation of A. fumigatus DNA following treatment with HpaII, an 
endonuclease specific for unmethylated CCGG sequences, was similar to the pattern seen 
after treatment with MspI, an endonuclease which cleaves both methylated and 
unmethylated CCGG sequences.  Consistent with these findings, A. fumigatus DNA 
stimulated DC cytokine responses comparable to that by E. coli DNA, which has a CpG 
frequency of 7.27%. 
An in silico genome-wide analysis of the fungal DNA demonstrated the abundant 
presence of CpG-rich motifs of the type predicted to be stimulatory for mouse and human 
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TLR9.  The analysis was conservative and additional stimulatory motifs likely exist 
within the genome. Synthetic ODNs containing CpG-rich motifs found in A. fumigatus 
DNA stimulated mouse and human cells. Interestingly, of the synthetic ODNs tested, the 
one that was most stimulatory had a sequence which appeared the most often in the A. 
fumigatus genome.  The potential for this ODN to be used as an immunostimulant in 
people should be considered given that it stimulated human cells as well as a CpG-rich 
ODN undergoing clinical trials. 
The relative contribution of A. fumigatus DNA to the immunology of human 
aspergillosis remains to be determined. Future studies will examine the conditions under 
which DNA is released from the fungal cell, an event that presumably would be a 
prerequisite for an interaction with TLR9 to occur. In addition, in its tissue-invasive 
hyphal phase, A. fumigatus is mostly an extracellular pathogen and TLR9 is located 
intracellularly in the endosomal compartments. Nevertheless, disparities between wild-
type and TLR9-/- mice with regards to their susceptibility to aspergillosis (Bellocchio et 
al. 2004a) suggest that the interaction of A. fumigatus DNA and TLR9 occurs in vivo.  In 
addition, a recent study examined variants in TLR genes in a population of Italian 
children with hematological malignancies (Lanciotti et al. 2007). The frequency of the C 
allele of the TLR9 T-1486C polymorphism was significantly higher in patients with 
invasive mold infections compared with patients without invasive fungal infections.  
Furthermore, a recent study (Carvalho et al. 2008b) found an association of the TLR9 T-
1237C polymorphism with allergic bronchopulmonary aspergillosis, a form of 
aspergillosis mainly found in patients that suffer from asthma and cystic fibrosis. 
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An inflammatory response is beneficial to the host if it enables it to contain or 
eliminate the pathogen. However, the immune response can be detrimental if it results in 
damage to host tissues.  The finding that TLR9-/- mice survived longer than wild-type 
mice following challenge with A. fumigatus suggests that, at least in some circumstances, 
the response to A. fumigatus DNA favors the pathogen rather than host. The nature of the 
immune response might be important too. In addition to direct inflammatory effects 
resulting from stimulation of proinflammatory cytokines, including type I interferons, 
CpG-rich DNA biases towards Th1-type responses (Krieg 2002). Finally, recent work by 
Miyazato et al. showed that BM-DCs are capable of stimulating a TLR9-dependent 
response following challenge with C. albicans DNA (Miyazato et al. 2009).  While TLR9 
has been suggested to play a role in recognition of fungal DNA, the role of type I IFNs 
during these infections remains to be elucidated. 
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Materials and Methods 
Reagents:  Reagents, unless otherwise stated, were obtained from Sigma-Aldrich (St 
Louis, Missouri).   Dulbecco’s Minimal Essential Media (DMEM) and RPMI-1640 
Media were obtained from GIBCO (Invitrogen; Carlsbad, California).  Low-endotoxin 
fetal bovine serum (FBS) was obtained from Tissue Culture Biologicals (Tulare, 
California).  R10 Media consisted of RPMI-1640 supplemented with 100U/mL Penicillin, 
100U/mL Streptomycin, 2mM L-glutamine, 50 µM β-2-Mercaptoethanol, and 10% heat 
inactivated FBS. E. coli K-12 DNA containing undetectable levels of endotoxin was 
purchased from Invivogen (San Diego, California). ODNs (Supplemental table) based 
upon the sequences found in the A. fumigatus genome were synthesized on a 
phosphothiorate backbone by Alpha DNA (Canada).  Stimulatory CpG 1826, CpG 2007, 
and CpG 2236 ODNs, and control GpC 2137, GpC 2243 ODNs, with phosphothiorate 
linkages were purchased from Coley Pharmaceuticals (Wellesley, Massachusetts).    
Genomic DNA preparation:  DNA was obtained from two strains of A. fumigatus. 
Strain Af293 was obtained from the Fungal Genetic Stock Center (University of 
Missouri, Kansas City).  The genome of this strain has been sequenced (Nierman et al. 
2005a). The other strain of A. fumigatus used was a clinical isolate (Mambula et al. 
2002). The data shown are with DNA from strain Af293, except for figure 2B which 
utilized DNA from the clinical isolate.  In preliminary studies, the two sources of DNA 
stimulated similar quantities of cytokines (data not shown). A. fumigatus was grown on 
minimal liquid media consisting of yeast extract supplemented with 2.5% Glucose, 3.4 
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G/L Yeast Nitrogen Base supplemented with ammonium sulfate and amino acids at 37o 
for 40-48 hours.  Fungi were harvested through a nylon mesh filter and washed with Tris-
Sodium-EDTA (TSE; 0.05M Tris-HCl pH 8.0, 0.150M NaCl, 0.1M EDTA pH8)(Specht 
et al. 1982).  Subsequently, hyphae were freeze-dried and ground to a powder, and the 
DNA was extracted with chloroform/isopropanol.  The DNA was treated with 20 µg/mL 
of RNAse B and 20 µg/mL of Proteinase K, and further extracted with ethanol.  Extracted 
fungal DNA was purified over a cesium-chloride gradient by centrifugation at 30K RPM 
(Beckman Ultracentrifuge L8-80M) for 40 hours at 20oC.  Purified DNA collected from 
the gradient was extracted with saturated N-butanol and further extracted by ethanol 
extraction.  DNA was then tested for the presence of glucans and endotoxin using the 
Limulus Amebocyte Lysate Test (Cape Cod Associates).  Endotoxin levels were found to 
be ≤0.03 endotoxin units/μg of DNA. 
Enzyme Treatment of DNA:  Isolated genomic A. fumigatus DNA was subjected to 
CpG methylation using CpG methyltransferase, M.SssI (NEB).  The methylation reaction 
was performed following the manufacturer’s instructions.  In addition, DNA that was 
either methylated or untreated was subjected to cleavage at CpG sequences by restriction 
enzyme digest with the isoschizomers MspI or HpaII.  Restriction digest was confirmed 
by 1% agarose gel electrophoresis of the treated and untreated samples.  Sizes of the 
resulting digested DNA fragments were compared to a DNA ladder (NEB).   
Mice:  All mice were specific pathogen-free and housed in the University of 
Massachusetts Medical Center animal facility. C57Bl/6J mice were purchased from 
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Jackson Laboratories (Bar Harbor, Maine).  The TLR9-deficient mice were obtained 
from Robert Finberg (UMass Medical School) who obtained the mice from Shizuo Akira 
(Osaka, Japan).  The knockout mice were backcrossed 12 times to a C57Bl/6 background.  
Generation and stimulation of BMDCs:  BMDCs were obtained according to the 
protocol of Lutz et.al (Lutz et al. 1999), and as in our previous studies (Kelly et al. 2005; 
Mansour et al. 2006; Wozniak et al. 2006).  Briefly, mice were euthanized and bone 
marrow cells were harvested from the femurs and tibiae.  After treatment with RBC lysis 
buffer, the remaining cells were suspended at a final density of 1 X 106 cells per mL in 
R10 media supplemented with 10% supernatant from J558L cells (as a source of GM-
CSF).  Cells were seeded in non-tissue cultured treated Petri dishes and incubated at 37oC 
in air supplemented with 5% CO2.  Media was changed every 3 days. On day 8 or 9, cells 
were harvested and the BMDCs were positively selected on a magnetic column using 
CD11c-coated magnetic beads, as per the manufacturer’s instructions (Miltenyi Biotech).  
BMDCs (2 X 105 cells per well) were added to 48-well plates containing a final volume 
of 500 uL media (R10 with 10% J558L supernatant).  BMDC were transfected with DNA 
using 30 μg/mL of N-[1-(2,3-Dioloyloxy)propyl-N,N,N-trimethylammonium 
methylsulfate (DOTAP; Roche) according to the manufacturer’s instructions.  Briefly, 
DNA and DOTAP were mixed together in HEPES-buffered saline and incubated for 15 
minutes at 25˚C. The DNA-DOTAP complexes were then added to BMDC and further 
mixed by pipetting.  Treated cells were incubated for 24 hours at 37oC in air 
supplemented with 5% CO2.  Supernatants were collected and cytokine production was 
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analyzed for TNFα and IL-12p70 by ELISA according to the manufacturer’s instructions 
(eBioscience; San Diego, California). 
Isolation and stimulation of human pDC:  pDC were isolated as described (Wang et al. 
2006). Briefly, peripheral blood was obtained by venipuncture following informed 
consent from healthy volunteers using a protocol approved by the University of 
Massachusetts Medical Center Institutional Review Board.  Blood was anticoagulated 
with heparin, diluted 1:1 with HBSS (BioWhittaker; Walkersville, MD) and the 
peripheral blood mononuclear cells (PBMC) collected following Ficoll-Hypaque 
(LymphoprepTM; Westbury, NY) density gradient centrifugation .   Human pDCs were 
positively selected from the PBMC using CD304 magnetic beads according to the 
manufacturer’s instructions (Miltenyi Biotec, Auburn, CA).   
pDCs (5x104) were stimulated with DNA-DOTAP complexes in 96-well flat-bottom 
plates containing a final volume of 200 µl RPMI 1640 supplemented with 10% FCS and 
10 ng/ml rIL-3 (R&D Systems, Minneapolis, MN).  After 20 hours culture in a 37°C/5% 
CO2 incubator, supernatants were collected and human IFNα levels were measured using 
a commercially available ELISA kit (Bender MedSystems module set, Burlingame, CA).  
Samples were assayed in duplicate at dilutions that fell within the range of the standard 
curves. 
Luciferase Assay: HEK293 cells stably transfected with hTLR9 and a NF-kB-driven 
luciferase construct (HEK/hTLR9/NF-kB), and HEK293 cells stably transfected with 
hTLR7and a NF-kB luciferase construct (HEK/hTLR7/NF-kB) were a gift from the Eisai 
Research Institute (Andover, MA). Cells were maintained in tissue culture flasks 
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containing DMEM supplemented with 10% FBS. Cells were treated with the ODNs at the 
specified concentrations at a final volume of 150 μl/well, and incubated at 37°C in air 
supplemented with 5% CO2 for 18 hours. Luciferase activity in cell lysates was measured 
using the Steady Glo Luciferase Assay System (Promega, Madison, WI) on a 
luminometer (Envision, Perkin Elmer). 
Genome-wide scanning for GC content, CpG dinucleotides, and TLR9 stimulatory 
sequences:   Both mouse- and human-like motifs were searched for in both DNA strands 
of the assembled contigs, release date 05/12/2007 (AF.contigs.031704), downloaded 
from the Sanger fpt site (ftp://ftp.sanger.ac.uk/pub/pathogens/A_fumigatus). Sequences 
matching the following patterns were selected:  human-like, 
[CT][CT]GTCGTTN(0,4)GTCGTT, and  mouse-like, 
[CT][CT]GACGTTN(0,4)GACGTT.  Residues between square parentheses indicate 
ambiguities acceptable in the specified positions, N indicates any nucleotide and the 
numbers between parentheses indicate the number of times residues can appear in that 
position. Mismatches were allowed only at the eighth or the last position. GC content was 
calculated from the number of G’s and C’s found for one strand divided by the number of 
base pairs sequenced. CpG dinucleotides were found searching both strands, and the 
frequency calculated using two times the number of base pairs sequenced.  The “fuzznuc” 
algorithm (EMBOSS program: http://bioweb.pasteur.fr/seqanal/EMBOSS) was used for 
each of the searches. 
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Statistical Analysis:  Means ± standard errors (SE) were analyzed by one-way or two-
way ANOVA using a statistical software package (GraphPad Prism 4.02, San Diego, 
CA).  Pairs of group means were then compared by Bonferroni’s multiple comparison 
test.  Statistical significance was defined as p<0.05. 
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Chapter III 
Interactions of plasmacytoid dendritic cells with Aspergillus fumigatus 
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Abstract: 
While plasmacytoid dendritic cells (pDCs) are regarded as critical components of the 
innate immune responses to viruses, their role in host defenses against fungal infections 
has received scant study.  We examined the interactions of human peripheral blood 
pDCs, purified by positive selection for CD304, with Aspergillus fumigatus hyphae.  
pDCs spread over hyphae and inhibited their growth, as determined by assays for fungal 
metabolic activity and by direct measurement of hyphal length via microscopy.  pDC-
mediated antifungal activity was retained in cell lysates, did not require direct contact 
with fungi, and was partially reversed by zinc, suggesting a contribution of calprotectin.  
After a 2 hour incubation with hyphae, >60% of the pDC died and stained positive for 
fragmented DNA by TUNEL assay.   pDC cytotoxicity could be partly attributed to 
fungal gliotoxin secretion, as determined by studies with gliotoxin-deficient A. fumigatus 
mutants and with clinically relevant concentrations of purified gliotoxin.  Furthermore, 
following hyphal stimulation, pDCs released the proinflammatory cytokines, TNFα and 
IFNα, via mechanism independent of TLR7 and TLR9.  Finally, mice depleted of pDCs 
were more susceptible to A. fumigatus infection than their control counterparts. These 
data demonstrate two broad mechanisms by which pDCs may contribute to antifungal 
defenses.  First, pDCs directly inhibit fungal growth via a mechanism that involves A. 
fumigatus-induced pDC death and the release of antifungal mediators.  Second, when 
stimulated with A. fumigatus hyphae, pDCs release cytokines known to activate and 
recruit antifungal effector cells. 
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Introduction: 
  
Aspergillus fumigatus has emerged as the most common cause of invasive mold 
infections. Mortality rates for persons with invasive aspergillosis are very high due to the 
severely immunocompromised status of most inflicted individuals and the relatively weak 
fungicidal activity of the available therapeutic options (Hohl and Feldmesser 2007a; 
Walsh et al. 2008).  Morbidity and mortality can also result from allergic and saprophytic 
forms of aspergillosis. Exposure to this ubiquitous fungus is frequent and typically occurs 
by inhalation of airborne conidia. In the suitable host, the inhaled conidia swell and 
germinate into hyphae, the invasive form of the fungus. Clinical and experimental studies 
have strongly implicated both innate and adaptive immune responses as being critical for 
protection against aspergillosis. While neutrophils appear to be of paramount importance, 
vital contributions of monocytes, macrophages, conventional dendritic cells (DC) and T 
cells have been demonstrated (Bozza et al. 2002; Dagenais and Keller 2009; Diamond et 
al. 1983; Diamond et al. 1978; Feldmesser 2006).  While conidia are efficiently ingested 
by phagocytes, the large size of the hyphal morphotype generally precludes phagocytosis. 
However, phagocytes can spread over the hyphae surface and inhibit and kill the fungus 
via oxidative and non-oxidative mechanisms (Bruns et al. 2010; Diamond and Clark 
1982; Diamond et al. 1983; Levitz et al. 1986; Philippe et al. 2003).  Moreover, co-
incubation of neutrophils and A. fumigatus results in the formation of neutrophil 
extracellular traps (NETs) with direct antifungal activity (Bruns et al. 2010).     
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Plasmacytoid DCs (pDCs), also known as natural type I IFN producing cells, 
rapidly produce copious amounts of type I interferons upon stimulation with viruses 
(Colonna et al. 2004).  In humans, pDCs comprise 0.2 – 0.8% of the total peripheral 
blood mononuclear cells (PBMCs) and express the endosomal Toll-like receptors (TLRs) 
7 and 9, but not any of the other known TLRs.  Upon viral exposure, pDCs initiate 
protective antiviral responses by secreting up to 1000-fold more type I interferon (IFNs) 
than other cell types, predominantly via mechanisms dependent on sensing viral nucleic 
acids via TLR7 and TLR9 (Blasius and Beutler 2010; Lande and Gilliet 2010; Lui et al. 
2009; Masten et al. 2006; Yang et al. 2005; Yu et al. 2010).  Activated pDCs link innate 
to adaptive immunity by secreting cytokines such as IFNα and tumor necrosis factor 
(TNFα) and by differentiating into mature pDCs with upregulated MHC and co-
stimulatory molecules capable of priming naïve T cells (Lande and Gilliet 2010; Stary et 
al. 2009; Yu et al. 2010).  
pDCs have also been implicated in the pathogenesis of autoimmune diseases and 
in maintenance of the immunosuppressive environments in neoplasms (Lande and Gilliet 
2010; Lande et al. 2007). Recently, certain bacteria were shown to stimulate pDCs via 
TLR9 dependent and independent mechanisms (Ang et al. 2010; Krieg 2002; Parcina et 
al. 2008; Petzke et al. 2009; Pietras et al. 2006; Veckman and Julkunen 2008).  However, 
whether pDCs play a role in the detection and responses to fungal pathogens has not been 
well studied.    We have shown that unmethylated CpG motifs in A. fumigatus DNA 
stimulate human pDCs to produce IFNα (Ramirez-Ortiz et al. 2008) while Perruccio et al. 
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demonstrated that A. fumigatus and Candida albicans RNA can stimulate a cytokine 
response in murine and human pDCs (Perruccio et al. 2004). However, it is uncertain 
whether quantities of fungal DNA and RNA released during the course of a mycotic 
infection are sufficient to stimulate pDCs. Therefore, in the present investigation, we 
sought to determine whether human pDCs sense live A. fumigatus hyphae and, if so, what 
are the consequences of the interaction.  We found that pDCs directly inhibit fungal 
growth via a mechanism that involves A. fumigatus-induced pDC death and the release of 
antifungal mediators.  Moreover, following stimulation with A. fumigatus hyphae, pDCs 
release IFNα and TNFα via a TLR-independent mechanism.   
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Results: 
Antimicrobial activity of pDCs against A. fumigatus.  Initial experiments focused on 
determining whether human pDCs, purified from peripheral blood, had direct 
antimicrobial activity against the invasive hyphal morphotypes of A. fumigatus.  pDCs 
were incubated with A. fumigatus hyphae for 2 hours at 37°C.  Antifungal activity was 
then measured by the XTT assay.  We found that pDCs have potent antifungal activity 
against A. fumigatus, with nearly 80% antifungal activity observed at the highest ratio 
(50:1) of pDCs to hyphae tested (Figure 3.2A).  Surprisingly, even at a ratio of 1 pDC to 
20 hyphae, over 40% antifungal activity was seen.  To confirm the XTT data using an 
independent assay, we directly measured the hyphal length of A. fumigatus following 2 
and 4 hour incubations with pDCs at a 1:2 pDCs to hyphae ratio (Figure 3.2B).  
Consistent with the XTT data, hyphal growth was significantly inhibited in the presence 
of pDCs.  Nevertheless, it should be noted that the hyphae did show modest growth 
suggesting that the pDCs were predominantly fungistatic, rather than fungicidal.  
Confocal microscopy of pDCs incubated with A. fumigatus.  Following a 2 hours co-
incubation of pDCs and A. fumigatus, the cells were fixed and observed via confocal 
microscopy (Figure 3.2C).  Nearly all pDCs were found to be closely associated with 
fungi.  The pDCs spread over hyphae that were too large to be ingested and phagocytosed 
A. fumigatus swollen conidia.  
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Figure 3.1.  Purity of pDC population following CD304+ enrichment.   
pDCs were isolated from whole blood by CD304+ selection.  The purity of the pDCs was 
measured by staining 100,000 cells with αCD123-APC antibody and αCD303-FITC 
antibody.  Cells were fixed and analyzed by flow cytometry.  Double positive stain 
represents pDC population.  Representative experiment of 3 individual experiments with 
similar results.
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Figure 3.2. Antimicrobial activity of pDCs against A. fumigatus.   
(A) pDCs (5x104) were incubated with the indicated number of A. fumigatus hyphae for 2 
hours. Antifungal activity of pDCs was then measured by the XTT assay. Data represent 
means ± SE from two donors, each tested in duplicate. (B) A. fumigatus hyphae were 
incubated for the specified times with or without pDCs and hyphal length determined. 
Data represent means ± SE from two experiments. For each variable, at least 75 hyphal 
measurements were recorded. p<0.0001 by Student t-test, when comparing hyphal 
lengths in the presence or absence of pDCs at the 2 and 4 hour time points.  (C)  pDCs 
(1x105) were incubated with A. fumigatus (1x105) at 37°C for 2 hours.  After fixation, 
pDCs were stained with anti-CD123-efluor650 (red) and A. fumigatus hyphae were 
stained with Uvitex (green).  Samples were analyzed by confocal microscopy. 
Arrowheads point to two swollen conidia phagocytosed by a pDC. Arrows point to a 
hypha which is covered by a pDC. The photomicrographs depicted are representative of 
three independent experiments with similar results. 
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Effect of A. fumigatus on viability of pDCs.  While observing pDCs by microscopy, we 
noticed that many of the pDCs incubated with A. fumigatus did not appear healthy, as 
judged by poor adherence to tissue culture wells and swollen morphology.  Thus, we 
examined pDC death, as measured by LDH release, following a 2 hour incubation with or 
without A. fumigatus hyphae (Figure 3.3A).  Remarkably, there was a large increase in 
death of the pDCs in the presence of A. fumigatus.    
Antifungal activity of pDC lysates.  The finding that pDCs died following incubation 
with hyphae raised the question of whether dying pDC had antifungal activity.  To 
examine whether this was indeed the case, we lysed pDCs and compared the activity of 
pDC lysates with intact pDCs against A. fumigatus hyphae (Figure 3.3B). We found that 
the lysates and the live pDCs had comparable antifungal activity. 
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Figure 3.3.  Effect of A. fumigatus on viability of pDCs.   
(A) The indicated number of pDCs was incubated with or without 3x104 A. fumigatus 
hyphae for 2 hours. Supernatants were then collected and cytotoxicity of pDC was 
assessed by LDH release. Data represent means ± SE of three donors, each studied in 
triplicate.  p< 0.0001 by Student t-test when comparing cytotoxicity with and without 
hyphae for each concentration of pDCs.  (B) A. fumigatus hyphae were incubated with 
live pDCs or lysates obtained from the indicated number of pDCs.  Antifungal activity 
was measured by the XTT assay. Data represent means ± SE of three donors, each 
studied in triplicate.  There were no significant differences comparing pDC lysates with 
live pDCs at any of the cell concentrations studied.   
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The contribution of Zn++ and Fe+++ deprivation to the antifungal activity of pDCs.  
The zinc-binding protein calprotectin and iron-binding proteins, such as lactoferrin, are 
constituents of some phagocytic populations and can exert broad antifungal activity by 
chelating divalent cations essential for fungal growth (Mambula et al. 2000; Okutomi et 
al. 1998; Urban et al. 2009).  To determine whether nutritional deprivation of zinc or iron 
contributes to the antifungal activity of the pDCs, we examined whether ZnCl2 or FeCl3 
supplementation rescued pDC-mediated growth inhibition of A. fumigatus hyphae (Figure 
3.4A).  These experiments were performed by direct microscopic measurement of fungal 
growth as high ferric concentrations can interfere with the XTT assay (Knight and Dancis 
2006).  We found that while addition of exogenous FeCl3 had no effect, 10µM ZnCl2 
partially, but significantly, reversed pDC-mediated growth inhibition.  While these data 
suggest a role for calprotectin, the presence of calprotectin in pDCs has not, to our 
knowledge, been previously documented.  Therefore, Western blots probing for 
calprotectin were performed on pDC lysates.  A band of the expected size was found, 
suggesting that pDCs contain calprotectin (Figure 3.4B).  
Effect of cell contact on pDC cytotoxicity and antifungal activity:  Given our 
observations that incubation with A. fumigatus results in both pDC cell death and fungal 
growth inhibition, we next sought to determine whether contact between the pathogen 
and the pDCs was required for these events to transpire.  This was accomplished by 
growing hyphae on the bottom of tissue culture wells fitted with a permeable insert 
(Transwell) with a size exclusion of 0.4 µm.  pDCs were then added either to the top of  
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Figure 3.4.  Contribution of Zn++ and Fe+++ deprivation to the antifungal activity of 
pDCs.   
(A) A. fumigatus hyphae were incubated with or without pDCs (5x104) in the presence or 
absence of 10mM ZnCl2 or 10mM FeCl3.  At the specified times, hyphal length was 
measured as described in Methods.  Solid lines represent A. fumigatus alone whereas 
dotted lines represent A. fumigatus incubated with pDCs. Data represent means ± SE of 
two individual experiments.  p<0.001 by two-way ANOVA, when comparing fungal 
growth in the presence or absence of pDCs. (B) pDCs were hypotonically lysed and 100 
µg of total protein were analyzed by Western blot using a monoclonal antibody against 
human calprotectin. Blot is representative of 3 separate experiments. Arrows point to 
where the indicated molecular size standards ran on the gel.  
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the insert (so that no contact of intact pDCs with hyphae could occur) or underneath the 
insert (allowing contact to occur).  We then measured pDC cytotoxicity and the 
antifungal activity of the pDCs (Figure 3.5).  pDC cell death occurred regardless of 
whether the pDCs were in direct contact with hyphae, although cytotoxicity was greater 
when contact was allowed (Figure 3.5A).  Similarly, while direct contact promoted 
antifungal activity, some antifungal activity was still observed in the absence of contact 
(Figure 3.5B).  
Role of gliotoxin and other A. fumigatus secondary metabolites in the induction of 
pDC cell death:  Our findings that pDC cell death occurs independently of contact with 
A. fumigatus suggest that secreted factor(s) are responsible for the observed effect.  One 
such candidate is A. fumigatus gliotoxin, which is known to induce apoptosis in many cell 
types (Bok et al. 2006; Murayama et al. 1996; Stanzani et al. 2005).  Therefore, we 
incubated pDCs with concentrations of purified gliotoxin within the range found in 
patients with invasive aspergillosis (Lewis et al. 2005; Spikes et al. 2008; Stanzani et al. 
2005).  We found that gliotoxin induced pDC cell death in a dose-dependent manner 
(Figure 3.6).   
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Figure 3.5.  Influence of cell contact on pDC cytotoxicity and antifungal activity.  
(A) A. fumigatus hyphae (5x104) were grown on the bottom of wells containing a 
permeable insert (Transwell) with a size exclusion limit of 0.4 µm.  pDCs (5x104) were 
then added either to the top of the insert (No Contact) or below the insert (Contact). After 
a 2 hour incubation, supernatants were collected and pDC cytotoxicity was measured by 
LDH assay.  p<0.0001 by one-way ANOVA, when comparing pDCs in the presence or 
absence of A. fumigatus for both the “No Contact” and “Contact” groups.  (B) As in part 
A, except antifungal activity was measured by the XTT assay. In addition, the antifungal 
activity of lysates from 5x104 pDCs was assayed.  p< 0.0001 by two-way ANOVA, when 
comparing any two groups except “Contact” and “Lysates”.  For both parts A and B, the 
data represent means ± SE from four different pDC donors, each tested in triplicate. 
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Figure 3.6.  Gliotoxin induces pDC cell death.   
pDCs (5x104) were treated with the indicated concentrations of gliotoxin.  After a 2 hour 
incubation, supernatants were collected and cell mediated cytotoxicity was measured by 
LDH assay. Data represent means ± SE from four pDC donors, each tested in duplicate. 
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Next, we sought to determine whether hyphae-stimulated pDC cell death was due to 
gliotoxin secretion.  Before performing our assay we wanted to determine whether fungal 
growth was comparable between wild-type and gliotoxin deficient and complemented 
strains; therefore we performed XTT assay for all strains (Figure 3.7).  Our results show 
that all strains grow a similar rate.  pDC cytotoxicity was compared following incubation 
with hyphae from wild-type, gliotoxin-deficient and complemented A. fumigatus strains 
(see Table 3.1).  Our results suggest that pDC cell death is partially mediated by A. 
fumigatus gliotoxin, as strains mutated for gliotoxin production induced significantly less 
pDC cell death compared with wild type or complemented strains (Figure 3.8A).  
Similarly, we observed that the antifungal activity of pDCs against A. fumigatus strains 
deficient in gliotoxin production was reduced compared with wild-type or complemented 
strains (Figure 3.8B). In contrast, as expected, the antifungal activity of pDC lysates was 
similar against wild-type, gliotoxin-deficient and gliotoxin-complemented A. fumigatus 
strains (Figure 3.8C).   
Mechanism of pDC cell death.  In order to gain insights on the mechanism of pDC cell 
death, we performed TUNEL assays on pDCs incubated with A. fumigatus hyphae 
(Figure 3.9).  We found DNA fragmentation in approximately 60% of the pDCs 
stimulated with hyphae (Figure 3.9), suggesting that the pDC cell death demonstrated in 
figure 2 is due to apoptosis or pyroptosis.  A similar percentage of TUNEL positive cells 
were seen following incubation of pDCs with gliotoxin.  In contrast, only about 10% of 
unstimulated pDCs had TUNEL-positive staining. 
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Strain name Genotype Phenotype Mutation Reference 
Af293  Wild type Wild type None (Nierman et 
al. 2005b; 
Ramirez-
Ortiz et al. 
2008) 
ΔGliZ gliZ::pyrG 
pyrG1 
Deficient in 
gliotoxin 
production 
Deletion of a putative 
Zn
2
Cys
6
 binuclear
 
transcription factor  
(Bok et al. 
2005; Bok et 
al. 2006) 
GliZ Comp gliZ hygB 
,gliZ::pyrG 
pyrG1 
Complemented 
for gliotoxin 
Complemented ΔGliZ 
strain  
(Bok et al. 
2005; Bok et 
al. 2006) 
ΔLaeA laeA::pyrG 
pyrG1 
Deficient in 
production of  
gliotoxin and 
other secondary 
metabolites 
Aberrant in toxin 
biosynthesis and spore 
development  
(Bok et al. 
2005; Bok et 
al. 2006) 
LaeA Comp laeA hygB, 
laeA::pyrG 
pyrG  
Complemented 
for production of 
gliotoxin and 
other secondary 
metabolites 
Complemented ΔLaeA 
strain  
(Bok et al. 
2005; Bok et 
al. 2006) 
 
Table 3.1.  Description of the A. fumigatus strains used in our studies.  
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Figure 3.7.  Growth curves for A. fumigatus strains deficient in production of 
secondary metabolites.   
Growth of A. fumigatus (5x104) from the indicated strains was determined by XTT assay.  
Graph representative of two individual experiments, both with similar results.  No 
significant differences were found between mutant strains and WT A. fumigatus.  Data 
represent means ± SE of triplicate samples. 
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Figure 3.8.  Role of gliotoxin and other A. fumigatus secondary metabolites in the 
induction of pDC cell death.   
(A, B) pDCs (5x104) were left unstimulated (Unstim) or incubated for 2 hours with 
hyphae (5x104) from the indicated strain of A. fumigatus (see Table 3.1).  pDC 
cytotoxicity and antifungal activity were analyzed by LDH and XTT assays, respectively.   
Data represent means ± SE of duplicate experiments from separate donors, each of which 
was performed in triplicate. p<0.0001 by one-way ANOVA, when comparing deletion 
strains with their complemented counterparts as well as wild-type A. fumigatus (Af293).   
(C) pDC lysates were generated by hypotonic lysis and the indicated strains of  A. 
fumigatus hyphae were incubated for 2 hours at 37°C with volume of pDC lysate 
comparable to 5x104 cells.  The antifungal activity of the lysates against the hyphae was 
measured by XTT assay.  No statistical differences were found among the different 
treatments. 
 
  
 115 
 
 116 
 
Figure 3.9.  Mechanism of pDC cell death.   
pDCs (1x105) were left unstimulated (Unstim) or stimulated for 2 hours with either A. 
fumigatus (1x105) hyphae or gliotoxin (20 ng/ml). Following incubation, samples were 
fixed and stained for DNA fragmentation by TUNEL (Alexa 594) and total DNA 
(Hoechst 33342).  Cells were then examined by confocal microscopy.  (A) TUNEL 
positivity was determined for at least 100 pDCs per group. Data represent means ± SE of 
two individual experiments performed in duplicate; p<0.01 by one-way ANOVA, when 
comparing unstimulated with A. fumigatus or gliotoxin.  (B) Representative confocal 
microscopy images. 
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Cytokine release by pDCs stimulated with A. fumigatus hyphae.  In the final set of 
experiments, we examined whether the interaction of pDCs with hyphae could lead to 
enhanced immune responses due to cytokine release.  pDCs were stimulated with A. 
fumigatus hyphae for 6 hours following which concentrations of IFNα and TNFα were 
determined in the supernatants (Figure 3.10).  For comparison, the “flow through” 
fraction, consisting of the PBMCs which did not adhere to the CD304-coated magnetic 
beads, was also studied.  We found IFNα and TNFα were released from both the pDCs 
and flow through fractions following stimulation with A. fumigatus hyphae.  Human 
pDCs are TLR9+ but TLR4- (Gilliet et al. 2008; Lande and Gilliet 2010; Pietras et al. 
2006; Schreibelt et al. 2010; Tel et al. 2010).  Consistent with this observation, the TLR9 
ligand, CpG, potently stimulated the pDCs whereas the TLR4 ligand, lipopolysaccharide 
(LPS), failed to stimulate these cells.  As expected, LPS stimulated the flow through 
fraction (which contains LPS-responsive monocytes) to release IFNα and TNFα.  
Role of TLR9 in hyphal stimulation of IFNα by pDCs.  We previously demonstrated 
that purified A. fumigatus DNA stimulates TLR9-dependent cytokine release (Ramirez-
Ortiz et al. 2008).  Here we sought to determine whether stimulation of IFNα release by 
intact A. fumigatus hyphae was also mediated by TLR9.  As endosomal acidification is 
essential for TLR9 signaling (Lewis and Cobb 2010; Rutz et al. 2004), we studied the 
effect of pDC pretreatment with the endosomal acidification inhibitors chloroquine and 
bafilomycin A on IFNα release stimulated by A. fumigatus hyphae (Figure 3.10C).  
Inhibiting endosomal acidification did not affect hyphae-induced IFNα release by pDCs,  
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Figure 3.10. Cytokine release by pDCs stimulated with A. fumigatus hyphae. 
(A) and (B). PBMC were separated into pDC positive (pDCs) and negative (Flow 
through) fractions using CD304-coated magnetic beads.  The pDCs and flow through 
cells  (5x104/well) were then left unstimulated (Unstim) or stimulated for 6 hours with A. 
fumigatus hyphae (5x104), CpG (100 ng/ml) or LPS (10 ng/ml).  Supernatants were 
collected and analyzed by ELISA for IFNα (A) and TNFα (B). Data represent means ± 
SE of cytokine concentrations from two donors, each analyzed in duplicate. p<0.0001 by 
two-way ANOVA when comparing cytokine secretion by unstimulated cells with any 
stimulus except for unstimulated pDCs compared with LPS-stimulated pDCs.  (C) pDCs 
(5x104) were pretreated for 60 minutes with 10 µg/ml chloroquine (Chl), 10 µg/ml of 
bafilomycin A (BafA), or left untreated prior to 6 hour stimulation with A. fumigatus 
hyphae (5x104), CpG (100 ng/ml) or LPS (10 ng/ml).  Supernatants were analyzed by 
ELISA for IFNα. Data represent means ± SE of cytokine concentrations from two donors, 
each analyzed in triplicate. p<0.0001 by two-way ANOVA, when comparing 
unstimulated pDCs to pDCs incubated with A. fumigatus or CpG.  IFNα levels stimulated 
by A. fumigatus were not significantly affected by treatment with BafA or Chl. 
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suggesting a TLR9-independent mechanism of stimulation. As expected, chloroquine and 
bafilomycin A abrogated CpG-stimulated IFNα release.  
pDCs are recruited into the lungs of A. fumigatus-infected mice.  In order to 
determine whether pDCs were recruited into the lungs of A. fumigatus-infected mice, 
single cell suspensions obtained from lungs of infected mice were analyzed by flow 
cytometry 48 hours post infection (Figure 3.11).  Our results show an approximately 5-
fold increase in the number of pDCs, defined as CD45+ F4/80-CD11cInt PDCA-1+ cell 
populations following challenge with A. fumigatus.  In addition, we confirmed that 
administration of 120G8 results in profound depletion of pDCs in the lungs.    
pDCs play a non-redundant role in host defenses against A. fumigatus.  In order to 
determine whether pDCs play roles in vivo during A. fumigatus infection, mice were 
treated with either the pDC-depleting mAb 120G8 or a control mAb and then challenged 
with A. fumigatus.  Our results show that mice depleted of pDCs were more susceptible 
to A. fumigatus infection, regardless of whether the challenge was via the pulmonary or 
intravenous route (Figure 3.12).   As pDCs are the major producer of type I IFNs, Next, 
we examined the susceptibility of IFNα/βR-/- mice to invasive aspergillosis. We found the 
KO mice were significantly more susceptible compared with their wild-type counterparts, 
although not as susceptible as mice which were depleted of pDCs.    
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Figure 3.11.  pDCs are recruited into the lungs of A. fumigatus infected mice.  Age 
and sex matched C57Bl/6J mice were either pretreated with 250 µg of 120G8 pDC 
depleting antibody via i.p. injection or left untreated.  24-hours later mice received a 
second dose of 150 µg of pDC depleting antibody.  Following the second i.p. injection, 
mice were infected with 5x107 A. fumigatus conidia via o.t. infection or mock infected 
with PBS/0.01% Tween 20.  Mice were euthanized 48 hours post infection.  Lungs were 
harvested and collagenase and DNAse digested for 1 hour at 37°C.  Total number of lung 
cells was determined by counting on a hemocytometer. Then the lung cells were stained 
for the following cell surface markers:  CD45-PE, F4/80-PercpCy5.5, CD11c-FITC and 
PDCA1- APC.  Stained cells were analyzed by flow cytometry (A) following the diagram 
depicted above (B).  pDC cell counts (C) were calculated using the following equation:  
(total number of cells*%pDC from total file)/% lymphocytes.  Data represent means +/- 
SEM of one experiment performed with n=4 mice per group.  p<0.0001 when comparing 
the total number of pDC of uninfected or depleted mice to the total number of pDCs of 
untreated/infected group.   
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Figure 3.12.  pDCs are required in-vivo during A. fumigatus infection.  C57Bl/6J 
mice were infected with 5x107 A. fumigatus conidia via o.t. infection (A) or 1x106 
conidia via i.v. injection (B and C).  (A and B) Mice were pretreated with 250 µg of 
120G8 monoclonal pDC depleting antibody or control antibody via i.p. injection 24 hours 
prior to infection.  On the day of the infection, mice were treated with 150µg of either 
antibody followed by infection with A. fumigatus.  Mice were then injected with 150 µg 
of either depleting antibody or control antibody every other day for 14 days. (C) 
IFNα/βR-/- mice (which lack receptors for type I IFN) and WT mice were infected with 
1x106 A. fumigatus conidia via i.v. infection.  All groups were followed for survival for 
up to 30 days.  Data represent combined survival curves of 2 independent experiments, 
each with similar results.  p<0.0001 when comparing survival of pDC depleted mice vs 
control antibody treated mice.  p<0.003 when comparing survival of INFα/βR-/- mice to 
WT mice.  
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Discussion: 
Innate responses of phagocytes are thought to be paramount to host defenses 
against A. fumigatus.  Neutrophils, monocytes, macrophages and conventional DCs have 
been shown to recognize and exert antifungal responses that promote clearance of this 
opportunistic fungus (Bozza et al. 2009; Diamond et al. 1983; Feldmesser 2006; Ibrahim-
Granet et al. 2003; Latge 1999; Mezger et al. 2008; Serbina et al. 2009).  Here we show 
that human pDCs inhibit the growth of A. fumigatus hyphae and produce cytokines 
capable of activating and recruiting other immune cells.  
Hyphae, the tissue invasive form of A. fumigatus, rapidly grow to a size that 
precludes phagocytosis.  However, upon incubation of pDCs with A. fumigatus, we found 
that within two hours, pDCs had spread over the hyphal surface.  While the repertoire of 
surface receptors on pDCs associated with fungal recognition has not been well defined, 
human pDCs have been shown to express dectin-2, but not dectin-1, mannose receptor 
and DC-SIGN (Graham and Brown 2009; Meyer-Wentrup et al. 2008).  Moreover, 
human pDCs express some complement and Fc receptors, although we found that hyphal 
recognition did not require opsonization.  Future studies are needed to define receptor(s) 
and their cognate ligand(s) responsible for recognition of A. fumigatus hyphae by pDCs.  
Other cell types, including neutrophils and monocytes, spread over hyphae and 
cause damage to A. fumigatus by oxidative and non-oxidative mechanisms (Diamond et 
al. 1983; Diamond et al. 1978).  Using two independent assays, one that assesses 
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metabolic activity and the other that directly measures hyphal elongation; we 
demonstrated that human pDCs have antifungal activity against A. fumigatus.  However, 
as opposed to the situation with neutrophils and monocytes, where both growth inhibition 
and killing of A. fumigatus have been demonstrated, we only found evidence for growth 
inhibition following incubation of hyphae with pDCs.  Thus, hyphal growth proceeded, 
but at a significantly slower rate, in the presence of pDCs.  
In the absence of activating signals, pDCs reportedly undergo spontaneous 
apoptosis (Grouard et al. 1997; Lepelletier et al. 2010). Interestingly though, after a 2 
hours incubation of pDCs with A. fumigatus hyphae, over half of the pDCs died.  
Moreover, pDC cell lysates had antifungal activity against A. fumigatus and some 
antifungal activity was retained even if the pDCs were separated from the hyphae by a 
0.4 µm permeable insert (Transwell).  These observations strongly suggest that diffusible, 
preformed mediators were responsible for the antifungal activity.  The essential role of 
Fe3+ and Zn2+ as fungal growth factors along with the known presence of chelators of 
these cations in other leukocyte populations (Mambula et al. 2000; Okutomi et al. 1998; 
Urban et al. 2009), led us to examine whether supplemental Fe3+ or Zn2+ would reverse 
the pDC-mediated growth inhibition.  The observation that ZnCl2 (but not FeCl3) 
partially restored fungal growth suggests a role for the Zn2+ binding protein, calprotectin 
(Urban et al. 2009).  Neutrophils contain large amounts of cytoplasmic calprotectin.  Free 
and NET-associated calprotectin, released from dying neutrophils, inhibit the growth of 
C. albicans and other fungi by chelating zinc (Lulloff et al. 2004).  Recently, NETs were 
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shown to have antifungal activity against A. fumigatus (Bruns et al. 2010).  Although it is 
unknown whether a process similar to NETosis occurs with pDCs, we do demonstrate 
that human pDCs contain calprotectin.  It is important to emphasize that Zn2+ 
supplementation only partially restored hyphal growth, suggesting that the antifungal 
activity of pDCs could be mediated by more than one pathway.  
Two lines of evidence strongly suggest that the high rate of pDC cytotoxicity 
following incubation with A. fumigatus hyphae is at least partially due to secreted factors 
released by the fungi.  First, pDC cytotoxicity was observed (albeit at a lower level) when 
the pDCs and hyphae were separated by a Transwell.  Second, pDC cytotoxicity was 
significantly reduced following incubation with hyphae from A. fumigatus strains 
genetically engineered to be deficient in gliotoxin production.  Moreover, purified 
gliotoxin at concentrations found in the lungs of patients with invasive pulmonary 
aspergillosis killed pDCs in a dose-dependent manner (Lewis et al. 2005; Stanzani et al. 
2005). 
 Gliotoxin is a low molecular weight mycotoxin secreted by many fungal species 
including A. fumigatus (Bok et al. 2006; Kupfahl et al. 2008; Sutton et al. 1994; Yoshida 
et al. 2000).  Induction of apoptosis by gliotoxin has been described in many cell types, 
including PMNs and monocytes (Stanzani et al. 2005).   To dissect the mechanism of 
pDC cell death induced by A. fumigatus hyphae, we performed a TUNEL assay.  The 
majority of pDCs incubated with hyphae or purified gliotoxin was TUNEL positive, 
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suggesting that the pDCs are dying by apoptosis.  However, recent studies have shown 
that cells undergoing pyroptosis may also exhibit degradation of DNA and a positive 
TUNEL reaction (Fink et al. 2008; Fink and Cookson 2006).  The finding that pDCs 
release cytokines when stimulated with hyphae points to their undergoing an 
inflammatory (rather than an apoptotic) cell death, although it is possible that the fraction 
of pDCs which remain viable is responsible for the cytokine secretion.  
 pDCs secrete large amounts of type I IFN in response to viral infections and 
certain DNA and RNA sequences (Cao and Liu 2007; Pietras et al. 2006).  Recent reports 
suggest that type I IFNs may play a role during fungal infections (Biondo et al. 2008; 
Inglis et al. 2010b).  Compared with wild-type mice, mice lacking the IFNα/β receptor 
died after challenge with Cryptococcus neoformans and failed to develop protective Th1 
cytokine responses (Biondo et al. 2008).  Moreover, Histoplasma capsulatum conidia 
were shown to induce type I IFN responsive genes in macrophages (Inglis et al. 2010b).  
While Romani et al. did not find INFα secretion by pDCs stimulated by A. fumigatus 
resting conidia (Romani et al. 2004), we found that the tissue invasive hyphal 
morphotype stimulates pDCs to release INFα.  Furthermore, induction of type I IFN 
appears to be independent of TLR7 and TLR9 as inhibition of endosomal acidification 
had no effect on hyphae-stimulated IFNα production.  This is perhaps not surprising 
given that hyphae are extracellular and TLR7 and TLR9 are endosomally localized.  
TLR-independent cytosolic viral sensors that lead to type I IFN responses have been 
identified, including RIG-1 (retinoic acid-inducible gene) and MDA-5 (melanoma 
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differentiation-associated gene 5) (Goutagny et al. 2010).  In addition, surface receptors 
on pDCs that down-modulate the type I IFN response have been described (Lande and 
Gilliet 2010).  However, the stimulatory receptors and downstream signaling pathways 
that enable pDCs to signal in response to A. fumigatus hyphae remain to be elucidated.  
 In an in-vivo infection model, we observe that mice lacking pDCs are more 
succeptible to A. fumigatus infection than their control counterparts suggesting that pDCs 
play a role in the antifungal response against the mold.  Our data show that both pDCs 
and type I INF are important in the clearance of A. fumigatus.  Furthermore, our data 
suggest that pDCs may be more important than type I IFN in the clearance of the mold, as 
mice depleted of their pDCs succumb to the infection faster that the IFNα/βR-/- mice.  In 
addition, we observe an approximately 5-fold increase in the total number of pDCs in the 
lungs of infected mice demonstrating that these cells are recruited to the site of infection. 
Thus, our data shows in an in-vivo infection model that pDCs play a nonredundant role in 
host defenses against A. fumigatus.  While the studies with IFNα/βR-/- implicate a 
contribution of pDC-derived type I IFNs, future studies are required to determine the 
exact mechanisms by which pDCs mediate protection.  Moreover, pending pathology 
studies should help resolve whether the observed survival trends are a result of damage 
caused by the fungus or due to an overly exuberant host inflammatory response.  
Thus, our data demonstrate a putative role for pDCs in host defenses against 
fungal infections.  The host-pathogen interaction between pDCs and A. fumigatus has 
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novel, yet seemingly paradoxical, features.  The significant antifungal activity of pDCs 
against A. fumigatus hyphae appears to be dependent, at least in part, on dying pDCs 
releasing antifungal effector molecules, such as zinc chelators.  This process is enhanced 
by fungal release of cytotoxic molecules, including gliotoxin, which induce apoptosis or 
pyroptosis of the pDCs.  Release of cytokines by fungal stimulated pDCs may serve to 
recruit and activate other immune cells, thereby boosting innate responses and helping to 
initiate adaptive immunity. 
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Materials and Methods: 
Ethics statement.  Informed consent was obtained from healthy volunteers using a 
protocol approved by the University of Massachusetts Medical School Institutional 
Review Board.   
Reagents and cell culture.  Reagents were obtained from Sigma-Aldrich (St Louis, 
Missouri), unless otherwise stated.  DMEM and RPMI-1640 without phenol red were 
obtained from GIBCO (Invitrogen; Carlsbad, California).  pDC media consisted of 
RPMI-1640 without phenol red supplemented with 100U/ml penicillin, 100U/ml 
streptomycin, 2mM L-glutamine, 0.5mM HEPES, 1mM sodium pyruvate and 10% 
autologous serum.  All incubations were in a 37°C incubator containing humidified air 
supplemented with 5% CO2, unless otherwise indicated.  The stimulatory TLR9 ligand, 
CpG 2007 oligonucleotide (ODN) (Latz et al. 2007a), was synthesized with 
phosphothiorate linkages by Integrated DNA Technologies (Coralville, IA).  Ultrapure 
LPS from Escherichia coli was generated as previously described (Huang et al. 2009).  
All antibodies were purchased from eBiosciences (San Jose, CA), unless otherwise 
specified.  Monoclonal antibody against human calprotectin (also known as Calgranulin 
A/B; clone 2Q396C) was obtained from Santa Cruz Biotechnology (Santa Cruz, CA). 
A. fumigatus strains and culture.  Wild-type A. fumigatus strain 293 was obtained from 
the Fungal Genetic Stock Center, Kansas City, MO.  ΔGliZ, GliZ Comp, ΔLaeA, and 
LaeA Comp (Bok et al. 2005; Bok and Keller 2004; Bouhired et al. 2007; Hohl et al. 
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2005) were generous gifts of Dr. Nancy Keller (University of Wisconsin, Madison).  
These genetically manipulated strains were all on the 293 background.  Table 1 contains 
a description of the fungal strains used.  There were no differences in growth rates among 
the different strains as determined using the XTT assay (data not shown).  Except where 
otherwise noted, strain 293 was used in the studies.   
Cultivation of A. fumigatus, harvesting of conidia and growth into hyphae was 
performed as in our previous studies with slight modifications (Mambula et al. 2002).  
Briefly, fungi were grown on Sabouraud Dextrose Agar slants at 37°C for 4 to 7 days.  
Conidia were harvested by adding PBS containing 0.01% Tween 20 followed by 
vortexing.  The collected conidia were then filtered through a 40-µm nylon mesh to 
remove hyphae and conidiophores.  The conidia in the filtrate were washed twice with 
phosphate buffered saline (PBS), counted and stored in water at 4°C for up to a week.  To 
generate hyphae, conidia were incubated at 21oC for 16 hours in pDC medium to swell 
the conidia, and then an additional 3 hours at 37°C to promote germination into hyphae.  
Isolation of human pDCs and autologous sera.  Human pDC were isolated as described 
(Ramirez-Ortiz et al. 2008; Wang et al. 2006). Peripheral blood was collected by 
venipuncture. A portion was clotted and the autologous serum collected following 
centrifugation.  The remainder of the blood was anticoagulated with heparin, diluted 1:1 
with Hank’s buffered salt solution (HBSS) (BioWhittaker; Walkersville, MD) and the 
peripheral blood mononuclear cells (PBMCs) purified by Ficoll-Hypaque 
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(LymphoprepTM; Westbury, NY) density gradient centrifugation.  Human pDCs were 
positively selected from the PBMC using CD304-coated magnetic beads, according to the 
manufacturer’s instructions (Miltenyi Biotech, Auburn, CA).  For some experiments, the 
negatively selected “flow through” cells, consisting of PBMCs depleted of CD304+ cells, 
were collected too. pDC lysates were generated by hypotonic lysis of the pDCs.  CD304+ 
pDCs were washed 3 times with PBS, resuspended in sterile distilled water and then 
incubated at 37°C for 30 minutes.  Lysis was verified by microscopy.  
The high purity of the pDC population (Figure 3.1) was confirmed by analyzing 
the expression of the pDC markers CD123 and CD303 by flow cytometry (Colonna et al. 
2004).  Briefly, freshly isolated pDCs were incubated on ice with anti-CD123-APC 
and/or anti-CD303-FITC for 30 minutes.  Non-specific binding was reduced by using Fc 
Block (Becton Dickinson).  Cells were fixed with 2% paraformaldehyde and analyzed 
using a Becton Dickinson LSRII flow cytometer (BD Biosciences, San Jose CA).  
Isotype controls were included in all experiments.  
XTT assay.  XTT assay was performed as described (Meshulam et al. 1995).  Briefly, A. 
fumigatus conidia were plated in 96-well half area plates and allowed to germinate in 
pDC media to hyphae of 10-20 µm average length.  The hyphae were preopsonized by 
incubation in 10% autologous serum for 30 minutes followed by washing.  Experiments 
comparing preopsonized and unopsonized hyphae yielded similar results (data not 
shown).  pDCs were then added to the hyphae in a final volume of 100 µl pDC media.  
 134 
 
For some experiments, where indicated, pDCs lysates were added in lieu of live pDCs or 
the experiments were conducted in Transwell chambers rather than half area wells.  
Following a 2 hour incubation, the pDCs were subjected to hypotonic lysis by three 
gentle washes and 20 minute incubation with sterile distilled water.  Supernatants then 
were removed, taking care not to remove the hyphae.  pDC media without serum 
containing 400 µg/ml of XTT and 50 µg/ml of Coenzyme Q were added and the wells 
were incubated for 2 hours at 37°C.  The OD450 and OD650 were then measured and data 
expressed as percent antifungal activity according to the following formula:   
% Antifungal Activity = 1001 









 
BlankAf
pDCspDCsAf
ODOD
ODOD
 
 ODAf + pDC is (OD450 – OD650) of wells containing A. fumigatus hyphae with pDCs. 
ODpDC is (OD450 – OD650) of wells containing pDCs.  ODAf is (OD450 – OD650) of wells 
containing A. fumigatus hyphae alone. ODblank is (OD450 – OD650) of wells containing 
media alone.  
Hyphae Growth Inhibition Assay.  A. fumigatus hyphae were incubated in pDC media 
at 37°C in 8-well coverslip chambers (Nunc, Rochester NY) with or without pDCs.  
Where indicated, pDC media were supplemented with 10 mM ZnCl2 or 10mM FeCl3.  At 
the specified times, pDCs were lysed with water and hyphae were fixed with 2% 
paraformaldehyde.  Hyphal length was then measured by microscopy (Nikon Eclipse 
TE200) using software (SOFTMax Advace, SPOT Imaging Solutions) equipped with a 
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curved and calibrated cursor.  A minimum of 10 visual fields containing at least 75 
hyphae were scored per group.  
Cytotoxicity Assay.  The LDH release assay (Roche Applied Science, Indianapolis IN) 
was performed and analyzed according to the manufacturer’s instructions.  Briefly, pDCs 
were incubated with or without preopsonized A. fumigatus or gliotoxin for 2 hours in 150 
µl pDC media.  Following centrifugation, supernatants were collected, incubated with an 
equal volume of developing solution for 25 minutes at room temperature and the OD492 
was measured.  The maximum LDH released was determined by lysing pDCS with 
Triton X-100.  All samples were measured in triplicate. 
Confocal Microscopy.  Preopsonized A. fumigatus hyphae in 35mm tissue culture slide 
dishes (Mattek Corporation, Andover, MA) were incubated with pDCs in pDC media for 
2 hours at 37oC.  Cell surface staining was then performed by incubating with the pDC 
specific antibody CD123-efluor650 (eBiosciences, San Jose CA) for 30 minutes at 0oC.  
Following three washes with PBS supplemented with 2% FBS, fungal cell walls were 
stained with the chitin-specific fluorescent dye, 1% Uvitex 2B (Polysciences, Warrington 
PA), by incubation for 20 minutes at 0oC.  Samples were fixed with 2% buffered 
paraformaldehyde and visualized by confocal microscopy using a Leica SP2 AOBS 
confocal microscope (Leica Microsystems, Bannockburn IL) with a 63X plan 
apochromatic objective (Zeiss).   
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Transwell Assay.  Transwell 96 well plates containing 0.4 µm pore size polycarbonate 
membrane inserts were obtained from Corning Life Sciences (Lowell, MA).  A. 
fumigatus conidia (5x105 in 100µl) were added to the surface of the wells and germinated 
to hyphae as described above.  pDCs (5x105 in 100µl) were then added either below 
(allowing direct contact with hyphae) or above (allowing no contact with hyphae) the 
insert.  After 2 hours incubation, pDC cytotoxicity and antifungal activity were assayed 
as described above. 
TUNEL Assay.  TUNEL assay was performed following the manufacturer’s instructions 
(Molecular Probes, Eugene OR).  Briefly, pDCs and A. fumigatus hyphae were incubated 
for 2 hours at 37°C in tissue culture chamber slides.  Cells were fixed with 2% 
paraformaldehyde for 20 minutes at room temperature.  pDCs were stained for the 
surface marker CD123 (CD123-efluor650) for 30 minutes at 0°C.  After washing 3 times, 
cells were permeabilized and stained for fragmented DNA by the Click-it reaction 
(Alexafluor 594).  After additional washes, total cellular DNA was stained using Hoechst 
33342.  All samples were visualized by confocal microscopy, as described above.   
Mice.  Wild-type (C57Bl/6J) mice were purchased from Jackson Laboratories (Bar 
Harbor, ME).  IFNα/βR-/- ,  which lack type I IFN receptors,were a kind gift from Jon 
Sprent and were backcrossed to the C57Bl/6J background for at least 12 generations  
(Kolumam et al. 2005; Thompson et al. 2006; Wang et al. 2010) .  Mice were 6 to 8 
weeks old at the start of the experiments and all groups were matched for sex and age.  
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Mice were maintained under microisolation conditions at the University of Massachusetts 
Medical School under a protocol approved by the Institutional Animal Use and Care 
Committee. 
For oro-tracheal infections (OT), mice were anesthesized with Isofluorane and 
subsequently infected with A. fumigatus conidia suspended in 100 µL of sterile PBS 
supplemented with 0.01% Tween20 and administered in two doses of 50 µL each.  For 
intravenous (i.v.) infections, mice were injected by the tail vein with 106 A. fumigatus 
conidia suspended in sterile PBS supplemented with 0.01% Tween 20 (Bellocchio et al. 
2004a; Werner et al. 2009).  For survival studies, infected mice were monitored at least 
daily for 30 days.  Moribund mice were euthanized.    
pDC Influx Assay.  Mice were infected OT as described above.  48-hours post infection, 
mice were euthanized by CO2 inhalation and their pulmonary arteries were perfused with 
PBS.  Lungs were harvested, minced and incubated with 1 mg/mL of Collagenase type 
IV (Sigma Aldrich, MO) and 75 µg/mL bovine pancreatic DNAse (Sigma) supplemented 
with 5% FBS in PBS for 1 hour at 37°C (Wozniak et al. 2006).  Following digestion, 
cells were passed through a 70µm filter in order to obtain single cell suspensions.  Cells 
were counted and stained for flow cytometry using the following markers:  PDCA-1, 
CD11c, CD45 and F4/80 (all antibodies were obtained from eBiosciences, San Diego 
CA) (Ang et al. 2010).  In order to establish the specificity of the antibodies, isotype 
controls were performed and analyzed for each antibody used.  Samples were analyzed 
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using BD LSRII (Becton Dickinson, San Jose, CA) and data were analyzed using Flojo 
7.6 version for PC (Tree Star Inc, Ashland, OR). 
pDC depletion.  pDC depletion in mice was achieved by intraperitoneal injection (i.p.) 
with monoclonal rat anti-mouse IgG 120G8 pDC depleting antibody or monoclonal rat 
anti-mouse IgG control antibody GL113 againt E.coli β-galactosidase (Ang et al. 2010) 
(Gift of Dr. Louis Boon, Bioceros).  Briefly, mice were injected with 250µg of either 
120G8 or GL113 the day before infection (day -1).  At day 0, mice received an additional 
dose of 150µg antibody.  Following treatment mice were infected with A. fumigatus as 
described above.  In order to maintain depletion, mice were treated with 150µg of 
antibody every 48 hours until day 14 post-infection.   
Cytokine Secretion.   The indicated concentrations of pDCs or flow through cells were 
incubated with A. fumigatus hyphae in 96-well flat-bottom plates containing a final 
volume of 200 µl pDC media supplemented with 10% autologous serum.  After 6 hours, 
supernatants were collected and human IFNα and TNFα levels were measured using 
ELISA kits (Bender MedSystems module set, Burlingame, CA for IFNα and 
eBiosciences, San Diego, CA for TNFα) according to the manufacturers’ instructions.  
Samples were assayed in duplicate at dilutions that fell within the range of the standard 
curve. 
For the inhibition experiments, pDCs were left untreated or incubated for one 
hour with either 10 µg/ml of bafilomycin A or 10 µg/ml of chloroquine. pDCs were then 
incubated for 6 hours with preopsonized A. fumigatus hyphae, CpG or LPS in a final 
 139 
 
volume of 200 µl of pDC media without serum.  Samples were then assayed for IFNα by 
ELISA as described above.  
Statistical Analysis.  For comparisons of two groups, means ± standard errors (SE) were 
analyzed by the two-tailed unpaired Student t-test with the Bonferroni correction applied 
when making multiple comparisons.  For comparisons of greater than two groups, 
significance was determining using the one- or two-way analysis of variance (ANOVA) 
with the Tukey multiple correction.  Calculations were performed using a statistical 
software package (GraphPad Prism 4.02, San Diego, CA) and statistical significance was 
defined as p<0.05.
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Abstract 
Upon maturation, pDCs acquire characteristics similar to cDCs.  While we showed that 
freshly isolated pDCs are capable of inducing an antifungal response against A. 
fumigatus, the role of mature pDCs during infection remains unclear.  Here, CD304+ 
human pDCs, isolated from the blood of donors were matured by incubation with IL-3, 
CD40L and GM-CSF for seven days.  Our results show that CD304+ mature pDCs 
produced Type I IFN and TNFα in response to incubation with live A. fumigatus.  As 
pDCs are characterized by being TLR4- and TLR9+, cells were tested with ultrapure LPS 
and CpG DNA as purity controls.  Cytokines were detected upon CpG DNA, but not LPS 
stimulation, suggesting that the cell population was not contaminated with macrophages 
or cDCs. Purity of the cell population was confirmed by flow cytometry.   These data 
demonstrate that A. fumigatus is capable of stimulating cytokine secretion in mature 
human pDCs.   
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Introduction 
 
Over the last three decades, Aspergillus fumigatus has emerged as the most 
common cause of invasive mold infections in the immunocompromised host (Sherif and 
Segal 2010).  A. fumigatus can be found widely distributed in the environment.  The 
small airborne spores or conidia are inhaled into the lungs, where in virtue of their small 
size, they can reach the alveoli.  In the immunocompetent host, the conidia are readily 
cleared by resident immune cells of the pulmonary system.  However, in the appropriate 
host, conidia can escape recognition by cells of the immune system and they can 
germinate to establish an infection (Hosseini-Moghaddam and Husain 2010).   
Germination of A. fumigatus starts when resting conidia encounter an appropriate 
niche.  Given nutrients and water, resting conidia begin to grow and germinate (Rhodes 
2006).  First, the resting conidia undergo a period of isotropic growth.  The outermost 
layer of the resting conidia is characterized by the presence of hydrophobins and melanin, 
both of which protect A. fumigatus from environmental distress and enable the mold to 
form a more efficient aerosol (Paris et al. 2003; Pihet et al. 2009).  One of the first steps 
of germination is the uncoating of this hydrophobic outer layer.  Within a few hours, A. 
fumigatus conidia undergoing isotropic growth undergo changes in the cell wall 
composition.  Swollen conidia exposes carbohydrate moieties such as β-(1-3)-glucans, β-
(1,3-1,4)-glucans and chitin (Bernard and Latge 2001; Gastebois et al. 2009).  Exposure 
of these carbohydrate moieties, upon conidial swelling, enables phagocytes to recognize 
and kill A. fumigatus. Once the conidia have undergone swelling, A. fumigatus switches 
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to polarized growth (Rhodes 2006).  During this polarized growth, germ tubes increase 
their adhesion properties. The fast growing rate of germ tubes gives rise to hyphae, the 
invasive form of the mold.   
Phagocytes are essential in the clearance of A. fumigatus. Upon inhalation, 
alveolar macrophages, dendritic cells (DCs) and neutrophils are the first line of defense 
against A. fumigatus conidia.  These phagocytes are capable of phagocytosing and killing 
the spores in the phagolysosome.  In some cases, conidia escape recognition by the 
alveolar macrophages and germinate into hyphae.  Neutrophils are responsible of 
eliminating hyphae via oxidative and non-oxidative mechanisms.  Immunocompromised 
hosts, particularly those that are neutropenic, are extremely susceptible to developing 
aspergillosis (Hohl and Feldmesser 2007a; Levitz 2004; Shoham and Levitz 2005).   
Plasmacytoid dendritic cells (pDCs) are characterized by secreting large amounts 
of type I Interferon (IFN) (Cella et al. 1999).  Initially pDCs were described as 
plasmacytoid T cells based on their plasma-cell-like morphology and the presence of 
CD4.  pDCs have been extensively characterized over the last decade.  Expression of the 
interleukin-3 receptor (IL3 or CD123), blood dendritic cell antigen-2 (BDCA-2 or 
CD303) and ILT7 distinguishes pDCs from other cells in the blood (Dzionek et al. 2001; 
Swiecki and Colonna 2010).  In addition, pDCs express CD4, major histocompatability 
complex (MHC) class II, CD68 and CD2 (Colonna and Cella 2007).  However, human 
pDCs lack the lineage markers CD3, CD19, CD14 and the DC marker CD11c.  pDCs are 
generated in the bone marrow, where they are released into the blood in very small 
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number.  These cells make less than 0.5% of the total peripheral blood mononuclear cells 
(PBMCs).  pDCs can be found mainly in T-cell areas such as the spleen and lymph 
nodes, in mucosal associated tissues and thymus (Barchet et al. 2005; Kreisel et al. 2006). 
 Immature pDCs can readily be found in the blood.  In their non-active state, pDCs 
are incapable of inducing T-cell proliferation.  However, upon encountering an antigen 
they become activated.  Upon activation, pDCs secrete large amounts of type I IFNs.  In 
addition, mature pDCs acquire DC morphology, upregulate MHC and T-cell 
costimulatory molecules that enables pDCs to directly activate naïve T-cells (Lande and 
Gilliet 2010).  When in culture, freshly isolated pDCs can be matured by incubation with 
IL3 or IL3 plus CD40L (Grouard et al. 1997).  Maturation of pDCs in-vitro by CD40L or 
viral infection results in the formation of a functionally distinct type of DC also known as 
DC2 (Cella et al. 2000).  These mature pDCs secrete bioactive IL12, and can induce Th2 
responses by secretion of lL4.  In vivo, pDCs migrate to the site of infection.  Once pDCs 
encounter antigen, they acquire cDC-like characteristics such as antigen uptake, MHC 
upregulation and antigen presentation to T-cells in the lymph nodes. In vitro, maturation 
of pDCs does not affect their ability to generate and secrete cytokines; however, it has 
been suggested that in vivo, mature pDCs downregulate secretion of type I IFN and IL12   
(Mittelbrunn et al. 2009).     
pDCs secrete huge amounts of type I IFN, which have been shown to play an 
important role in the antiviral response (Gilliet et al. 2008).  Secretion of type I IFN has 
been show to augment the expression of antiviral molecules and promote apoptosis of 
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infected cells.  In addition, human pDCs are the only subset of DCs that express the 
endosomal TLRs, TLR7 and TLR9.  These TLRs have been shown to recognize ssRNA 
and unmethylated CpG DNA, respectively (Ishii and Akira 2006; Vilaysane and Muruve 
2009).  Although a role for pDCs in the antifungal response has not been described to 
date, TLR9 has been shown to recognize and stimulate secretion of type I IFN in 
response to A. fumigatus DNA (Ramaprakash et al. 2009; Ramirez-Ortiz et al. 2008).  
However, whether pDCs are capable of inducing a cytokine response upon challenge 
with live A. fumigatus remains to be elucidated.  Here we show that pDCs, both mature 
and immature, secrete cytokines in response to stimulation with A. fumigatus conidia.
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Results 
 
Mature pDCs spread over A. fumigatus hyphae  
 In order to determine whether mature pDCs recognized and interacted with A. fumigatus, 
we incubated matured pDCs with conidia for 18 hours and analyzed the interaction by 
light microscopy (Figure 4.1).  While we incubated matured pDCs with A. fumigatus 
conidia, by the time we examined the cells, the conidia had already germinated into 
hyphae.  Therefore, our results show that mature pDCs are capable of interacting and 
spreading over A. fumigatus.   
Mature pDCs secrete proinflammatory cytokines in response to A. fumigatus   
Since the microscopy suggested that there was a close interaction between A. fumigatus 
and the mature pDCs, we sought to determine whether mature pDCs were capable of 
stimulating a proinflammatory response against conidia.  During infection, A. fumigatus 
can be encountered by the pDCs as either resting conidia or swollen conidia.  First we 
sought to determine whether day 1, day 5 and day 7 mature pDCs induce an antifungal 
response against A. fumigatus; therefore, we analyzed cytokine secretion by pDCs 
challenged with either resting or swollen conidia.  Our results show that A. fumigatus 
stimulates secretion of IFNα and TNFα in mature pDCs (Figure 4.2).   Although day 1 
mature pDCs secrete cytokines in response to A. fumigatus, optimal cytokine secretion 
for SC and RC was observed when pDCs were matured for 7 days in media 
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Figure 4.1:  Mature pDCs Recognize and Interact with Aspergillus fumigatus.  
CD304+ pDCs (5x104 cells per well in 96-well plates) were matured for 7 days in RPMI 
supplemented with 10% FBS, 10ng/mL of recombinant IL-3, 10ng/mL CD40L and 150 
ng/mL of GMCSF at 37°C.  At day 7, cells were washed and the media was changed 
(RPMI supplemented with 10% autologous serum, 10ng/mL IL-3, 10ng/mL CD40L and 
150 ng/mL GM-CSF).  Consequently, pDCs were challenged with pre-opsonized A. 
fumigatus conidia for 18 hours at 37°C.  Cell interactions were analyzed by microscopy.  
Photomicrograph represents 18 hours post-stimulation with swollen conidia.  Sample 
visualized at 40X magnification.   
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Figure 4.2: Secretion of IFNα and TNFα by day 1, 5, 7 mature pDCs in response to 
A. fumigatus.   
CD304+ pDCs (50,000/well in 96-well plates) were matured for 1, 5 or 7 days in RPMI 
supplemented with 10% FBS, 10 ng/mL of recombinant IL-3, 10 ng/mL CD40L and 150 
ng/mL of GMCSF at 37°C.  At the specified maturation day, pDCs were challenged with 
5x104 conidia per well (either swollen or resting) and incubated at 37°C for 6 hours.  
IFNα (A) and TNFα (B) secretion in supernatants were measured by ELISA.  Data 
represent means ±SE of two independent experiments performed in duplicate. 
SC- Swollen Conidia, RC- Resting Conidia 
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 supplemented with IL-3, GM-CSF and CD40L.  Based on our results, we decided to 
perform all the subsequent assays with day-7 mature pDCs.  
Our results show that mature pDCs secrete IFNα, TNFα and IL-12p70 in response to both 
morphologies of A. fumigatus (Figure 4.3).  Furthermore, our results show that mature 
pDCs secrete cytokines in response to A. fumigatus as early as 6 hours post-infection 
suggesting that mature pDCs recognize both conidial morphologies and induce a 
proinflammatory response against the mold. In addition, over the 6 hour and 18 hour 
incubation period, A fumigatus conidia undergoes morphological changes.  Within 6 
hours of incubation on a nutrient rich environment, the resting conidia will become 
swollen conidia and the swollen conidia will become hyphae.  Within 18 hours both 
morphologies will germinate into hyphae.  Therefore, the possibility of mature pDCs 
recognizing and secreting cytokines in response to hyphae cannot be eliminated.  
A. fumigatus recognition by mature pDCs is independent of opsonization 
 The pattern of cytokine secretion by mature pDCs was similar for all three cytokines 
tested regardless of the A. fumigatus morphology encountered, suggesting that there may 
be another factor involved in the recognition of the conidia.  In all our assays we have 
opsonized the conidia with autologous serum prior to addition to the mature pDCs.  Since 
serum contains Fc receptors and antibodies that have been shown to coat A. fumigatus, 
we wondered whether opsonization of the conidia was responsible for the observed 
cytokine secretion pattern.  Our results show that cytokine secretion by mature pDCs in 
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Figure 4.3:  Mature pDCs secrete cytokines within 6 hours of A. fumigatus 
challenge.   
CD304+ pDCs (50,000/well in 96-well plates) were matured for 7 days in RPMI 
supplemented with 10% FBS, 10ng/mL of recombinant IL-3, 10ng/mL CD40L and 150 
ng/mL of GMCSF at 37°C.  At day 7, cells were washed and the media was changed 
(RPMI supplemented with 10% autologous serum, 10ng/mL IL-3 and 150 ng/mL GM-
CSF).  Consequently, pDCs were infected with opsonized swollen or resting A. fumigatus 
Af293 conidia and incubated at 37°C at 1:1 ratio.  Supernatants were collected at 6 and 
18 hours and analyzed by IFNα (A), TNFα (B) and IL12p70 (C) ELISA. Unstimulated 
cells and LPS (10 ng/mL) were used as negative and cell purity controls, respectively.  
CpG2007 (100 ng/mL) was used as a positive control. Data represent means ±SE of 
triplicate values.  p value < 0.0001 when comparing 6 hours post- stimulation to 18 hours 
post-stimulation.  Experiment was performed with 2 individual donors.   
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 response to A. fumigatus conidia occurs independently of opsonization (Figure 4.4).  
Furthermore, our results show that secretion of IFNα and TNFα in response to un-
opsonized A. fumigatus conidia was independent of the morphology encountered. 
Only live A. fumigatus stimulates a cytokine response by mature pDCs  
Since recognition and cytokine secretion by pDCs occurs via a mechanism independent 
of opsonization, we wanted to determine whether heat killed A. fumigatus was able to 
induce a response.  Mature pDCs were capable of secreting IFNα only in response to live 
A. fumigatus (Figure 4.5).  Our results show that mature pDCs challenged with low 
concentrations of heat killed A. fumigatus do not secrete cytokines; however, a response 
can be observed upon challenge with live conidia.   
Mature pDC stimulation may be mediated by a fungal secreted factor 
We noticed that there was no difference in the cytokine secretion profile of mature pDCs 
when incubated with A. fumigatus resting conidia or swollen conidia.  As part of our 
method, the conidia were collected (resting) or swelled and stored at 4°C until ready to 
use, but not longer than two weeks.  It was possible that the observed stimulation was due 
to a secreted fungal factor.  In order to address whether there was a fungal factor secreted 
into the media capable of activating secretion of cytokines by mature pDCs, we incubated 
the mature pDCs with washed A. fumigatus, unwashed A. fumigatus or fungal 
supernatants.  Our results show that fungal supernatants are capable of inducing a 
proinflammatory response in mature pDCs (Figure 4.6). Furthermore, A. fumigatus 
supernatants are capable of inducing a strong IL-6 response (Figure 4.6C).  In addition,  
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Figure 4.4:  Stimulation of pDCs by Aspergillus conidia is independent of 
opsonization.  
CD304+ pDCs (50,000/well in 96-well plates) were matured for 7 days in RPMI 
supplemented with 10% FBS, 10ng/mL of recombinant IL-3, 10ng/mL CD40L and 150 
ng/mL of GMCSF at 37°C.  pDCs were infected with either swollen or resting A. 
fumigatus Af293 conidia and incubated for 6 hours at 37°C at 1:1 ratio in the presence of 
the following treatments:  10% complement preserved autologous serum; 10% heat 
inactivated autologous serum, 10% heat-inactivate FBS or no serum.  Supernatants were 
collected 6 hours post-incubation and analyzed by IFNα, TNFα and IL12p70 ELISA. 
Unstimulated cells and LPS (10 ng/mL) were used as negative and cell purity controls, 
respectively.  CpG2007 (100 ng/mL) was used as a positive control.  Data represent 
means ±SE of quadruplicate samples.  The experiment was performed with 2 individual 
donors.   No statistical differences were found when comparing challenge of pDCs by 
swollen or resting conidia.  
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Figure 4.5:  Live, but not heat-killed, Aspergillus stimulates pDCs to secrete 
cytokines.  
CD304+ pDCs (50,000/well in 96-well plates) were matured for 7 days in RPMI 
supplemented with 10% FBS, 10ng/mL of recombinant IL-3, 10ng/mL CD40L and 150 
ng/mL of GMCSF 37°C.  At day 7, cells were washed and the media were changed 
(RPMI supplemented with 10% autologous serum, 10 ng/mL IL-3, 10 ng/mL CD40L and 
150 ng/mL GM-CSF). Fungal conidia, swollen and resting, were heat-killed at 56°C for 
30 min.   Consequently, pDCs were infected with opsonized live or heat-killed A. 
fumigatus Af293 conidia (swollen or resting) and incubated at 37°C at the specified ratio.  
Supernatants were collected at 18 hours and analyzed by IFNα, TNFα and IL12p70 
ELISA.  Unstimulated cells and 10 ng/mL LPS were used as a negative control.  
CpG2007 (100 ng/mL) was used as a positive control.  No statistical differences were 
found when comparing challenge with either swollen or resting conidia. Data are 
representative experiment of 3 performed in duplicate.  Difference (p value ≤ 0.001) was 
observed when comparing challenge of pDCs with live vs. heat killed A. fumigatus. 
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our results show that unwashed A. fumigatus conidia stimulate higher secretion of IFNα 
when compared to conidia that underwent a washing step or to fungal supernatants 
(Figure 4.6A).  However, there was no difference in the secretion of TNFα and IL-12p70 
among the different treatments (Figure 4.6B and 4.6D).   
Since our results show that A. fumigatus supernatants induce a potent proinflammatory 
response in mature pDCs, we sought to determine whether a fungal immunogenic factor 
was secreted into the media during conidial growth and germination. In order to 
determine whether contact was required for A. fumigatus to secrete the potential 
immunostimulatory factor and induce a response by mature pDC, a Transwell assay was 
performed.  s  We challenged pDCs with A. fumigatus with either swollen or resting 
conidia incubated in the same compartment (contact) or separated by a permeable 
membrane (Figure 4.7).  Our results show that pDCs secrete IFNα independent of contact 
(Figure 4.7A).  However, secretion of TNFα is reduced when pDCs and A. fumigatus are 
separated by the Transwell (Figure 4.7B).  Our results suggest that A. fumigatus secretes 
an immunogenic factor into the environment during fungal growth.  
A. fumigatus secretes proteins and carbohydrates during conidial germination 
During condial germination, A. fumigatus secretes a large number of cell wall-associated 
proteins and carbohydrates.  Some of these secreted factors have been shown to be 
immunostimulatory.  In order to assess the nature of the fungal factor responsible for 
inducing a cytokine response in mature pDCs, we measured the protein and carbohydrate 
content secreted during A. fumigatus growth.  We grew A. fumigatus to the different  
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Figure 4.6:  Stimulation of pDCs appears to be mediated by a fungal secreted factor. 
CD304+ pDCs (50,000/well in 96-well plates) were matured for 7 days in RPMI 
supplemented with 10% FBS, 10 ng/mL of recombinant IL-3, 10 ng/mL CD40L and 150 
ng/mL of GMCSF at 37°C.  At day 7, cells were washed and the media was changed 
(RPMI supplemented with 10% autologous serum, 10ng/mL IL-3, 10ng/mL CD40L and 
150 ng/mL GM-CSF).  Consequently, pDCs were infected with washed swollen or 
resting A. fumigatus Af293 conidia and incubated for 6 hours at 37°C at 0.1:1 
(Fungi:pDC).  pDCs were also treated with 10µL of supernatants collected from 
centrifuged A. fumigatus conidia (swollen and resting).  Supernatants were collected after 
6 hours incubation and analyzed by IFNα (A), TNFα (B), IL6 (C) and IL12p70 (D) 
ELISA. Unstimulated cells and 10 ng/mL LPS were used as negative and cell purity 
controls, respectively.  CpG2007 (100 ng/mL) was used as a positive control. Data 
represent means ±SE of duplicate experiments.  Comparison between results from 
swollen and resting conidia does not yield statistical differences by 2-way ANOVA.  
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Figure 4.7.  A. fumigatus stimulates cytokine secretion in mature pDC via a secreted 
factor.    
pDCs (50,000/well) were matured for 7 days on pDC media supplemented with 10 ng/mL 
recombinant IL3, 10 ng/mL CD40L and 150 ng/mL GM-CSF.  On day 7, pDCs were 
challenged with 50,000 resting or swollen conidia either in contact with the pDCs or 
separated by a 1µm permeable insert (Transwell).  pDCs and A. fumigatus were co-
incubated for 6 hours at 37°C.  Supernatants were collected and analyzed for cytokine 
secretion by IFNα and TNFα ELISA.  Graphs represent means ±SE of duplicate 
experiments.  No statistical difference was found in the secretion of IFNα for pDCs in 
contact with conidia when compared to cells separated by a Transwell, p value < 0.001 
by Student’s T-test for TNFα secretion when comparing these treatments.  
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conidial germination stages and collected supernatants from each of the growth stages 
(Figure 4.8).  Our results show that A. fumigatus secretes between 600-1000 µg/mL of 
protein (Figure 4.8A).  Furthermore, A. fumigatus secretes large amounts of sugars into 
the media with concentrations reaching approximately 20 mg/mL (Figure 4.8B).   While 
our results show that A. fumigatus secretes proteins and carbohydrates into the 
environment, it is possible for other bioactive factors to be secreted during fungal growth.  
Therefore, future work is required in order to determine the nature of the 
immunostimulatory factor.   
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Figure 4.8.  A. fumigatus secretes proteins and carbohydrates into the environment 
during fungal growth.   
A. fumigatus (5x104 conidia per well) were grown to swollen conidia, germ tubes or 
hyphae, or plated as resting conidia on 96-well plate at 37°C in pDC media.  Once A. 
fumigatus reached the specified morphology (growth stage), 100 µL of supernatants were 
collected.  The concentration of protein (A) during fungal growth was determined by 
BCA Assay.  The concentration of carbohydrates (B) was determined by the Dubois 
Method (Dubois et al. 1951).  Data represent means ±SE of two individual experiments. 
For protein assay, p value ≤0.0001 by one way ANOVA for different fungal growth 
stages.  For carbohydrate assay, p value ≤ 0.0004 by one way ANOVA for different 
fungal growth stages. 
RC- resting conidia, SC- swollen conidia, GT- germ tubes, H- hyphae 
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Discussion 
Phagocytes have been shown to be essential in the antifungal response and 
clearance of A. fumigatus (Diamond 1988; Loeffler et al. 2009).  Although TLR9 has 
been shown to play a role in the detection of fungal DNA, and our results (Chapter 3) 
show that immature pDCs play a role in the antifungal response, whether mature pDCs 
are involved in the overall immune response against A. fumigatus remains to be 
determined (Ramirez-Ortiz et al. 2008).  Here we show that mature pDCs secrete 
cytokines in response to A. fumigatus conidia.  Furthermore, mature pDCs are inducing a 
proinflammatory response independent of opsonization. 
 pDCs play a vital role in the antifungal response (Gilliet et al. 2008; Lande and 
Gilliet 2010).  In addition to the role of pDCs in antiviral responses, these cells were 
shown to be involved in the antibacterial and antiparasite response (Bauer et al. 2001; 
Liese et al. 2008).  pDCs were found to be rapidly recruited to the lungs of mice infected 
with Legionella.  In addition, bacterial load was larger in mice depleted of their pDCs 
(Ang et al. 2010).  However, pDCs have not been shown to be involved in the antifungal 
response.   
 As mature pDCs have been shown to acquire DC-like morphology, and their 
phagocytic ability increases with maturation, we sought to determine whether they were 
capable of interacting with A. fumigatus (Lande and Gilliet 2010; Tan and O'Neill 2005).  
Our results show that mature pDCs spread over the hyphae.  This suggests that pDCs are 
capable of recognizing A. fumigatus, but does not tell us whether mature pDCs are 
capable of initiating a proinflammatory response.   
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 Upon maturation, cytokine secretion by pDCs decreases and their ability to induce 
an adaptive immune response increases (Lande and Gilliet 2010; Swiecki and Colonna 
2010).  Incubation of pDCs with IL3 and CD40L is one way of inducing maturation of 
these cells (Grouard et al. 1997).  Maximal response of the pDCs to A. fumigatus conidia 
was observed at day 7 post-isolation from blood.  pDCs secrete type I IFN and TNFα in 
response to A. fumigatus conidia.  The secretion of cytokines by mature pDCs is possibly 
a way of these cells to communicate with other cells and initiate the adaptive immune 
response.  Mature pDCs have been shown to initiate T-helper responses, and the secretion 
of different subsets of cytokines can lead to a Th1 vs Th2 response (Bellocchio et al. 
2005; Svirshchevskaya et al. 2001).  In the case of IA, a Th2 response is thought to be 
unfavorable to the host (Bozza et al. 2009; Chai et al. 2010; Gafa et al. 2010).  Therefore, 
future work will focus in determining whether challenge of pDCs with A. fumigatus leads 
to a Th1 or Th2 response. 
   Mature pDCs are capable of detecting A. fumigatus and inducing a response 
independent of serum opsonization.  This suggests that pDCs have a receptor that can 
recognize PAMPs in the conidia or hyphae.  It is also possible that as A. fumigatus grows, 
components of the cell wall or other molecules are secreted into the media.  During 
conidial germination, the conidia cell wall undergoes changes that result in the release of 
carbohydrates and other components into the environment (Dague et al. 2008).  One of 
those components is melanin.  This electron dense outer layer, imparts a grey-green color 
upon A. fumigatus conidia and has been described as a virulence factor for the mold and 
other pathogenic fungi (Youngchim et al. 2004).  It is possible that melanin released into 
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the PBS where we had been storing the conidia was responsible for the observed pDC 
stimulation.  However, it is important to note that swollen conidia do not have a melanin 
outer layer.  In addition, it is possible the combination of melanin with other secreted 
polysaccharides, such as galactosaminogalactan, can be highly immnunostimulatory. 
However, galactosaminogalactan is only secreted during hyphal growth. Other 
polyssacharides such as galactomannan are secreted in high concentrations during A. 
fumigatus growth (Pinel et al. 2003).  While we did not assess the nature of the 
immunostimulatory factor, we observed that heat killed conidia did not stimulate an 
inflammatory response in pDCs.  The cytokine response was only observed when pDCs 
were incubated with live A. fumigatus, suggesting that the factor responsible for the 
inflammatory response is exposed or released during fungal growth.  Future work should 
concentrate on determining the nature of the secreted factor, as well as determining what 
receptors are involved in the detection of this immunostimulatory molecule.  In addition, 
it is possible that the factor is released following germination; therefore, whether mature 
pDCs are capable of detecting A. fumigatus hyphae should be analyzed. 
 As we noted that there was no change in the response between swollen and resting 
conidia, we decided to look back at how we were generating the conidia.  For our assays, 
we collected the conidia as previously described, counted it and saved it at 4°C until 
ready to use for a maximum of two weeks.  The possibility that the stimulatory factor was 
released from the conidia as it germinated into other morphologies cannot be eliminated. 
Furthermore, supernatants from conidial growth stimulate cytokine secretion by pDCs.   
This suggests that the cytokine secretion was due to a released factor into the media, 
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rather than changes in the conidia cell wall or morphology.    However, since in our 
method we saved the conidia on PBS for up to two weeks, it is possible that the RC was 
starting to become SC.  Although we started our assays with either resting or swollen 
conidia, we were incubating the cells with live A. fumigatus.  As we co-incubated the 
pDCs with A. fumigatus for 6 hours, it is possible that the observed response was in 
response to hyphae rather than the starting morphology.  Furthermore, A. fumigatus 
grows slowly when stored at 4 degrees in media or PBS but not when stored in water 
(Osherov 2009); therefore, it is possible that for some of our assays the resting conidia 
had already started to swell.       
 Thus, our data demonstrate that mature pDCs secrete proinflammatory cytokines 
in response to A. fumigatus conidia as early as six hours post-challenge.  While both 
fungal growth stages stimulated pDCs to secrete similar levels of cytokines, it is possible 
that the stimulating factor is secreted during conidial germination.  In addition, pDCs 
only secrete cytokines in response to live A. fumigatus.  Further evidence was obtained by 
separating pDCs and A. fumigatus by a permeable membrane. During conidial 
germination and growth, A. fumigatus secretes proteins and carbohydrate that may have 
immunostimulatory activity.  Furthermore, recent reports showed that A. fumigatus 
secretes at least 35 immunoreactive fungal proteins during germination and growth 
(Singh et al. 2010a; Singh et al. 2010b).  It is possible that mature pDCs recognize and 
secrete cytokine to a mixture of carbohydrates and proteins secreted into the environment 
during fungal growth.  Mature pDCs may be contributing to the overall anti-Aspergillus 
response in multiple ways. First, since mature pDC acquire cDC-like characteristics it is 
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possible that they upregulate receptors such as Dectin-1 or the membrane bound TLR2 
and TLR4.  However, additional work is needed in order to determine whether mature 
pDCs express any of these receptors. In addition, by secreting cytokines, mature pDCs 
may be contributing to the anti-Aspergillus response by recruiting other immune cells and 
initiating adaptive immune responses to the mold.  
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Materials and Methods: 
Reagents and cell culture.  Reagents were obtained from Sigma-Aldrich (St Louis, 
Missouri), unless otherwise stated.  RPMI-1640 was obtained from GIBCO (Invitrogen; 
Carlsbad, California).  pDC media consisted of RPMI-1640 supplemented with 100U/ml 
penicillin, 100U/ml streptomycin, 2mM L-glutamine, 0.5mM HEPES, 1mM sodium 
pyruvate.  Opsonization media consisted of pDC media supplemented with 10% 
autologous serum.  All incubations were in a 37°C incubator containing humidified air 
supplemented with 5% CO2, unless otherwise indicated.  The stimulatory TLR9 ligand, 
CpG 2007 oligonucleotide (ODN) (Latz et al. 2007a), was synthesized with 
phosphothiorate linkages by Integrated DNA Technologies (Coralville, IA).  Ultrapure 
LPS from Escherichia coli was generated as previously described (Huang et al. 2009).  
All antibodies were purchased from eBiosciences (San Jose, CA), unless otherwise 
specified. 
Fungal Growth and Strains.  A. fumigatus Af293 was obtained from Fungal Genetic 
Stock center (Kansas City, Mo).  Cultivation of A. fumigatus, and harvesting of conidia 
was performed as in our previous studies with slight modifications (Mambula et al. 
2002).  Briefly, fungi were grown on Sabouraud Dextrose Agar slants at 37°C for 4 to 7 
days.  Conidia were harvested by adding PBS containing 0.01% Tween 20 followed by 
vortexing.  The collected conidia were then filtered through a 40-µm nylon mesh to 
remove hyphae and conidiophores.  The conidia in the filtrate were washed twice with 
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phosphate buffered saline (PBS), counted and stored in water at 4°C for up to two weeks 
in some cases.   
pDC Enrichment and Maturation.  Human pDC were isolated as described (Ramirez-
Ortiz et al. 2008; Wang et al. 2006). Peripheral blood was collected by venipuncture. A 
portion was clotted and the autologous serum collected following centrifugation.  The 
remainder of the blood was anticoagulated with heparin, diluted 1:1 with Hank’s buffered 
salt solution (HBSS) (BioWhittaker; Walkersville, MD) and the peripheral blood 
mononuclear cells (PBMCs) purified by Ficoll-Hypaque (LymphoprepTM; Westbury, 
NY) density gradient centrifugation.  Human pDCs were positively selected from the 
PBMC using CD304-coated magnetic beads, according to the manufacturer’s instructions 
(Miltenyi Biotech, Auburn, CA). 
After isolation, pDCs were incubated for 7 days at 37°C/5%CO2 in pDC media 
supplemented with 10ng/mL of recombinant IL3, 150 ng/mL granulocyte macrophage 
colony stimulating factor (GMCSF) and 10ng/mL CD40L (all three cytokines from 
Prepotech; Rocky Hill, NJ) .  At days 3 and 5, half of the media was removed and new 
media was added to the wells containing the pDCs.  At day 7, pDCs were considered to 
be mature.  
Flow Cytometry.   The purity of the immature pDC population was confirmed by 
analyzing the expression of the pDC markers CD123 and CD303 by flow cytometry 
(Colonna et al. 2004).  Briefly, freshly isolated pDCs were incubated on ice with anti-
CD123-APC and/or anti-CD303-FITC for 30 minutes.  All antibodies were obtained from 
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eBiosciences (San Jose CA).  Isotype controls were included in all experiments (Figure 
3.1).    
Cytokine Secretion.   The indicated concentrations of pDCs or flow through cells were 
incubated with A. fumigatus hyphae in 96-well flat-bottom plates containing a final 
volume of 200 µl pDC media supplemented with 10% autologous serum.  After 6 or 18 
hours, supernatants were collected and human IFNα (Bender Med Systems module set, 
Burlingame, CA), TNFα, IL12p70 and IL6 levels were measured using ELISA kits 
(eBiosciences, San Diego, CA for TNFα, IL12p70 and IL6) according to the 
manufacturers’ instructions.  Samples were assayed in duplicate at dilutions that fell 
within the range of the standard curve. 
Transwell Assay.  Transwell 96 well plates containing 1.0 µm pore size polycarbonate 
membrane inserts were obtained from Corning Life Sciences (Lowell, MA). Human 
pDCs (5x104 per well) were matured on the reservoir plate, as described above.  A. 
fumigatus resting or swollen conidia (5x104 in 100µL) were added either to the Transwell 
(no contact) or to the reservoir plate (contact).  Mature pDCs and A. fumigatus were co-
incubated for 6 hours at 37°C/5%CO2.  Supernatants were collected and cytokine 
secretion was measured by ELISA. 
Protein Assay.  We wanted to determine whether A. fumigatus was secreting proteins 
into the storage media.  For sample preparation, A. fumigatus was collected from slants 
and conidia were counted. Resting conidia were collected and stored at 4°C until ready to 
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use.  In order to generate swollen conidia, we collected resting conidia and incubated it 
on pDC media at 37 °C for approximately 4 hours.  Conidial swelling was determined by 
visualizing the conidia at different time points via microscopy.   All conidia were plated 
to a final concentration of 5x104 conidia per well in 100 µL pDC media. Germ tubes and 
hyphae were generated by plating 5x104 conidia per well on 96 well plate at 37°C for 8-
12 hours on pDC media (without FBS). For each one of the morphologies, the storage 
tubes or plates were centrifuged 800xg (Beckman TJ-6 Centrifuge) for 10 minutes and 
100 µl of supernatants were transferred to a clean 96-well plate.  BCA protein assay was 
performed and analyzed following manufacturer’s instructions (Pierce Cat # 23225; 
Thermo Scientific, Rockford IL).  Samples were assayed in triplicate dilutions that fell 
within the range of the standard curve.       
Carbohydrate Assay.  The phenol sulfuric acid method of Dubois was used to determine 
the polysaccharide concentration (Dubois et al. 1951) with the following changes:  A. 
fumigatus supernatants from the different morphologies were diluted (1:10 and 1:100) to 
a final volume of 40 µL in LAL reagent water (LRW; Associates of Cape Cod, East 
Falmouth, MA) and added to 360 l dH20 in 13 x 100 millimeter (mm) borosilicate glass 
test tubes (Fisher).  To each tube, 10 l of buffer-saturated phenol (Invitrogen) was 
added, followed by quickly adding 1 ml of 95-98% sulfuric acid (Sigma).  Using an 
Eppendorf repeater pipette, add 1 mL of ~98% Sulfuric acid (Sigma-Aldich, MO).  Color 
was allowed time to develop and 100 l samples were transferred to a 96-well flat-
bottom plate (Costar).  The concentration of carbohydrate is reflected by a colorimetric 
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change, and the plates were read at 490 nm on a plate reader (Molecular Devices, 
Sunnyvale, CA).  The carbohydrate content of the samples was calculated by comparing 
with a standard curve of known amounts of glucose. 
Statistical Analysis.  For comparisons of two groups, means ± standard errors (SE) were 
analyzed by the two-tailed unpaired Student t-test with the Bonferroni correction applied 
when making multiple comparisons.  For comparisons of greater than two groups, 
significance was determining using the one- or two-way analysis of variance (ANOVA) 
with the Tukey multiple correction.  Calculations were performed using a statistical 
software package (GraphPad Prism 4.02, San Diego, CA) and statistical significance was 
defined as p<0.05.  
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Chapter V 
Discussion 
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Overview: 
The research goal of the work presented in this thesis was to understand the 
contribution of TLR9 and pDCs, TLR9-rich cells, in the immune responses to A. 
fumigatus.  My work demonstrates that A. fumigatus DNA contains unmethylated CpG 
motifs that are capable of inducing a TLR9-dependent response.  Furthermore, we 
showed that A. fumigatus DNA contains both, human-like and mouse-like 
immunostimulatory motifs.  The observation that DNA isolated from A. fumigatus and 
transfected into pDCs results in the secretion of type I IFN, led us to investigate the role 
of human pDCs in the anti-Aspergillus response.  My work illustrates that pDCs are 
capable of inducing a cytokine response upon challenge with A. fumigatus hyphae.  pDCs 
spread over the hyphae, as the size of this fungal morphology is too big to induce 
phagocytosis.  The observed interaction between A. fumigatus hyphae and pDCs is 
paradoxical.  The interaction between A. fumigatus and the pDCs results in a fungistatic 
activity against the mold, possibly via the release of Zn2+ chelators such as calprotectin 
into the environment.  At the same time, A. fumigatus is secreting gliotoxin and inducing 
pDC cell death.  Thus, the immune evasion mechanism employed by A. fumigatus results 
in the initiation of a host response against the hyphae.  I also illustrate that pDCs, mature 
and immature, are capable of secreting proinflammatory cytokines in response to A. 
fumigatus suggesting a role for pDCs in the recruitment of other immune cells.  The work 
presented in this thesis describes a novel and unique host-pathogen interaction between 
pDCs and A. fumigatus, a major infectious agent among immunocompromised patients. 
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A. fumigatus DNA as a PAMP 
Work performed previously in our laboratory and others had shown that TLRs are 
essential in the recognition and clearance of A. fumigatus conidia (Mambula et al. 2002; 
Wang et al. 2001).  However, most of the previous work concentrated on the extracellular 
TLR2 and TLR4 (Chignard et al. 2007; Luther et al. 2007; Mambula et al. 2002).   In 
2004, Bellocchio et al. showed that mice deficient in MyD88 were extremely susceptible 
to A. fumigatus infection.  However, mice deficient in TLR9 showed increased survival 
and decreased fungal burden when compared to wild type mice (Bellocchio et al. 2004a).  
The observation that TLR9 mice were relatively resistant to infection with A. fumigatus 
suggested to us that the involvement of the receptor may be detrimental to the host.  As 
the natural ligand of TLR9 is unmethylated CpG DNA, we first wanted to determine 
whether A. fumigatus DNA was capable of mounting a TLR9-dependent immune 
response.  By restriction enzyme digest, we showed that A. fumigatus DNA contained 
multiple CCGG sequences in its genome.  In addition, we showed that A. fumigatus DNA 
can be enzymatically methylated.   
A. fumigatus DNA shows all the characteristics needed to stimulate TLR9, 
suggesting that it could be acting as a PAMP during infection.  Our results show that A. 
fumigatus DNA can stimulate the secretion of proinflammatory cytokines.  Furthermore, 
enzymatic methylation of the DNA and cells from mice deficient in TLR9 show 
decreased stimulation.  Our data suggests that A. fumigatus DNA can induce a response 
that is partially dependent on TLR9; therefore, other nucleic acid receptors may play a 
 182 
 
role in the detection of A. fumigatus DNA.   Cytoplasmic DNA receptors have been 
recently identified, including RIG-I, MDA-5, DAI (DNA-dependent activator or IFN-
regulatory factors) and multiple components of the inflammasome (Fernandes-Alnemri et 
al. 2009; Hise et al. 2009; Hornung et al. 2009; Muruve et al. 2008; Rathinam et al. 2010; 
Roberts et al. 2009; Vilaysane and Muruve 2009).  Further experimentation is needed in 
order to determine the contribution of other cytoplasmic receptors; however, our data 
suggest that they may be playing a role in the recognition of A. fumigatus DNA.  Another 
explanation for the residual cytokine response would be that the DNA is not completely 
methylated. The later explanation does not take into consideration that residual TNFα 
was observed when stimulating BMDCs from TLR9-/- mice with A. fumigatus DNA.  
Therefore, it is highly possible for other nucleic acid sensors such as the newly identified 
cytoplasmic DNA receptors to contribute to the antifungal response; although, additional 
experiments are required to determine whether these receptors play a role in the detection 
of A. fumigatus DNA.   
Previous data show that mammalian, but not microbial DNA, is highly methylated 
(Akira et al. 2006).  Although fungi and mammals are members of the eukaryotic 
kingdom, we found that A. fumigatus DNA had more in common with bacterial DNA 
than with mammalian DNA. In our studies, A. fumigatus DNA shows low levels of CpG 
methylation. The observed pattern of degradation of A. fumigatus DNA after treatment 
with the restriction endonuclease HpaII, which is specific for unmethylated CCGG 
sequences, was similar to the one observed when treated with MspI, an endonuclease that 
cleaves CCGG regardless of the level of methylation. Consistent with the theory that 
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unmethylated CpG DNA is the natural ligand of TLR9 (Akira et al. 2006), we found that 
enzymatic methylation of A. fumigatus DNA results in decreased cytokine secretion.  
Furthermore, degradation of the A. fumigatus DNA also results in a decreased response. 
The immunostimulatory activity of DNA directly correlates with the frequency of 
CpG dinucleotides, as shown in a survey of 15 bacterial species (Dalpke et al. 2006).  
Genomic analysis of the bacterial DNA revealed that the frequency of CG dinucleotides 
ranged from 1.44% to 12.21% among the different bacteria species analyzed.  Our data 
show that A. fumigatus contains approximately 5.35% CG dinucleotides in its DNA.  The 
frequency of CG dinucleotides found in the A. fumigatus genome is comparable to the 
frequency of CG in some bacterial species.  For example, E. coli contains approximately 
7.2% CG dinucleotides, Yersenia enterocolitica contains approximately 5.4% and 
Neisseria meningitidis contains approximately 7.9%.  In the study, all three bacterial 
species were capable of inducing similar levels of TLR9 activation; as measure by 
secretion of IL-8 (Dalpke et al. 2006).  Similarly, we observed that A. fumigatus and 
E.coli stimulate TNFα and IL12p70 to comparable levels in a TLR9-dependent manner. 
 Although the percentage of CpG dinucleotides is an important characteristic of 
the immunostimulatory activity of microbial DNA, the presence of specific sequences has 
also been shown to be important in the stimulation of human and mouse TLR9 (Putta et 
al. 2010; Struthers et al. 2010).  Even though TLR9 is an evolutionarily conserved germ-
line encoded receptor, the DNA binding-motif recognizes slightly different sequences in 
the human and the mouse.  An in silico genome wide analysis of the A. fumigatus DNA 
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demonstrated the presence of immunostimulatory sequences specific for mouse and 
human TLR9.  Our analysis was extremely conservative, and given the high percentage 
of CpG dinucleotides, it is possible that other stimulatory motifs exist within the fungal 
genome.  In addition, we found that synthetic ODNs containing CpG motifs found in A. 
fumigatus DNA induced a TLR9-dependent response.  The immunostimulatory activity 
of one of our ODNs was of particular interest, as it induces a TLR9 dependent response 
in human cells to levels comparable to a CpG ODN undergoing clinical trials.  Given the 
high immunostimulatory activity of the A. fumigatus ODN, the possibility of using it as 
an adjuvant in a vaccine against A. fumigatus cannot be eliminated.   
Possible Contribution of A. fumigatus DNA to Immunology of Aspergillosis 
Even though our data show that A. fumigatus DNA is acting as a TLR9 agonist, 
the contribution of the fungal DNA to the overall host response during aspergillosis 
remains to be elucidated.  It has been suggested that A. fumigatus DNA can be detected in 
the early stages of infection (Chamilos and Kontoyiannis 2006); however, future work is 
required to determine whether the DNA is capable of reaching endosomal compartments 
where TLR9 is present.  In addition, three factors most be taken into consideration:  1) in 
its invasive hyphal form, A. fumigatus is an extracellular organism  and TLR9 is found in 
the endosomal compartments, 2) neutropenia is a major risk factor in the development of 
invasive aspergillosis, 3) all PCR-based methods used in the diagnosis of aspergillosis 
require a cell lysis step.  Considering these factors, the large size of the hyphae restricts it 
from endosomal compartments.  In addition, neutrophils are the primary cell type 
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responsible for killing hyphae; therefore, further work should focus on determining 
whether A. fumigatus damage caused by neutrophils results in the release of fungal DNA 
into the environment.  It is possible that during aspergillosis, other immune cells are 
trying to control hyphal growth and the damage made by those cell results in the 
secretion of DNA into the environment where it can be taken into endosomal 
compartments rich in TLR9.  Nevertheless, the observed differences in survival between 
wild-type and TLR9-/- infected with A. fumigatus suggest a role for this receptor in-vivo 
(Bellocchio et al. 2004a).   
The observed differences in survival between WT and TLR9-/- mice may be due 
to defects in the anti-Aspergillus response mediated by macrophages.  A. fumigatus 
conidia are readily phagocytosed by macrophages (Brakhage et al. 2010b; Segal 2007).  
In the mouse, TLR9 can be found in the endosome of most immune cells.  Once in the 
endosome of macrophages, conidia are killed by oxidative mechanisms, where DNA can 
be released into a TLR9+ compartment (Ibrahim-Granet et al. 2003; Luther et al. 2006; 
Luther et al. 2008; Luther et al. 2007; Philippe et al. 2003).  In this scenario, A. fumigatus 
DNA may be responsible for inducing a TLR9 dependent response.  Although this is true 
in the mouse infection model, humans mainly express TLR9 in pDCs and B-cells (Gilliet 
et al. 2008).  To date, neither one of these human cell populations has been shown to 
phagocytose A. fumigatus conidia. It is possible that monocytes phagocytose A. fumigatus 
conidia and kill it in the endosome, where it can induce activation of low levels of TLR9.  
A recent report (Fiola et al. 2010) suggested that monocytes express low levels of TLR9 
and that these cells are responsive to TLR9 agonist.  Furthermore, Fiola et al. showed that 
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TLR2 and TLR9 collaborate to induce a cytokine response during Epstein Bar Virus 
(EBV) infection (Fiola et al. 2010).  It is possible for A. fumigatus to be inducing a 
response similar to EBV in monocytes, as TLR2 has been shown to be a key receptor in 
the detection of the mold.  Future work should determine whether A. fumigatus conidia 
(and hyphae) induce a TLR2/TLR9 dependent response in monocytes and whether A. 
fumigatus conidia are killed in the endosomes of pDCs. 
Polymorphisms in the TLR9 gene have also been shown to play a role in the susceptibility 
to development ofaspergillosis.  One study examined variants of the TLR genes in a 
population of Italian children with hematological malignancies (Lanciotti et al. 2008).  
Two variants in TLR9 were analyzed:  T-1237C and T-1486C. Lanciotti et al. showed 
that the frequency of the C allele in the TLR9 T-1486C polymorphism was significantly 
higher in patients with invasive mold infections than the healthy controls.  An association 
between TLR9 T-1237C and patients suffering from allergic bronchopulmonary 
aspergillosis, a disease that affects mainly patients suffering from allergy or asthma, was 
also established (Carvalho et al. 2008a; Carvalho et al. 2008c). 
TLR9-dependent Host Responses to A. fumigatus  
 An inflammatory response is only beneficial to the host if the infection can be 
contained or eliminated.  In some cases the pathogen is not eliminated and host tissue 
damage results from the inflammatory response.  The observation that TLR9-/- mice 
survived longer than the wild-type counterparts suggests that the immune response is 
favoring the pathogen rather than the host.  In addition, using an asthma infection model, 
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Ramaprakash et al. showed that TLR9-/- mice infected with resting conidia have lower 
airway hyper-responsiveness than TLR9+/+ counterparts (Ramaprakash et al. 2009).  
Furthermore, in their infection model, mice deficient in TLR9 appear to have higher 
fungal growth than the TLR9+/+ counterparts (Ramaprakash et al. 2009).  
 The nature of the immune response to A. fumigatus is of great importance to the 
outcome of the infection.   In addition to secretion of proinflammatory cytokines such as 
type I IFNs, activation of TLR9 also signals the activation of T helper (Th) cell 
responses.  CpG-rich DNA is known to bias towards a Th1 response (Krieg 2002).  While 
a Th1 bias will provide protective immunity to A. fumigatus (Brakhage et al. 2010b), the 
Th1/Th2 deregulation constitutes an important aspect of disease development (Bozza et 
al. 2009).   
Role of pDCs in the anti-Aspergillus response  
 Controlling the immune responses against pathogens is essential in the prevention 
of host tissue damage due to prolonged inflammation, a hallmark of chronic diseases. 
Inflammatory responses to A. fumigatus often serve to limit the infection; however, the 
exacerbated host inflammatory response may contribute to the pathogenicity of the mold.  
The involvement of TLR9 in the host response against A. fumigatus may be beneficial to 
the pathogenicity of the fungus.  Our initial studies were focused on the role of TLR9 in 
the detection of A. fumigatus DNA using an in-vitro system.  While our results showed a 
contribution to the host response upon recognition of the fungal PAMP, additional studies 
are necessary to show the mechanism of A. fumigatus DNA release and entry into TLR9-
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rich compartments in host cells..  During infection, host cells are most likely to encounter 
live A. fumigatus. 
 In humans, TLR9 is found in the endosomal compartments of pDCs and B cells.  
The finding that human pDCs secrete type I IFN in response to A. fumigatus DNA made 
us wonder whether pDCs mount an inflammatory response against live fungi.  The role of 
pDCs in the immune response to pathogens has been extensively described during viral 
infections (Swiecki and Colonna 2010).  However, whether pDCs play a role in the 
detection and antifungal responses to fungal pathogens has received scarce attention.   
Recognition of A. fumigatus by pDCs 
 While neutrophils, macrophages, monocytes and conventional DCs have been 
shown to recognize and exert antifungal responses against A. fumigatus (Balloy and 
Chignard 2009; Dagenais and Keller 2009), a role for pDCs has been suggested but has 
not been established (Romani et al. 2006).  Fungal recognition by monocytes, 
macrophages and neutrophils has been well characterized.  Receptors such as TLR2, 
TLR4 and members of the C-type lectin receptor family have been shown to be involved 
in the recognition of A. fumigatus by these cell types (Gersuk et al. 2006; Luther et al. 
2007; Reid et al. 2009).  We show that pDCs are capable of interacting with A. fumigatus 
hyphae.  While pDCs have been shown to phagocytose viruses and bacteria (Petzke et al. 
2009; Swiecki and Colonna 2010), the size of the hyphae is too big to be phagocytosed.  
Instead, we observed that pDCs were capable of ingesting conidia and spreading over the 
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A. fumigatus hyphae within 2 hours. However, the repertoire of surface receptors on 
pDCs associated with fungal recognition has not been well defined.   
 Human pDCs have been shown to express dectin-2, but not dectin-1, mannose 
receptor and DC-SIGN (Graham and Brown 2009; Meyer-Wentrup et al. 2009).   In 
addition, dectin-2 in mouse BMDCs has been shown to stimulate a rapid and robust 
stimulation of inflammatory lipid mediators against A. fumigatus (Barrett et al. 2009).  
Since dectin-2 has been shown to be expressed in pDCs (Seeds et al. 2009), it is possible 
for this receptor to be involved in the detection of A. fumigatus in our experimental 
system.  Future studies should look at the receptor-ligand interactions between dectin-2 
and A. fumigatus in human pDCs.    
 In addition to dectin-2, other receptors on pDCs may also be involved in the 
recognition of A. fumigatus.  pDCs express some complement receptors, as well as some 
Fc receptors (Gilliet et al. 2008).  We observed that pDCs were capable of interacting 
with A. fumigatus hyphae independent of opsonization, suggesting that the pDCs express 
a receptor capable of directly detecting the hyphae.  Although we can speculate on which 
pDC receptors are responsible for the detection and interaction with A. fumigatus, further 
experimentation is required to define these interactions. 
pDCs required for the anti-Aspergillus response in-vivo 
 While the role of pDCs in the antiviral and bacterial response has been 
extensively studied, the role of these cells during mycosis has received little attention.  To 
date, there is no evidence that pDCs play a role in anti-Aspergillus responses in-vivo.  
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Here we show, for the first time, that mice lacking pDCs are more susceptible to A. 
fumigatus infection than control mice. These results are similar to the observation made 
by Ang et al where depletion of pDCs in mice increased their susceptibility to Legionella 
infection (Ang et al. 2010).  In addition to the observation that mice depleted of their 
pDCs have lower survival rates than control mice, we observed an influx of pDCs in to 
the lungs of A. fumigatus infected mice 48 hours post-infection.  However, there is one 
fundamental difference between the observations with Legionella and our studies.  In our 
infection model, type I IFN appears to play a role in the anti-Aspergillus response while 
during Legionella infection type I IFN may be dispensable.  While we observed that mice 
deficient in type I IFN receptors had lower survival rates than WT mice, we did not 
analyze the role of this cytokine during mycosis.  One could speculate that type I IFNs 
may be involved in the activation of the adaptive immune response.  A recent study 
showed that during viral infection, depletion of pDCs affects the expansion of NK-cells 
and the accumulation of cytotoxic T-lymphocytes (Swiecki et al. 2010).  While it is 
possible for a similar mechanism to be involved in the anti-Aspergillus response, future 
work should analyze the number of T-lymphocytes and NK cells in mice depleted of 
pDCs following infection with the mold.  
Fungistatic Activity of pDCs 
 Previous work concentrated on the role of neutrophils and monocytes against A. 
fumigatus.  Both of these cell types spread over the hyphae and cause damage to A. 
fumigatus via oxidative and non-oxidative mechanisms (Bozza et al. 2002; Diamond et 
al. 1978).  The interactions of these phagocytes with A. fumigatus are of prime 
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importance in the clearance of infection; however, during infection other cell types such 
as pDCs may be involved in the antifungal response. In our assays, we observe that 
human pDCs have antifungal activity against A. fumigatus.  Using two independent 
assays, one that measures metabolic activity and one that measures hyphal enlongation, 
we were able to demonstrate that pDCs inhibit fungal growth.  The antifungal activity of 
pDCs appears to be different than the activity observed in monocytes and neutrophils.  
These two cell types have been shown to both inhibit growth and kill A. fumigatus; 
however, we did not observed hyphal killing by the pDCs.  Instead, hyphal growth 
proceeded at a significantly slower rate in the presence of pDCs. 
 The fungistatic activity of pDCs led us to further analyze the interactions between 
pDCs and A. fumigatus hyphae.  Confocal microscopy results show that pDCs are 
capable of spreading over A. fumigatus hyphae, suggesting that pDCs are capable of 
detecting fungal components.  In 1978, Diamond et al. showed that PMNs damaged A. 
fumigatus hyphae by spreading over the hyphae and undergoing degranulation (Diamond 
et al. 1978).  It is possible that the fungistatic activity of pDCs is mediated by a 
mechanism similar to the one used by PMNs.  We noted that pDCs interacting with A. 
fumigatus hyphae were looking sick.  Since pDCs have been reported to undergo 
apoptosis in the absence of activating signals and in response to some viral infections we 
analyzed pDC cell viability (Grouard et al. 1997; Lepelletier et al. 2010).  In our assay, 
we observed over 50% pDC cytotoxicity when the pDCs were stimulated with A. 
fumigatus hyphae.  During viral and parasitic infections, pDCs have been shown to 
undergo apoptosis as a mechanism to prevent viral replication inside the cell via 
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activation of TNF-related apoptosis inducing ligand (TRAIL).  DC apoptosis during these 
conditions results in a bystander effect of immunosuppression (Kushwah and Hu 2010).  
Interactions between pDCs and A. fumigatus are similar to those with viruses; however, 
further experiments are necessary to determine whether a receptor such as TRAIL is 
involved in pDC cell death.  Our results show that pDCs have fungistatic activity against 
A. fumigatus while undergoing cell death.  These two independent observations led us to 
analyze whether pDC cell lysates were playing a role in the anti-Aspergillus response.  
pDC cell death may result in the secretion of cytoplasmic factors that could be 
responsible for the fungistatic activity of pDCs.  Our results show that pDC cell lysates 
induce an antifungal response against A. fumigatus, with up to 70% antifungal activity as 
measured by XTT assay.  Furthermore, the response mediated by the pDC cell lysates 
was similar to the response mediated by live pDCs suggesting that the observed 
fungistatic activity may be mediated by secreted pDC factors resulting from cell death.     
 Iron and zinc are essential growth factors.  These two transition metals play 
critical roles in a variety of biochemical processes in microbes and host cells.  Therefore, 
it is not surprising that leukocytes and other professional phagocytes have proteins 
responsible for chelating these factors.  Moreover, chelators of Fe3+ and Zn2+ in host cells 
have been shown to play a role in antifungal responses (Mambula et al. 2000; Urban et al. 
2009).  Since other immune cells contain chelators of these cations, we wondered 
whether supplemental Fe3+ and Zn2+ would revert the observed antifungal effect of pDCs.  
The observation that ZnCl2, but not FeCl3, partially restored growth of A. fumigatus 
hyphae suggests a role for Zn2+ binding protein.  Induction of hypozincemia can be 
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induced by secretion of calprotectin by neutrophils, monocytes, epithelial and endothelial 
cells in response to infection (Striz and Trebichavsky 2004).  Calprotectin, free and 
associated with NETs, has been shown to inhibit the growth of C. albicans and other 
pathogenic fungi (Lulloff et al. 2004; Urban et al. 2009).   In addition, NETs were 
recently shown to play a role in host responses against A. fumigatus (McCormick et al. 
2010).  Similar to our findings, McCormick et al. found that A. fumigatus growth is 
inhibited and that fungal growth can be restored with the addition of exogenous Zn2+ 
(McCormick et al. 2010).  Although additional work should be performed in order to 
determine whether pDCs are capable of inducing a NETosis-like antifungal response, we 
demonstrate that human pDCs contain calprotectin. In addition, given the high number of 
Zn2+-binding proteins in the cell, future experiments should be performed to confirm that 
calprotectin is involved in the antifungal response against A. fumigatus. The observation 
that exogenous Zn2+ only partially restores A. fumigatus growth suggests that pDCs may 
have more than one pathway mediating the antifungal response.  
A. fumigatus hyphae fights back  
 pDC cell death appears to be a mechanism employed by the cells to halt hyphal 
growth; however, our data strongly suggest that pDC cell death is partly induced by 
secreted fungal factors.  Although at a lower level, we observed pDC cytotoxicity when 
the pDCs and the hyphae were separated by a Transwell suggesting that cell death was 
mediated by a secreted factor.    
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 A. fumigatus produces a wide variety of secondary metabolites. The best 
characterized of these metabolites is gliotoxin, a low molecular weight mycotoxin shown 
to be immunosuppressive.  A. fumigatus gliotoxin has been shown to induce cell death in 
multiple immune cells including neutrophils and monocytes (Murayama et al. 1996; 
Stanzani et al. 2005).  Furthermore, A. fumigatus gliotoxin has been shown to play a role 
in immune evasion by inhibiting NF-κB and the oxidative response (Spikes et al. 2008).  
We found that A. fumigatus gliotoxin induces pDC cell death.  However, whether 
gliotoxin is affecting signaling pathways that would lead to killing of A. fumigatus 
remains to be determined.   
 To dissect the mechanism of pDC cell death induced by A. fumigatus hyphae we 
performed TUNEL assay.  We observed that pDCs incubated with A. fumigatus or 
purified gliotoxin resulted in TUNEL positive staining, suggesting apoptosis-mediated 
cell death.  Even though TUNEL positive staining suggests that apoptosis is the 
mechanism of cell death, other mechanisms such as pyroptosis may be playing a role in 
pDC cell death.  Recently, it was shown that cells undergoing pyroptosis exhibit DNA 
degradation and upregulation of pro-apoptotic proteins resulting in a positive TUNEL 
reaction (Fink et al. 2008; Fink and Cookson 2005; Fink and Cookson 2006).  
Furthermore, TUNEL staining confirmed our finding that more than fifty percent of the 
pDCs undergo cell death.  Further experimentation, including staining for apoptosis-
specific and pyroptosis-specific markers, is required in order to determine the mechanism 
of pDC cell death.  One way of determining the mechanism of cell death would be to 
perform intracellular staining with Annexin 5 and IL1β.  A pyroptosis positive stain 
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would show staining for both Annexin 5 and IL1β; while an apoptosis positive result 
should only show staining of Annexin 5.  This staining assay can also be performed using 
TUNEL Assay, where cells undergoing pyroptosis should show TUNEL positive and 
IL1βbright staining. 
 It is possible that pDC cell death is a combination of A. fumigatus immune 
evasion via immunosuppression and a mechanism of pDCs to induce tolerance.  During 
viral infections, DCs undergo apoptosis via death receptor pathways (extrinsic pathways), 
which results in a bystander effect of induced immunosuppression (Fugier-Vivier et al. 
1997).  In addition, it has been shown that transplant patients treated with corticosteroids 
have decreased levels of circulating pDCs (Kushwah and Hu 2010), and these patients are 
highly susceptible to A. fumigatus infection.   Additional experiments are required in 
order to understand the relationship between pDC cell death and the antifungal response 
to A. fumigatus mediated by these cells.   
Inflammatory cytokines  
 The antifungal response of pDCs against A. fumigatus goes beyond halting hyphal 
growth.  Human pDCs have been shown to secrete huge amounts of type I IFN in 
response to viruses and certain RNA and DNA sequences; however, the role of IFNs in 
the antifungal response has received little attention.  Recent reports have suggested a role 
for type I IFN during fungal infections (Biondo et al. 2008; Inglis et al. 2010a).  In a 
mouse infection model, infection of mice deficient in IFNα/β receptor with Cryptococcus 
neoformans resulted in decreased survival when compared to the wild-type counterparts.  
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In addition, IFNα/β receptor knock-out mice infected with C. neoformans failed to 
generate a protective Th1 response (Biondo et al. 2008).  Upregulation of type I IFN 
genes has also been observed in macrophages infected with Histoplasma capsulatum 
(Inglis et al. 2010a).  Even though these publications suggest a role for type I IFN during 
fungal infections, the role of type I IFN during infection in humans remains to be 
elucidated.  One report by Romani et al. showed that pDCs are capable of inducing a 
tolerogenic response to A. fumigatus; however, they observed low concentrations of IFNα 
secretion by pDCs infected with conidia (Romani et al. 2006).  While Romani et al. did 
not see much of a IFNα response by pDCs following challenge with A. fumigatus conidia, 
our result show that pDCs are capable of secreting IFNα and TNFα in response to A. 
fumigatus hyphae.  The differences observed may be due to a number of reasons, such as 
the method used to generate the pDCs by each group.   
TNFα plays an important role in the clearance of A. fumigatus by enhancing 
leukocyte-mediated killing of the mold (Filler et al. 2005).  We found that pDCs secrete 
TNFα upon stimulation with A. fumigatus hyphae.  It is possible that TNFα secretion by 
pDCs is a communication mechanism employed by these cells to augment hyphal killing.  
One report showed that incubation of neutrophils with recombinant TNFα increases 
killing of the hyphae by these immune cells (Roilides et al. 1998).  Furthermore, this 
group showed that alveolar macrophages phagocytose more A. fumigatus conidia in the 
presence of recombinant TNFα.  Although further experimentation is required, it is 
possible for secretion of TNFα by pDCs to be involved in the observed antifungal 
response against A. fumigatus hyphae.  TNFα may be playing multiple roles in the 
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antifungal response to A. fumigatus.  The pDC-secreted TNFα could be acting as a 
chemotaxin, attracting neutrophils to the site of infection to kill the hyphae. In addition, 
TNFα may be playing a role in pDC cell death by activation of apoptotic pathways in 
pDCs.  Future work should focus on determining the role of TNFα during A. fumigatus 
infection.   
The cytokine response by pDCs is induced via a TLR7/9-independent mechanism.  
Pre-treatment of pDCs with either bafilomycin A or chloroquine, both V-ATPase 
inhibitors (Martinson et al. 2010; Nakamura et al. 2008) did not affect secretion of type I 
IFN in response to A. fumigatus hyphae.  It is possible during infection for other host 
cells such as macrophages and neutrophils to kill A. fumigatus, resulting in release of 
fungal DNA into the environment.  While our results show that pDCs secrete cytokines 
independent of activation of TLR7/9, we were looking at the responses of pDCs in 
isolation from other cell types.  For example, neutrophils release NETs that cause fungal 
damage.  These NETs contain host DNA and DNA binding proteins that can possibly 
bind fungal DNA and deliver the complexes into TLR9+ compartments 
(Papayannopoulos and Zychlinsky 2009). In addition, whether A. fumigatus DNA can 
stimulate a response by cytoplasmic DNA receptors such as DAI or the inflammasome 
remains to be determined. 
Mature pDCs and A. fumigatus conidia 
 Upon maturation, pDCs become more phagocytic and behave more like 
conventional DCs (Drenou et al. 2005; Gibson et al. 2002; Guiducci et al. 2006).  While 
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pDC maturation in the blood is dependent on encountering antigen and communication 
with other cells via cytokines and chemokines, maturation of pDCs in culture requires 
supplementing the media with IL3 and CD40L (Schnurr et al. 2004).  Mature pDCs have 
been shown to be involved in antigen presentation and modulation of adaptive immune 
responses (Cella et al. 2000; Mittelbrunn et al. 2009); however, these cells have not been 
shown to be involved in antimicrobial responses.  While immature pDCs have fungistatic 
activity against A. fumigatus hyphae, mature pDCs do not appear to mediate an antifungal 
response.  Similar to immature pDCs, seven-day mature pDCs stimulated with A. 
fumigatus recognize the fungi and spread over the hyphae. 
 “Mature” pDCs secrete an array of cytokines in response to A. fumigatus conidia. 
We observed that seven-day mature pDCs secrete IFNα, TNFα and IL12-p70 in response 
to stimulation with A. fumigatus conidia.  This array of cytokines correlates with the 
induction of an inflammatory response against the mold; however, mature pDCs are not 
known to secrete large amounts of cytokines in response to infection (Schnurr et al. 
2004).  One report showed that maturation of pDCs is mediated by detection of an 
antigen, in this scenario the main role of mature pDCs is to uptake the antigen and 
present it to T-cells to initiate an adaptive immune response (Jahn et al. 2010; Jegalian et 
al. 2009; Tel et al. 2010).  However, maturation of pDCs in vitro requires supplementing 
the media with CD40L and IL-3 (Schnurr et al. 2004).  It is possible that at the time of 
performing our assays, the pDCs were still immature.  Therefore, further 
experimentation, by flow cytometry, should analyze whether pDC maturation occurs in 
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vitro.   Independent of whether we had mature or immature pDCs, we found that pDCs 
recognized and induced a response against A. fumigatus.  
 Detection of A. fumigatus conidia showed similar cytokine profiles for both 
resting and swollen conidia.  It is possible that cytokine secretion by pDCs was mediated 
by detection of hyphae rather than conidia, as we stimulated pDCs for 18 hours.  In 
addition, cytokine secretion by pDCs required A. fumigatus to be alive.  These findings 
correlate with the observed responses of immature pDCs stimulated with hyphae.  In the 
case of mature pDCs, during the maturation process these cells acquire characteristics 
that resemble cDCs (Sadaka et al. 2009).  It is possible that mature pDCs express surface 
receptors such as dectin-1 or TLR2 that allow for recognition of A. fumigatus.  However, 
whether there is a difference in the expression of surface receptors between mature and 
immature pDCs remains to be elucidated.       
Stimulation of cytokine secretion by A. fumigatus conidia occur independent of 
contact.  During conidial germination and hyphal growth, A. fumigatus secretes 
components of the cell wall such as melanin or galactomannan into the environment 
where it can have immunostimulatory activity.  Further experiments should concentrate 
on determining the nature of the immunostimulatory factor secreted by A. fumigatus.  
 
Future Directions: 
Multiple lines of research will need to be pursued in order to further understand 
the role of human pDCs and nucleic acid sensors during A. fumigatus infection. 
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 First, my research shows that A. fumigatus DNA can act as ligand for TLR9 and 
initiate a TLR9-dependent immune response.  However, upon treatment with restriction 
enzymes, our data show a decrease in the cytokine response rather than complete 
abrogation of the response.  One line of investigation should determine whether other 
nucleic acid receptors, such as DAI or RIG-I, detect and respond to A. fumigatus DNA 
and/or RNA.  One approach to accomplish this is to determine whether A. fumigatus 
DNA or RNA stimulates a cytokine response following transfection into the cytoplasm of 
BMDCs.  The responses of cells deficient in DAI, RIG-I or MDA-5 should be compared 
with those of WT cells.  If any of these receptors play a role in the detection of A. 
fumigatus nucleic acids, one would expect a decrease of the cytokine response in cells 
that lack DAI, RIG-I or MDA-5.  Since it is possible for TLR9 responses to overwhelm 
the system, another approach would include analyzing the response of mice deficient in 
TLR9 and each of the cytoplasmic nucleic acid receptors.  
A second line of investigation should determine whether the inflammasome plays 
a role in the detection of fungal DNA.  These molecular platforms or inflammasomes 
become activated upon cellular infection or stress.  Activation of the inflammasomes 
results in the maturation of proinflammatory cytokines such as IL-1β, engaging innate 
immune responses (Franchi et al. 2010; Schroder and Tschopp 2010).  Recent work has 
suggested that pathogenic DNA could induce a response mediated by the Nalp3, NLCR3 
and AIM2 inflammasomes (Malireddi et al. 2010; Rathinam et al. 2010; Warren et al. 
2010).  It would be interesting to test whether BMDC from mice deficient in Nalp3, 
Nlcr3 or AIM2 inflammasomes show a difference in IL-1β and IL-18in response to A. 
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fumigatus DNA.   Understanding the role of other nucleic acid receptors in the response 
to fungal DNA will provide further insights into the host response to fungal PAMPs. 
Another line of research arises from Chapter III.  The data show that addition of 
exogenous Zn++ partially restores A. fumigatus growth in the presence of pDCs; 
furthermore, we found by western blot that pDCs contain calprotectin.  However, the data 
presented in this thesis does not establish whether calprotectin is responsible for the 
fungistatic effect of pDCs.  One way to analyze whether calprotectin mediates the 
fungistatic activity would involve depleting calprotectin from pDC lysates by 
immunoprecipitation.  Following the depletion, A. fumigatus hyphae would be incubated 
with the lysates and the metabolic activity of the hyphae easured by XTT following the 
incubation.  Another way of analyzing whether calprotectin in pDCs is responsible for the 
observed antifungal effect would be by confocal microscopy.  Calprotectin has been 
shown to be part of NETs; however, whether pDCs produce NET-like structures has not 
been investigated.  One line could analyze whether pDCs generate NETs-like structures, 
and if pDCs undergo a NETosis-like mechanism.     
Our data show for the first time that pDCs recognize and induce an antifungal 
response against A. fumigatus.  However, we did not investigate which receptor is 
responsible for the observed response.  Previous investigators have shown that murine 
pDCs contain the mannan-binding receptor dectin-2, and that this receptor could induce a 
response against A. fumigatus (Barrett et al. 2009; Graham and Brown 2009).  While it is 
possible that dectin-2 is the receptor responsible for the observed antifungal response, 
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future work should concentrate on answering a few questions:  1) Do human pDCs 
express Dectin-2?; 2) If we block or inhibit expression of the receptor, is there a decrease 
in cytokine production and antifungal activity upon infection with A. fumigatus?; and 3) 
What signaling pathway or pathways is Dectin-2 activating following infection with A. 
fumigatus?  Even though the future work proposed in this paragraph concentrates on 
Dectin-2, it is possible for other C-type lectins such as MR, dectin-1 and DC-SIGN to be 
involved in the detection of A. fumigatus by pDCs.  Whether these receptors are present 
on human pDCs and whether they play a role in the detection of the mold should also be 
investigated. 
Multiple questions remain unanswered about the interactions between mature 
pDCs and A. fumigatus.  While we observed that pDCs secrete cytokines in response to 
live A. fumigatus, the project was abandoned.  In order to understand the interactions 
between mature pDCs and A. fumigatus, future work should determine whether mature 
pDCs play an antifungal role against the mold.  Assays similar to those performed in 
Chapter III, such as XTT and LDH, could be used to study the interaction.  In addition, 
our results show that A. fumigatus secrete a putative immunostimulatory factor.  We 
know that mature pDCs secrete cytokines in response to A. fumigatus independent of 
contact, and we found that during fungal growth the mold secretes carbohydrate and 
proteins into the environment; however, the specific fungal component or factor that is 
inducing a response in pDCs remains unidentified.  A. fumigatus releases a number of 
bioactive proteins, carbohydrates and lipids that could be immunostimulatory.  One way 
to determine the nature of the factor could be to treat fungal supernatants with proteases, 
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glycosidases or lipases.  Following treatment, supernatants could be used to stimulate 
mature pDCs and measure the cytokine response to the fungal supernatants.  Using the 
interaction of immature pDCs with A. fumigatus as groundwork, it is possible for A. 
fumigatus to secrete gliotoxin or other secondary metabolites that could induce a cytokine 
response of mature pDCs.  In our assay, we usually stimulate the pDCs with conidia 
which germinate into hyphae within the incubation period.  Furthermore, gliotoxin has 
been shown to be secreted during hyphal growth (Bok et al. 2005; Chiang et al. 2008).  
Future work should analyze whether A. fumigatus secrete gliotoxin when incubated with 
mature pDCs, and whether the observed cytokine response mediated by the mature pDCs 
is induced by the secondary metabolite. 
 The role of pDCs and IFNs during infections due to non-viral pathogens remains 
a fairly new area of investigation.  Over the past few years, multiple reports have 
evaluated the role of these cells during bacterial infection; however, the role of pDCs 
during fungal infections remains largely unexplored.  My work provides evidence that 
pDCs contribute to the antifungal responses to A. fumigatus; however, additional work is 
required in order to better understand the full role of pDCs during fungal infections. 
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Concluding Remarks:  Interactions between pDCs and A. fumigatus 
 The data presented in this dissertation suggest a putative role for pDCs in host 
defenses against A. fumigatus infection.  Although pDCs are capable of detecting “free” 
A. fumigatus DNA, during infection pDCs are most likely to encounter live fungi rather 
than naked DNA.  Not only are pDCs present at low concentrations in tissues, but human 
serum contains endonucleases that could digest any DNA released by the fungus.  
However, the possibility of A. fumigatus DNA reaching TLR9-rich compartments in 
pDCs cannot be completely eliminated.  A. fumigatus DNA has been found in the sera of 
patients with IA (Chamilos and Kontoyiannis 2006), and there is a possibility that the 
fungal DNA could be acting as a PAMP. Furthermore, it is possible that A. fumigatus 
DNA could be interacting with other DNA receptors such as DAI and the NOD-like 
receptors. Nonetheless, we found that pDCs are capable of secreting cytokines in 
response to A. fumigatus hyphae independent of TLR9 activation.  The data suggest a 
seemingly complex host-pathogen interaction. 
 The following model is proposed for the interactions between A. fumigatus and 
pDCs (Figure 5.1):  inhaled conidia in the alveoli that are not eliminated by alveolar 
macrophages, monocytes and neutrophils germinate into hyphae.  Professional 
phagocytes kill the hyphae via oxidative and non-oxidative mechanisms that may release 
fungal factors, such as DNA (alone or associated with fungal proteins/carbohydrates).  
These secreted or released factors could be taken up or phagocytosed by other phagocytes 
and antigen presenting cells such as pDCs.  In the case of fungal DNA, in the endosomes 
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of pDCs, it is capable of stimulating a proinflammatory response.  In addition, circulating 
pDCs in the blood are capable of recognizing A. fumigatus hyphae and establishing an 
antifungal response.  Although our results are from an in-vitro system, human pDCs 
spread over the hyphae and are capable of delaying fungal growth.  Following 
recognition of A. fumigatus, pDCs undergo cell death.  This results in the release of Zn2+ 
binding proteins such as calprotectin, which has been shown to inhibit fungal growth by 
mechanisms that involve nutritional deprivation of the essential metal.  While the 
mechanism of pDC cell death remains to be further analyzed, it appears to be mediated in 
part by fungal mycotoxins released during hyphal growth. As a result of incubation with 
A. fumigatus, pDCs are dying by an apoptosis or pyroptosis mediated mechanism.  In 
addition, pDCs secrete IFNα and TNFα in response to hyphae.  The fact that pDCs are 
capable of secreting cytokines while undergoing cell death suggest that they are dying by 
a pyroptosis-like mechanism. 
 The interactions between immune cells and A. fumigatus are of extreme 
importance, as these interactions are responsible for the outcome of the disease.  A 
deregulation between Th1 and Th2 responses will lead to protective or nonprotective 
responses, respectively.  While engagement of TLR9 during A. fumigatus may be 
detrimental to the host rather than the pathogen, we show a novel mechanism of A. 
fumigatus detection by TLR9-rich pDCs.  The mechanism of cytokine secretion by pDCs 
is independent of TLR9 activation.  While further experimentation is required in order to 
determine whether pDCs induce a protective or non-protective response in vivo, we show 
that pDCs mediate fungistatic activity against A. fumigatus in vitro.  Furthermore, upon 
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fungal stimulation, pDCs secrete cytokines which can recruit and activate other immune 
cells to come into the site of infection and eliminate the hyphae. 
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Figure 5.1.  Proposed model: Interactions between pDCs and A. fumigatus 
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